[
  {
    "id": 1281,
    "name": "ABACAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1243,
    "name": "ABALOPARATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05AA",
    "level4_name": "Parathyroid hormones and analogues",
    "ahfs_category": "68:24.08 - Parathyroid Agents - 317036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 249,
    "name": "ABAMETAPIR",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "P03AX",
    "level4_name": "Other ectoparasiticides, incl. scabicides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 328,
    "name": "ABARELIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BX",
    "level4_name": "Other hormone antagonists and related agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 329,
    "name": "ABEMACICLIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EF",
    "level4_name": "Cyclin-dependent kinase (CDK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317058",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 330,
    "name": "ABIRATERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BX",
    "level4_name": "Other hormone antagonists and related agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 311027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1141,
    "name": "ABROCITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 331,
    "name": "ACALABRUTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EL",
    "level4_name": "Bruton's tyrosine kinase (BTK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317059",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1447,
    "name": "ACAMPROSATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BB",
    "level4_name": "Drugs used in alcohol dependence",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 734,
    "name": "ACARBOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BF",
    "level4_name": "Alpha glucosidase inhibitors",
    "ahfs_category": "68:20.02 - alpha-Glucosidase Inhibitors - 396015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 954,
    "name": "ACEBUTOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 387003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1644,
    "name": "ACECLIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EB",
    "level4_name": "Parasympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 159,
    "name": "ACETAMINOPHEN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N02BE",
    "level4_name": "Anilides",
    "ahfs_category": "28:08.92 - Analgesics and Antipyretics, Miscellaneous -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1645,
    "name": "ACETAZOLAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EC",
    "level4_name": "Carbonic anhydrase inhibitors",
    "ahfs_category": "52:40.12 - Carbonic Anhydrase Inhibitors - 382756",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1196,
    "name": "ACETIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G01AD",
    "level4_name": "Organic acids",
    "ahfs_category": "40:36 - Irrigating Solutions - 308023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 735,
    "name": "ACETOHEXAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1197,
    "name": "ACETOHYDROXAMIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": "40:10 - Ammonia Detoxicants - 384050",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 617,
    "name": "ACETOPHENAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1743,
    "name": "ACETRIZOATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 1744,
    "name": "ACETYLCHOLINE CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EB",
    "level4_name": "Parasympathomimetics",
    "ahfs_category": "52:40.20 - Miotics - 382406",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1564,
    "name": "ACETYLCYSTEINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05CB",
    "level4_name": "Mucolytics",
    "ahfs_category": "92:12 - Antidotes - 382638",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1565,
    "name": "ACETYLCYSTEINE LYSINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05CB",
    "level4_name": "Mucolytics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 955,
    "name": "ACETYLDIGITOXIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01AA",
    "level4_name": "Digitalis glycosides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1142,
    "name": "ACITRETIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05BB",
    "level4_name": "Retinoids for treatment of psoriasis",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1566,
    "name": "ACLIDINIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 313022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1745,
    "name": "ACOLTREMON",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 956,
    "name": "ACORAMIDIS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1746,
    "name": "ACRISORCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 1567,
    "name": "ACRIVASTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 394040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 732,
    "name": "ACYCLOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 381045",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 332,
    "name": "ADAGRASIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1143,
    "name": "ADAPALENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AD",
    "level4_name": "Retinoids for topical use in acne",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1282,
    "name": "ADEFOVIR DIPIVOXIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 957,
    "name": "ADENOSINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": "24:04.04.24 - Class IV Antiarrhythmics - 304010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1144,
    "name": "AFAMELANOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D02BB",
    "level4_name": "Protectives against UV-radiation for systemic use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1747,
    "name": "AFATINIB DIMALEATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1748,
    "name": "AIR POLYMER-TYPE A",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 22, 2019 (Lumason) for ultrasound contrast"
  },
  {
    "id": 1283,
    "name": "ALATROFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 123,
    "name": "ALBENDAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P02CA",
    "level4_name": "Benzimidazole derivatives",
    "ahfs_category": "8:08 - Anthelmintics - 397043",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1749,
    "name": "ALBUMIN HUMAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "16:00 - Blood Derivatives - 382142",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Human albumin. Blood volume expander/plasma substitute. Mapped 2025-10-16."
  },
  {
    "id": 1568,
    "name": "ALBUTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1646,
    "name": "ALCAFTADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01GX",
    "level4_name": "Other antiallergics",
    "ahfs_category": "52:02 - Antiallergic Agents - 311014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1750,
    "name": "ALCLOMETASONE DIPROPIONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D07AB",
    "level4_name": "Corticosteroids, moderately potent (group II)",
    "ahfs_category": "84:06.08 - Corticosteroids - 387002",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 333,
    "name": "ALECTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01ED",
    "level4_name": "Anaplastic lymphoma kinase (ALK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1752,
    "name": "ALENDRONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 395025",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name (USAN): alendronate; WHO name (INN): alendronic acid. Bisphosphonate for osteoporosis. Mapped 2025-10-16."
  },
  {
    "id": 1448,
    "name": "ALFENTANIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AH",
    "level4_name": "Opioid anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1198,
    "name": "ALFUZOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "12:16.04.12 - Selective alpha-1-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1753,
    "name": "ALISKIREN HEMIFUMARATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09XA",
    "level4_name": "Renin-inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 252,
    "name": "ALITRETINOIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1395,
    "name": "ALLOPURINOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M04AA",
    "level4_name": "Preparations inhibiting uric acid production",
    "ahfs_category": "92:16 - Antigout Agents - 382673",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1755,
    "name": "ALMOTRIPTAN MALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 736,
    "name": "ALOGLIPTIN BENZOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BH",
    "level4_name": "Dipeptidyl peptidase 4 (DPP-4) inhibitors",
    "ahfs_category": "68:20.05 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 737,
    "name": "ALOSETRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AE",
    "level4_name": "Serotonin receptor antagonists",
    "ahfs_category": "56:36 - Anti-inflammatory Agents - 300011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 334,
    "name": "ALPELISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EM",
    "level4_name": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 197,
    "name": "ALPHA-TOCOPHEROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 583,
    "name": "ALPRAZOLAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 384001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 958,
    "name": "ALPROSTADIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EA",
    "level4_name": "Prostaglandins",
    "ahfs_category": "24:12.92 - Vasodilating Agents, Miscellaneous - 395022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1756,
    "name": "ALSEROXYLON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AA",
    "level4_name": "Rauwolfia alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 335,
    "name": "ALTRETAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 308015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 739,
    "name": "ALUMINUM HYDROXIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A02AB",
    "level4_name": "Aluminium compounds",
    "ahfs_category": "56:04 - Antacids and Adsorbents - 379007",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US spelling: aluminum hydroxide; WHO spelling: aluminium hydroxide. Antacid. Corrected 2025-10-16."
  },
  {
    "id": 740,
    "name": "ALVIMOPAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AH",
    "level4_name": "Peripheral opioid receptor antagonists",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 308028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1449,
    "name": "AMANTADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BB",
    "level4_name": "Adamantane derivatives",
    "ahfs_category": "8:18.04 - Adamantanes - 382064",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 893,
    "name": "AMBENONIUM CHLORIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05XA",
    "level4_name": "Electrolyte solutions",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 959,
    "name": "AMBRISENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KX",
    "level4_name": "Antihypertensives for pulmonary arterial hypertension",
    "ahfs_category": "48:48 - Vasodilating Agents - 307014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 229,
    "name": "AMCINONIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "84:06.08 - Corticosteroids - 382745",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 69,
    "name": "AMDINOCILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: amdinocillin; WHO/INN name: mecillinam. Different penicillin than ampicillin. Corrected 2025-10-16."
  },
  {
    "id": 1450,
    "name": "AMIFAMPRIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1676,
    "name": "AMIFOSTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AF",
    "level4_name": "Detoxifying agents for antineoplastic treatment",
    "ahfs_category": "92:56 - Protective Agents - 396014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 315,
    "name": "AMIKACIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "8:12.02 - Aminoglycosides - 382661",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 960,
    "name": "AMILORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03DB",
    "level4_name": "Other potassium-sparing agents",
    "ahfs_category": "40:28.16 - Potassium-sparing Diuretics - 381046",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 182,
    "name": "AMINO ACIDS",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B05BA",
    "level4_name": "Solutions for parenteral nutrition",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 894,
    "name": "AMINOCAPROIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02AA",
    "level4_name": "Amino acids",
    "ahfs_category": "20:28.16 - Hemostatics - 382093",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 336,
    "name": "AMINOGLUTETHIMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "L02BG",
    "level4_name": "Aromatase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1757,
    "name": "AMINOHIPPURATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CH",
    "level4_name": "Tests for renal function and ureteral injuries",
    "ahfs_category": "36:40 - Kidney Function - 382526",
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 337,
    "name": "AMINOLEVULINIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XD",
    "level4_name": "Sensitizers used in photodynamic/radiation therapy",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1569,
    "name": "AMINOPHYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DA",
    "level4_name": "Xanthines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1284,
    "name": "AMINOSALICYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AA",
    "level4_name": "Aminosalicylic acid and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Calcium aminosalicylate (salt form); WHO lists sodium aminosalicylate under same code"
  },
  {
    "id": 1285,
    "name": "AMINOSALICYLIC ACID",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J04AA",
    "level4_name": "Aminosalicylic acid and derivatives",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382146",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1758,
    "name": "AMINOSALICYLIC ACID RESIN COMPLEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01BC",
    "level4_name": "Antiinflammatory agents, non-steroids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 961,
    "name": "AMIODARONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BD",
    "level4_name": "Antiarrhythmics, class III",
    "ahfs_category": "24:04.04.20 - Class III Antiarrhythmics - 387009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 638,
    "name": "AMISULPRIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AL",
    "level4_name": "Benzamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 677,
    "name": "AMITRIPTYLINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 741,
    "name": "AMLEXANOX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AD",
    "level4_name": "Other agents for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 962,
    "name": "AMLODIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 392044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 963,
    "name": "AMLODIPINE BENZOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1677,
    "name": "AMMONIA N-13",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09GX",
    "level4_name": "Other cardiovascular system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1759,
    "name": "AMMONIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05XA",
    "level4_name": "Electrolyte solutions",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 895,
    "name": "AMMONIUM CHLORIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05XA",
    "level4_name": "Electrolyte solutions",
    "ahfs_category": "84:28 - Keratolytic Agents - 379010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 721,
    "name": "AMODIAQUINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 680,
    "name": "AMOXAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 70,
    "name": "AMOXICILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": "8:12.16.08 - Aminopenicillins - 385001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 595,
    "name": "AMPHETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.04 - Amphetamines - 382069",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1760,
    "name": "AMPHETAMINE ADIPATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Salt form of amphetamine (adipate); WHO lists as amphetamine"
  },
  {
    "id": 1761,
    "name": "AMPHETAMINE ASPARTATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Salt form of amphetamine (aspartate); WHO lists as amphetamine"
  },
  {
    "id": 1762,
    "name": "AMPHETAMINE RESIN COMPLEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Resin complex formulation of amphetamine; WHO lists as amphetamine"
  },
  {
    "id": 716,
    "name": "AMPHOTERICIN B",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:14.28 - Polyenes - 382643",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 274,
    "name": "AMPICILLIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": "8:12.16.08 - Aminopenicillins - 385002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 275,
    "name": "AMPICILLIN TRIHYDRATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1286,
    "name": "AMPRENAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 338,
    "name": "ANAGRELIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "20:12.14 - Platelet-reducing Agents - 308022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 339,
    "name": "ANASTROZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BG",
    "level4_name": "Aromatase inhibitors",
    "ahfs_category": "68:16.08 - Antiestrogens - 396018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 964,
    "name": "ANGIOTENSIN II",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01CX",
    "level4_name": "Other cardiac stimulants",
    "ahfs_category": "68:44 - Renin-Angiotensin-Aldosterone System",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 109,
    "name": "ANIDULAFUNGIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AX",
    "level4_name": "Other antimycotics for systemic use",
    "ahfs_category": "92:12 - Antidotes - 382759",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1451,
    "name": "ANILERIDINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N01AH",
    "level4_name": "Opioid anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1764,
    "name": "ANISINDIONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; anticoagulant no longer available in United States (Miradon brand discontinued 1982); replaced by safer anticoagulants"
  },
  {
    "id": 742,
    "name": "ANISOTROPINE METHYLBROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BB",
    "level4_name": "Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1570,
    "name": "ANTAZOLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01AC",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 340,
    "name": "APALUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 896,
    "name": "APIXABAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AF",
    "level4_name": "Direct factor Xa inhibitors",
    "ahfs_category": "20:12.04.14 - Direct Factor Xa Inhibitors - 313017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1199,
    "name": "APOMORPHINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "G04BE",
    "level4_name": "Drugs used in erectile dysfunction",
    "ahfs_category": "28:36.20.08 - Nonergot-derivative Dopamine Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1647,
    "name": "APRACLONIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EA",
    "level4_name": "Sympathomimetics in glaucoma therapy",
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 388017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 341,
    "name": "APREMILAST",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 743,
    "name": "APREPITANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 965,
    "name": "APROCITENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KN",
    "level4_name": "Other antihypertensives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 966,
    "name": "ARBUTAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1765,
    "name": "ARDEPARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Low molecular weight heparin. Would belong to B01AB (heparin group) if listed. Product discontinued; not in current WHO ATC database."
  },
  {
    "id": 1571,
    "name": "ARFORMOTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 897,
    "name": "ARGATROBAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AE",
    "level4_name": "Direct thrombin inhibitors",
    "ahfs_category": "20:12.04.12 - Direct Thrombin Inhibitors - 301006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 183,
    "name": "ARGININE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B05XB",
    "level4_name": "Amino acids",
    "ahfs_category": "36:66 - Pituitary Function - 382240",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1452,
    "name": "ARIMOCLOMOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 640,
    "name": "ARIPIPRAZOLE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 302040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 603,
    "name": "ARMODAFINIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.80 - Wakefulness-promoting Agents - 310018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 342,
    "name": "ARSENIC TRIOXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 301014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 722,
    "name": "ARTEMETHER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BE",
    "level4_name": "Artemisinin and derivatives, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 723,
    "name": "ARTESUNATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BE",
    "level4_name": "Artemisinin and derivatives, plain",
    "ahfs_category": "8:30.08 - Antimalarials - 379012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 243,
    "name": "ARTICAINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": "72:00 - Local Anesthetics - 301010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 343,
    "name": "ASCIMINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1200,
    "name": "ASCORBIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G01AD",
    "level4_name": "Organic acids",
    "ahfs_category": "88:12 - Vitamin C - 382583",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 636,
    "name": "ASENAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 310014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 160,
    "name": "ASPIRIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N02BE",
    "level4_name": "Anilides",
    "ahfs_category": "28:08.04.24 - Salicylates - 382878",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: aspirin; WHO name: acetylsalicylic acid. Primary code: B01AC06 (antiplatelet). Alternative codes: A01AD05 (stomatological), N02BA01 (analgesic/antipyretic). Corrected 2025-10-16."
  },
  {
    "id": 1287,
    "name": "ATAZANAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 303032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 967,
    "name": "ATENOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 384031",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1453,
    "name": "ATOGEPANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 600,
    "name": "ATOMOXETINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 968,
    "name": "ATORVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 300045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 111,
    "name": "ATOVAQUONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01AX",
    "level4_name": "Other agents against amoebiasis and other protozoal diseases",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 393003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1396,
    "name": "ATRACURIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 384052",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 969,
    "name": "ATRASENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09XX",
    "level4_name": "Other agents acting on the renin-angiotensin system",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 744,
    "name": "ATROPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BA",
    "level4_name": "Belladonna alkaloids, tertiary amines",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1397,
    "name": "AURANOFIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01CB",
    "level4_name": "Gold preparations",
    "ahfs_category": "60:00 - Gold Compounds - 385038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 255,
    "name": "AVACINCAPTAD PEGOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Automatically mapped via exact search on 2025-10-16"
  },
  {
    "id": 344,
    "name": "AVACOPAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1201,
    "name": "AVANAFIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BE",
    "level4_name": "Drugs used in erectile dysfunction",
    "ahfs_category": "24:12.12 - Phosphodiesterase Type 5 Inhibitors - 316042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 345,
    "name": "AVAPRITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 898,
    "name": "AVATROMBOPAG",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:16 - Hematopoietic Agents - 318017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1766,
    "name": "AVIBACTAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Beta-lactamase inhibitor used only in combination with antibiotics (e.g., ceftazidime). WHO code J01DD52 is ceftazidime and avibactam. Not used as standalone."
  },
  {
    "id": 1768,
    "name": "AVUTOMETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 8, 2025 (with defactinib) for KRAS-mutated recurrent low-grade serous ovarian cancer"
  },
  {
    "id": 346,
    "name": "AXITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EK",
    "level4_name": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 347,
    "name": "AZACITIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 304015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1572,
    "name": "AZATADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 348,
    "name": "AZATHIOPRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 382167",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1145,
    "name": "AZELAIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AX",
    "level4_name": "Other anti-acne preparations for topical use",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1573,
    "name": "AZELASTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AC",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": "52:02 - Antiallergic Agents - 397014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 970,
    "name": "AZILSARTAN KAMEDOXOMIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 102,
    "name": "AZITHROMYCIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01FA",
    "level4_name": "Macrolides",
    "ahfs_category": "8:12.12.92 - Other Macrolides - 397037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 72,
    "name": "AZLOCILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 100,
    "name": "AZTREONAM",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DF",
    "level4_name": "Monobactams",
    "ahfs_category": "8:12.07.16 - Monobactams - 387010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2152,
    "name": "Abatacept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2153,
    "name": "Abciximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 395014",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2154,
    "name": "Adalimumab; -adaz",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AB",
    "level4_name": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2300,
    "name": "Adenovirus Vaccine Live Oral",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 315016",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2155,
    "name": "Ado-Trastuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FD",
    "level4_name": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313041",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2237,
    "name": "Afatinib",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 314007",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2156,
    "name": "Aflibercept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 312025",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2089,
    "name": "Agalsidase Beta",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 303023",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2238,
    "name": "Alafenamide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 318025",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2239,
    "name": "Albiglutide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 314021",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2240,
    "name": "Aldesleukin",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AC",
    "level4_name": "Interleukins",
    "ahfs_category": "10:00 - Antineoplastic Agents - 392009",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2157,
    "name": "Alefacept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2158,
    "name": "Alemtuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "10:00 - Antineoplastic Agents - 301034",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2090,
    "name": "Alglucosidase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 310013",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2159,
    "name": "Alirocumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.24 - Proprotein Convertase Subtilisin Kexin Type",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2241,
    "name": "Allogeneic Cultured Keratinocytes and Fibroblasts",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "26:04 - Cellular Therapy - 379005",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2242,
    "name": "Alteplase",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AD",
    "level4_name": "Enzymes",
    "ahfs_category": "20:12.20 - Thrombolytic Agents - 389001",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2243,
    "name": "Amsacrine",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 379011",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2244,
    "name": "Anakinra",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2123,
    "name": "Anthrax Immune Globulin IV (Human)",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 317015",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2301,
    "name": "Anthrax Vaccine Adsorbed",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AC",
    "level4_name": "Anthrax vaccines",
    "ahfs_category": "80:12 - Vaccines - 301062",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2108,
    "name": "Antihemophilic Factor (Human)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 382075",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2109,
    "name": "Antihemophilic Factor (Recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 394027",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2110,
    "name": "Antihemophilic Factor (Recombinant), Fc fusion protein",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 316033",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2111,
    "name": "Antihemophilic Factor (Recombinant), GlycoPEGylated-",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XY",
    "level4_name": "Combinations of antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312023",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2112,
    "name": "Antihemophilic Factor (Recombinant), PEGylated-aucl",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 318041",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2113,
    "name": "Antihemophilic Factor (Recombinant), Porcine Sequence",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 316034",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2077,
    "name": "Antithrombin alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BC",
    "level4_name": "Local hemostatics",
    "ahfs_category": "20:12.04.92 - Anticoagulants, Miscellaneous - 309004",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2245,
    "name": "Antithymocyte Globulin (Equine)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 385025",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2246,
    "name": "Antithymocyte Globulin (Rabbit)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 301042",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2091,
    "name": "Asfotase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 316049",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2247,
    "name": "Asunaprevir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 379014",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2160,
    "name": "Atezolizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316021",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2248,
    "name": "Autologous Cultured Chondrocytes",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "26:04 - Cellular Therapy - 379015",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2161,
    "name": "Avelumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317023",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2249,
    "name": "Axicabtagene Ciloleucel",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XL",
    "level4_name": "Antineoplastic cell and gene therapy",
    "ahfs_category": "26:12 - Gene Therapy - 379016",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2250,
    "name": "Azficel-T",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "26:04 - Cellular Therapy - 379017",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 276,
    "name": "BACAMPICILLIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 218,
    "name": "BACITRACIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "8:12.28.08 - Bacitracins - 382292",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1398,
    "name": "BACLOFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BX",
    "level4_name": "Other centrally acting agents",
    "ahfs_category": "12:20.12 - GABA-derivative Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1288,
    "name": "BALOXAVIR MARBOXIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1769,
    "name": "BALSALAZIDE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EC",
    "level4_name": "Aminosalicylic acid and similar agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 349,
    "name": "BARICITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AF",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1770,
    "name": "BARIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08BA",
    "level4_name": "Barium sulfate containing X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1202,
    "name": "BAZEDOXIFENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03XC",
    "level4_name": "Selective estrogen receptor modulators",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 315045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2302,
    "name": "BCG Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "80:12 - Vaccines - 382809",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 1771,
    "name": "BECLOMETHASONE DIPROPIONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "52:08.08 - Corticosteroids - 381047",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US spelling: beclomethasone; WHO spelling: beclometasone. Salt form (dipropionate) removed. Corticosteroid. Primary code R03BA01 (respiratory); alternatives: D07AC15 (topical), A07EA07 (intestinal), R01AD01 (nasal). Mapped 2025-10-16."
  },
  {
    "id": 1289,
    "name": "BEDAQUILINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AK",
    "level4_name": "Other drugs for treatment of tuberculosis",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 313023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 350,
    "name": "BELINOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XH",
    "level4_name": "Histone deacetylase (HDAC) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 351,
    "name": "BELUMOSUDIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 352,
    "name": "BELZUTIFAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 971,
    "name": "BEMPEDOIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 972,
    "name": "BENAZEPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 353,
    "name": "BENDAMUSTINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 308024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 973,
    "name": "BENDROFLUMETHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": "40:28.20 - Thiazide Diuretics - 382573",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1454,
    "name": "BENOXINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02BA",
    "level4_name": "Salicylic acid and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: benoxinate; WHO/INN name: oxybuprocaine. Local anesthetic for ophthalmic use. Corrected 2025-10-16."
  },
  {
    "id": 1678,
    "name": "BENTIROMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V04CK",
    "level4_name": "Tests for pancreatic function",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1772,
    "name": "BENTOQUATAM",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Ivy Block (bentoquatam) approved August 26, 1996 for poison ivy/oak/sumac prevention; brand discontinued from market though generic formulations may exist"
  },
  {
    "id": 712,
    "name": "BENZGALANTAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1574,
    "name": "BENZHYDROCODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": "28:08.08 - Opiate Agonists - 379020",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 303,
    "name": "BENZNIDAZOLE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "P01CA",
    "level4_name": "Nitroimidazole derivatives",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 318001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1575,
    "name": "BENZONATATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R05DB",
    "level4_name": "Other cough suppressants",
    "ahfs_category": "48:08 - Antitussives - 382640",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1146,
    "name": "BENZOYL PEROXIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D10AE",
    "level4_name": "Peroxides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 651,
    "name": "BENZPHETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BD",
    "level4_name": "Dibenzo-bicyclo-octadiene derivatives",
    "ahfs_category": "28:20.04 - Amphetamines - 382070",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 637,
    "name": "BENZQUINAMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AL",
    "level4_name": "Benzamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1774,
    "name": "BENZTHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Thiazide diuretic; WHO category C03AA (thiazides, plain) but specific benzthiazide code not listed"
  },
  {
    "id": 1455,
    "name": "BENZTROPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04AC",
    "level4_name": "Ethers of tropine or tropine derivatives",
    "ahfs_category": "28:36.08 - Anticholinergic Agents - 382155",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 172,
    "name": "BENZYL ALCOHOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P03AX",
    "level4_name": "Other ectoparasiticides, incl. scabicides",
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 311001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 247,
    "name": "BENZYL BENZOATE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "P03AX",
    "level4_name": "Other ectoparasiticides, incl. scabicides",
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 382655",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1775,
    "name": "BEPOTASTINE BESILATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved September 8, 2009 (Bepreve) for allergic conjunctivitis"
  },
  {
    "id": 974,
    "name": "BEPRIDIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08EA",
    "level4_name": "Phenylalkylamine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1776,
    "name": "BERDAZIMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 30, 2024 (Zelsuvmi) for molluscum contagiosum"
  },
  {
    "id": 899,
    "name": "BEROTRALSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AC",
    "level4_name": "Drugs used in hereditary angioedema",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 251,
    "name": "BESIFLOXACIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "S01AE",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "52:04.04 - Antibacterials - 309022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 161,
    "name": "BETA CAROTENE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CA",
    "level4_name": "Vitamin A, plain",
    "ahfs_category": "88:04 - Vitamin A - 382615",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 745,
    "name": "BETAINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A09AB",
    "level4_name": "Acid preparations",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 746,
    "name": "BETAMETHASONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EA",
    "level4_name": "Corticosteroids acting locally",
    "ahfs_category": "68:04 - Adrenals - 382799",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 747,
    "name": "BETAMETHASONE BENZOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EA",
    "level4_name": "Corticosteroids acting locally",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 975,
    "name": "BETAXOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 393047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1679,
    "name": "BETAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CG",
    "level4_name": "Tests for gastric secretion",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1777,
    "name": "BETHANECHOL CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "PARASYMPATHOMIMETICS",
    "level4_name": "N07AB",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 976,
    "name": "BETHANIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02CC",
    "level4_name": "Guanidine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 900,
    "name": "BETRIXABAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AF",
    "level4_name": "Direct factor Xa inhibitors",
    "ahfs_category": "20:12.04.14 - Direct Factor Xa Inhibitors - 317044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 748,
    "name": "BEXAGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 354,
    "name": "BEXAROTENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XF",
    "level4_name": "Retinoids for cancer treatment",
    "ahfs_category": "10:00 - Antineoplastic Agents - 300029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 355,
    "name": "BICALUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 397047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1290,
    "name": "BICTEGRAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AJ",
    "level4_name": "Integrase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Bictegravir is an active component; WHO lists only as combination J05AR25 (bictegravir, emtricitabine and tenofovir alafenamide). Always used in fixed-dose combination. Corrected 2025-10-16."
  },
  {
    "id": 1648,
    "name": "BIMATOPROST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": "52:40.28 - Prostaglandin Analogs - 301015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 356,
    "name": "BINIMETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EE",
    "level4_name": "Mitogen-activated protein kinase (MEK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 167,
    "name": "BIOTIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11HA",
    "level4_name": "Other plain vitamin preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1456,
    "name": "BIPERIDEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04AA",
    "level4_name": "Tertiary amines",
    "ahfs_category": "28:36.08 - Anticholinergic Agents - 382164",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1778,
    "name": "BIRCH TRITERPENES",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved July 14, 2023 (Filsuvez) for epidermolysis bullosa wound healing"
  },
  {
    "id": 749,
    "name": "BISACODYL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A06AB",
    "level4_name": "Contact laxatives",
    "ahfs_category": "56:12 - Cathartics and Laxatives - 382604",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 156,
    "name": "BISMUTH SUBCITRATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A02BX",
    "level4_name": "Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 157,
    "name": "BISMUTH SUBSALICYLATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A02BX",
    "level4_name": "Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 977,
    "name": "BISOPROLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 393024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1576,
    "name": "BITOLTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 901,
    "name": "BIVALIRUDIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AE",
    "level4_name": "Direct thrombin inhibitors",
    "ahfs_category": "20:12.04.12 - Direct Thrombin Inhibitors - 301002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 357,
    "name": "BLEOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DC",
    "level4_name": "Other cytotoxic antibiotics",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382125",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1291,
    "name": "BOCEPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 358,
    "name": "BORTEZOMIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XG",
    "level4_name": "Proteasome inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 303026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 978,
    "name": "BOSENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KX",
    "level4_name": "Antihypertensives for pulmonary arterial hypertension",
    "ahfs_category": "48:48 - Vasodilating Agents - 301066",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 359,
    "name": "BOSUTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1203,
    "name": "BREMELANOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CX",
    "level4_name": "Other gynecologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1779,
    "name": "BRETYLIUM",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "ANTIARRHYTHMICS, CLASS I AND III",
    "level4_name": "C01BD",
    "ahfs_category": "24:04.04.20 - Class III Antiarrhythmics - 379024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 706,
    "name": "BREXANOLONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 644,
    "name": "BREXPIPRAZOLE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 316045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 360,
    "name": "BRIGATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01ED",
    "level4_name": "Anaplastic lymphoma kinase (ALK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1,
    "name": "BRILLIANT BLUE G",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 28, 2019 (MembraneBlue) for ophthalmology surgery"
  },
  {
    "id": 1147,
    "name": "BRIMONIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "52:40.04 - alpha-Adrenergic Agonists - 303015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1292,
    "name": "BRINCIDOFOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1649,
    "name": "BRINZOLAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EC",
    "level4_name": "Carbonic anhydrase inhibitors",
    "ahfs_category": "52:40.12 - Carbonic Anhydrase Inhibitors - 301037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1457,
    "name": "BRIVARACETAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 316044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1650,
    "name": "BROMFENAC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01BC",
    "level4_name": "Antiinflammatory agents, non-steroids",
    "ahfs_category": "52:08.20 - Nonsteroidal Anti-inflammatory Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1204,
    "name": "BROMOCRIPTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CB",
    "level4_name": "Prolactine inhibitors",
    "ahfs_category": "28:36.20.04 - Ergot-derivative Dopamine Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1148,
    "name": "BROMODIPHENHYDRAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1577,
    "name": "BROMPHENIRAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382545",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1578,
    "name": "BUCLIZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "R06AE",
    "level4_name": "Piperazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 750,
    "name": "BUDESONIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EA",
    "level4_name": "Corticosteroids acting locally",
    "ahfs_category": "52:08.08 - Corticosteroids - 303008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 979,
    "name": "BUMETANIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.08 - Loop Diuretics - 384051",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 318,
    "name": "BUPIVACAINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": "72:00 - Local Anesthetics - 382703",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 569,
    "name": "BUPRENORPHINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AE",
    "level4_name": "Oripavine derivatives",
    "ahfs_category": "28:08.12 - Opiate Partial Agonists - 387004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 697,
    "name": "BUPROPION",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.92 - Antidepressants, Miscellaneous - 395033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 652,
    "name": "BUSPIRONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BE",
    "level4_name": "Azaspirodecanedione derivatives",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 361,
    "name": "BUSULFAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AB",
    "level4_name": "Alkyl sulfonates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382248",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 654,
    "name": "BUTABARBITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CA",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": "28:24.04 - Barbiturates - 382417",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: butabarbital; WHO name: butobarbital. Barbiturate sedative-hypnotic. Corrected 2025-10-16."
  },
  {
    "id": 655,
    "name": "BUTALBITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CA",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": "28:24.04 - Barbiturates - 379025",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 216,
    "name": "BUTENAFINE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "84:04.08.12 - Benzylamines - 397019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1205,
    "name": "BUTOCONAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G01AF",
    "level4_name": "Imidazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 386012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 570,
    "name": "BUTORPHANOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AF",
    "level4_name": "Morphinan derivatives",
    "ahfs_category": "28:08.12 - Opiate Partial Agonists - 382667",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2162,
    "name": "Basiliximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 301050",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2163,
    "name": "Belatacept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 312008",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2164,
    "name": "Belimumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 311017",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2251,
    "name": "Belladonna",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BA",
    "level4_name": "Belladonna alkaloids, tertiary amines",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384021",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2165,
    "name": "Benralizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DX",
    "level4_name": "Other systemic drugs for obstructive airway diseases",
    "ahfs_category": "48:10.20 - Interleukin Antagonists - 317063",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2166,
    "name": "Bevacizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FG",
    "level4_name": "VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 304008",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2167,
    "name": "Bezlotoxumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J06BC",
    "level4_name": "Antibacterial monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 316082",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2252,
    "name": "Bictegravir, Emtracitabine, Tenofovir Alafenamide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.12 - HIV Integrase Inhibitors - 318011",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2168,
    "name": "Blinatumomab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316001",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2124,
    "name": "Botulism Antitoxin (Equine)",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 315015",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2125,
    "name": "Botulism Equine Trivalent Antitoxin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 379023",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2126,
    "name": "Botulism Immune Globulin IV",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 303046",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2169,
    "name": "Brentuximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312011",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2170,
    "name": "Brodalumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2171,
    "name": "Burosumab-twza",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": "40:92 - Electrolytic, Caloric, and Water Balance Agents;",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2253,
    "name": "C1-Esterase Inhibitor (Human)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "92:32 - Complement Inhibitors - 309014",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2078,
    "name": "C1-Esterase Inhibitor (Recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "92:32 - Complement Inhibitors - 315050",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 362,
    "name": "CABAZITAXEL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CD",
    "level4_name": "Taxanes",
    "ahfs_category": "10:00 - Antineoplastic Agents - 311007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1206,
    "name": "CABERGOLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CB",
    "level4_name": "Prolactine inhibitors",
    "ahfs_category": "28:36.20.04 - Ergot-derivative Dopamine Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1293,
    "name": "CABOTEGRAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AJ",
    "level4_name": "Integrase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1780,
    "name": "CABOZANTINIB S-MALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "PROTEIN KINASE INHIBITORS",
    "level4_name": "L01EX",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 189,
    "name": "CAFFEINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 165,
    "name": "CALCIFEDIOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CC",
    "level4_name": "Vitamin D and analogues",
    "ahfs_category": "88:16 - Vitamin D - 317005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1149,
    "name": "CALCIPOTRIENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AX",
    "level4_name": "Other antipsoriatics for topical use",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 153,
    "name": "CALCITONIN HUMAN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H05BA",
    "level4_name": "Calcitonin preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 151,
    "name": "CALCITONIN SALMON",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H05BA",
    "level4_name": "Calcitonin preparations",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Approximation: Mapped to WHO category code; specific substance code may not exist"
  },
  {
    "id": 152,
    "name": "CALCITONIN SALMON RECOMBINANT",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H05BA",
    "level4_name": "Calcitonin preparations",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Approximation: Mapped to WHO category code; specific substance code may not exist"
  },
  {
    "id": 163,
    "name": "CALCITRIOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CC",
    "level4_name": "Vitamin D and analogues",
    "ahfs_category": "88:16 - Vitamin D - 382335",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 751,
    "name": "CANAGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": "68:20.18 - Sodium-glucose Cotransporter 2 (SGLT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 980,
    "name": "CANDESARTAN CILEXETIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1207,
    "name": "CANDICIDIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G01AA",
    "level4_name": "Antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 902,
    "name": "CANGRELOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 315040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1458,
    "name": "CANNABIDIOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 318047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2,
    "name": "CANTHARIDIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved July 21, 2023 (Ycanth) for molluscum contagiosum"
  },
  {
    "id": 363,
    "name": "CAPECITABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 399003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 364,
    "name": "CAPIVASERTIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 365,
    "name": "CAPMATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1294,
    "name": "CAPREOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382147",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 240,
    "name": "CAPSAICIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "M02AB",
    "level4_name": "Capsaicin and similar agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 981,
    "name": "CAPTOPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1459,
    "name": "CARBACHOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07AB",
    "level4_name": "Choline esters",
    "ahfs_category": "52:40.20 - Miotics - 382404",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1460,
    "name": "CARBAMAZEPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AF",
    "level4_name": "Carboxamide derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 382237",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1781,
    "name": "CARBENICILLIN DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "level4_name": "J01CA",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1782,
    "name": "CARBENICILLIN INDANYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "level4_name": "J01CA",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 3,
    "name": "CARBIDOPA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Combination component; carbidopa is ONLY used in combination with levodopa (not as standalone); FDA-approved combinations include Sinemet, Rytary, Duopa, etc.; WHO ATC codes exist for carbidopa-levodopa combinations (N04BA02); active medication"
  },
  {
    "id": 1579,
    "name": "CARBINOXAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AA",
    "level4_name": "Aminoalkyl ethers",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382883",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 366,
    "name": "CARBOPLATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XA",
    "level4_name": "Platinum compounds",
    "ahfs_category": "10:00 - Antineoplastic Agents - 395017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1783,
    "name": "CARBOPROST TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02AD",
    "level4_name": "Prostaglandins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 367,
    "name": "CARFILZOMIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XG",
    "level4_name": "Proteasome inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 752,
    "name": "CARGLUMIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AA",
    "level4_name": "Amino acids and derivatives",
    "ahfs_category": "40:10 - Ammonia Detoxicants - 313016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 643,
    "name": "CARIPRAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 316046",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1399,
    "name": "CARISOPRODOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "M03BA",
    "level4_name": "Carbamic acid esters",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 368,
    "name": "CARMUSTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AD",
    "level4_name": "Nitrosoureas",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382060",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 612,
    "name": "CARPHENAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 982,
    "name": "CARTEOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 983,
    "name": "CARVEDILOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AG",
    "level4_name": "Alpha and beta blocking agents",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 397042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1400,
    "name": "CASIMERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 107,
    "name": "CASPOFUNGIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AX",
    "level4_name": "Other antimycotics for systemic use",
    "ahfs_category": "8:14.16 - Echinocandins - 301008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1785,
    "name": "CEDAZURIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Substance only exists in combination products in WHO database"
  },
  {
    "id": 89,
    "name": "CEFACLOR",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": "8:12.06.08 - Second Generation Cephalosporins -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 84,
    "name": "CEFADROXIL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": "8:12.06.04 - First Generation Cephalosporins - 382730",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1786,
    "name": "CEFAMANDOLE NAFATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 83,
    "name": "CEFAZOLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": "8:12.06.04 - First Generation Cephalosporins - 382731",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 290,
    "name": "CEFDINIR",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 398001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1787,
    "name": "CEFDITOREN PIVOXIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 291,
    "name": "CEFEPIME",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DE",
    "level4_name": "Fourth-generation cephalosporins",
    "ahfs_category": "8:12.06.16 - Fourth Generation Cephalosporins - 398021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 297,
    "name": "CEFIDEROCOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DI",
    "level4_name": "Other cephalosporins and penems",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 97,
    "name": "CEFIXIME",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 390007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 96,
    "name": "CEFMENOXIME",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 92,
    "name": "CEFMETAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 90,
    "name": "CEFONICID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 289,
    "name": "CEFOPERAZONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 286,
    "name": "CEFORANIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 94,
    "name": "CEFOTAXIME",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 382765",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1788,
    "name": "CEFOTETAN DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 91,
    "name": "CEFOTIAM",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 86,
    "name": "CEFOXITIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": "8:12.07.12 - Cephamycins - 382737",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 98,
    "name": "CEFPIRAMIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1789,
    "name": "CEFPODOXIME PROXETIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 93,
    "name": "CEFPROZIL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": "8:12.06.08 - Second Generation Cephalosporins -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 296,
    "name": "CEFTAROLINE FOSAMIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DI",
    "level4_name": "Other cephalosporins and penems",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 287,
    "name": "CEFTAZIDIME",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 386007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 99,
    "name": "CEFTIBUTEN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 398023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 288,
    "name": "CEFTIZOXIME",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 295,
    "name": "CEFTOBIPROLE MEDOCARIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DI",
    "level4_name": "Other cephalosporins and penems",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1790,
    "name": "CEFTOLOZANE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Ceftolozane active moiety. WHO lists only as combination J01DI54 (ceftolozane and tazobactam). Always used with beta-lactamase inhibitor. Mapped 2025-10-16."
  },
  {
    "id": 95,
    "name": "CEFTRIAXONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DD",
    "level4_name": "Third-generation cephalosporins",
    "ahfs_category": "8:12.06.12 - Third Generation Cephalosporins - 385032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 87,
    "name": "CEFUROXIME",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": "8:12.06.08 - Second Generation Cephalosporins -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 88,
    "name": "CEFUROXIME AXETIL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 369,
    "name": "CELECOXIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "28:08.04.08 - Cyclooxygenase-2 (COX-2) Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1461,
    "name": "CENOBAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 81,
    "name": "CEPHALEXIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": "8:12.06.04 - First Generation Cephalosporins - 382733",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1791,
    "name": "CEPHALOGLYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "First-generation cephalosporin; WHO category J01DB but specific code not listed (discontinued)"
  },
  {
    "id": 82,
    "name": "CEPHALOTHIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 85,
    "name": "CEPHAPIRIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 284,
    "name": "CEPHRADINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DB",
    "level4_name": "First-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 370,
    "name": "CERITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01ED",
    "level4_name": "Anaplastic lymphoma kinase (ALK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 314016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 984,
    "name": "CERIVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1792,
    "name": "CERULETIDE DIETHYLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 1580,
    "name": "CETIRIZINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AE",
    "level4_name": "Piperazine derivatives",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 398026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1244,
    "name": "CETRORELIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CC",
    "level4_name": "Anti-gonadotropin-releasing hormones",
    "ahfs_category": "68:18.04 - Antigonadotropins - 301029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1462,
    "name": "CEVIMELINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07AX",
    "level4_name": "Other parasympathomimetics",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1793,
    "name": "CHENODIOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "56:14 - Cholelitholytic Agents - 384039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match to WHO ATC substance"
  },
  {
    "id": 1245,
    "name": "CHLOPHEDIANOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Antitussive (cough suppressant); WHO category R05DA but specific code for chlophedianol may not exist"
  },
  {
    "id": 371,
    "name": "CHLORAMBUCIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382899",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 313,
    "name": "CHLORAMPHENICOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "8:12.08 - Chloramphenicol - 382216",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 578,
    "name": "CHLORDIAZEPOXIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 382078",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 753,
    "name": "CHLORHEXIDINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "52:04.92 - Anti-infectives, Miscellaneous - 302009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1795,
    "name": "CHLORMERODRIN HG-197",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; mercurial diuretic discontinued by FDA in 1989 due to mercury toxicity; replaced by safer diuretic classes"
  },
  {
    "id": 1401,
    "name": "CHLORMEZANONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BB",
    "level4_name": "Oxazol, thiazine, and triazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 317,
    "name": "CHLOROPROCAINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N01BA",
    "level4_name": "Esters of aminobenzoic acid",
    "ahfs_category": "72:00 - Local Anesthetics - 382699",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 113,
    "name": "CHLOROQUINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 382318",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 985,
    "name": "CHLOROTHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": "40:28.20 - Thiazide Diuretics - 382341",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 309,
    "name": "CHLOROTRIANISENE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 114,
    "name": "CHLOROXINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1796,
    "name": "CHLORPHENESIN CARBAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1581,
    "name": "CHLORPHENIRAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382543",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1582,
    "name": "CHLORPHENIRAMINE POLISTIREX",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1583,
    "name": "CHLORPHENTERMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Chlorphentermine is chlorinated analog of phentermine. Chlorphentermine not in WHO ATC database. Mapped to A08AA01 (phentermine) as closest structural analog. Anorectic agent. Corrected 2025-10-16."
  },
  {
    "id": 605,
    "name": "CHLORPROMAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AA",
    "level4_name": "Phenothiazines with aliphatic side-chain",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 754,
    "name": "CHLORPROPAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 382479",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 628,
    "name": "CHLORPROTHIXENE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AF",
    "level4_name": "Thioxanthene derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 755,
    "name": "CHLORTETRACYCLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 986,
    "name": "CHLORTHALIDONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03BA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.24 - Thiazide-like Diuretics - 382342",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1402,
    "name": "CHLORZOXAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BB",
    "level4_name": "Oxazol, thiazine, and triazine derivatives",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 164,
    "name": "CHOLECALCIFEROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CC",
    "level4_name": "Vitamin D and analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 190,
    "name": "CHOLESTYRAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C10AC",
    "level4_name": "Bile acid sequestrants",
    "ahfs_category": "24:06.04 - Bile Acid Sequestrants - 382672",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 756,
    "name": "CHOLIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A05AA",
    "level4_name": "Bile acids and derivatives",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 316058",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 4,
    "name": "CHOLINE C-11",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved 2012 for prostate cancer PET imaging"
  },
  {
    "id": 987,
    "name": "CHOLINE FENOFIBRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AB",
    "level4_name": "Fibrates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1797,
    "name": "CHROMATE CR-51",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 1798,
    "name": "CHROMIC CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V10AX",
    "level4_name": "Other antiinflammatory therapeutic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1799,
    "name": "CHROMIC P-32",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 1584,
    "name": "CICLESONIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AD",
    "level4_name": "Corticosteroids",
    "ahfs_category": "52:08.08 - Corticosteroids - 308032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 213,
    "name": "CICLOPIROX",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "84:04.08.20 - Hydroxypyridones - 384047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1295,
    "name": "CIDOFOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 396037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 988,
    "name": "CILASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Cilastatin is a dehydropeptidase inhibitor used only with imipenem. WHO code J01DH51 (imipenem and cilastatin). Corrected 2025-10-16."
  },
  {
    "id": 903,
    "name": "CILOSTAZOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 301045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 757,
    "name": "CIMETIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BA",
    "level4_name": "H2-receptor antagonists",
    "ahfs_category": "56:28.12 - Histamine H2-Antagonists - 382256",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1246,
    "name": "CINACALCET",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05BX",
    "level4_name": "Other anti-parathyroid agents",
    "ahfs_category": "68:24.04 - Antiparathyroid Agents - 304009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1296,
    "name": "CINOXACIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01MB",
    "level4_name": "Other quinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1297,
    "name": "CIPROFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "8:12.18 - Quinolones - 388016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 758,
    "name": "CISAPRIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03FA",
    "level4_name": "Propulsives",
    "ahfs_category": "56:32 - Prokinetic Agents - 394006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1403,
    "name": "CISATRACURIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 307021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 372,
    "name": "CISPLATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XA",
    "level4_name": "Platinum compounds",
    "ahfs_category": "10:00 - Antineoplastic Agents - 384036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 683,
    "name": "CITALOPRAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 759,
    "name": "CITRIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A09AB",
    "level4_name": "Acid preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 373,
    "name": "CLADRIBINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "20:28.16 - Hemostatics - 316037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 101,
    "name": "CLARITHROMYCIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01FA",
    "level4_name": "Macrolides",
    "ahfs_category": "8:12.12.92 - Other Macrolides - 392005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1150,
    "name": "CLASCOTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AX",
    "level4_name": "Other anti-acne preparations for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 198,
    "name": "CLAVULANATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Clavulanate (clavulanic acid) is beta-lactamase inhibitor. Most commonly in combination J01CR02 (amoxicillin and clavulanic acid). Not used as standalone antibiotic. Mapped 2025-10-16."
  },
  {
    "id": 1151,
    "name": "CLEMASTINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382542",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 989,
    "name": "CLEVIDIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 308026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1585,
    "name": "CLIDINIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384006",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1152,
    "name": "CLINDAMYCIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D10AF",
    "level4_name": "Antiinfectives for treatment of acne",
    "ahfs_category": "8:12.28.20 - Lincomycins - 382399",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 238,
    "name": "CLIOQUINOL",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D08AH",
    "level4_name": "Quinoline derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 581,
    "name": "CLOBAZAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:12.08 - Benzodiazepines - 313025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 234,
    "name": "CLOBETASOL",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AD",
    "level4_name": "Corticosteroids, very potent (group IV)",
    "ahfs_category": "84:06.08 - Corticosteroids - 386008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1800,
    "name": "CLOCORTOLONE PIVALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D07AB",
    "level4_name": "Corticosteroids, moderately potent (group II)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 374,
    "name": "CLOFARABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 305004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1298,
    "name": "CLOFAZIMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04BA",
    "level4_name": "Drugs for treatment of lepra",
    "ahfs_category": "8:16.92 - Antimycobacterials, Miscellaneous - 387012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 990,
    "name": "CLOFIBRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AB",
    "level4_name": "Fibrates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1208,
    "name": "CLOMIPHENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03GB",
    "level4_name": "Ovulation stimulants, synthetic",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 382704",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 674,
    "name": "CLOMIPRAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 576,
    "name": "CLONAZEPAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AE",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:12.08 - Benzodiazepines - 382279",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 991,
    "name": "CLONIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AC",
    "level4_name": "Imidazoline receptor agonists",
    "ahfs_category": "24:08.16 - Central alpha-Agonists - 382243",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1801,
    "name": "CLOPIDOGREL BISULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1802,
    "name": "CLORAZEPATE DIPOTASSIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "WHO lists as potassium clorazepate. Benzodiazepine anxiolytic. Mapped 2025-10-16."
  },
  {
    "id": 760,
    "name": "CLOTRIMAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": true,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "84:04.08.08 - Azoles - 382753",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 77,
    "name": "CLOXACILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 632,
    "name": "CLOZAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 391001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1680,
    "name": "COBICISTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AX",
    "level4_name": "Other therapeutic products",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 375,
    "name": "COBIMETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EE",
    "level4_name": "Mitogen-activated protein kinase (MEK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 322,
    "name": "COCAINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01BC",
    "level4_name": "Esters of benzoic acid",
    "ahfs_category": "52:16 - Local Anesthetics - 382372",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1586,
    "name": "CODEINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382065",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1587,
    "name": "CODEINE POLISTIREX",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1404,
    "name": "COLCHICINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M04AC",
    "level4_name": "Preparations with no effect on uric acid metabolism",
    "ahfs_category": "92:16 - Antigout Agents - 382711",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 992,
    "name": "COLESEVELAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AC",
    "level4_name": "Bile acid sequestrants",
    "ahfs_category": "24:06.04 - Bile Acid Sequestrants - 301041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 993,
    "name": "COLESTIPOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AC",
    "level4_name": "Bile acid sequestrants",
    "ahfs_category": "24:06.04 - Bile Acid Sequestrants - 382157",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1588,
    "name": "COLFOSCERIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AA",
    "level4_name": "Lung surfactants",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1803,
    "name": "COLISTIMETHATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "8:12.28.28 - Polymyxins - 382860",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 761,
    "name": "COLISTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 994,
    "name": "CONIVAPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03XA",
    "level4_name": "Vasopressin antagonists",
    "ahfs_category": "40:28.28 - Vasopressin Antagonists - 306025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 376,
    "name": "COPANLISIB DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EM",
    "level4_name": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1247,
    "name": "CORTICOTROPIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01AA",
    "level4_name": "ACTH",
    "ahfs_category": "68:28 - Pituitary - 382743",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1248,
    "name": "CORTISONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": "68:04 - Adrenals - 382800",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1804,
    "name": "COSYNTROPIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "36:04 - Adrenocortical Insufficiency - 382557",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name (USAN): cosyntropin; WHO name (INN): tetracosactide. Synthetic ACTH analog. Mapped 2025-10-16."
  },
  {
    "id": 1805,
    "name": "CRINECERFONT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved June 21, 2024 (Likarda) for congenital adrenal hyperplasia"
  },
  {
    "id": 1153,
    "name": "CRISABOROLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "84:06.92 - Anti-inflammatory Agents, Miscellaneous -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 377,
    "name": "CRIZOTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01ED",
    "level4_name": "Anaplastic lymphoma kinase (ALK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 762,
    "name": "CROFELEMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07XA",
    "level4_name": "Other antidiarrheals",
    "ahfs_category": "56:08 - Antidiarrhea Agents - 313045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 173,
    "name": "CROMOLYN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A07EB",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": "48:10.32 - Mast-cell Stabilizers - 382713",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1806,
    "name": "CROTAMITON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 382833",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1982 (Eurax) for scabies; some formulations discontinued but medication still available"
  },
  {
    "id": 1808,
    "name": "CU-64 DOTATATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved September 8, 2020 (Detectnet) for neuroendocrine tumors PET imaging - first Cu-64 radiopharmaceutical"
  },
  {
    "id": 239,
    "name": "CUPRIC CHLORIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D08AK",
    "level4_name": "Mercurial products",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Cupric chloride (copper(II) chloride) not in WHO ATC database. Trace element supplement. WHO lists only copper sulfate (V03AB20), copper oleinate (P03AX02), and copper usnate (G01AX15). Would belong to V03AB (trace elements) if listed. Corrected 2025-10-16."
  },
  {
    "id": 184,
    "name": "CYANOCOBALAMIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B03BA",
    "level4_name": "Vitamin B12 (cyanocobalamin and analogues)",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 904,
    "name": "CYANOCOBALAMIN CO-57",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B03BA",
    "level4_name": "Vitamin B12 (cyanocobalamin and analogues)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; Co-57 cyanocobalamin (Dicopac Kit) for vitamin B12 absorption testing (Schilling test); name variant between FDA and WHO nomenclature; largely obsolete but historically FDA-approved"
  },
  {
    "id": 905,
    "name": "CYANOCOBALAMIN CO-58",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B03BA",
    "level4_name": "Vitamin B12 (cyanocobalamin and analogues)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; Co-58 cyanocobalamin for vitamin B12 studies; name variant between FDA and WHO nomenclature; largely obsolete but historically FDA-approved"
  },
  {
    "id": 279,
    "name": "CYCLACILLIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1589,
    "name": "CYCLIZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AE",
    "level4_name": "Piperazine derivatives",
    "ahfs_category": "56:22.08 - Antihistamines - 379036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1405,
    "name": "CYCLOBENZAPRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BX",
    "level4_name": "Other centrally acting agents",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1651,
    "name": "CYCLOPENTOLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01FA",
    "level4_name": "Anticholinergics",
    "ahfs_category": "52:24 - Mydriatics - 382488",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 378,
    "name": "CYCLOPHOSPHAMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382080",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1299,
    "name": "CYCLOSERINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382148",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1300,
    "name": "CYCLOSPORINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "52:08.92 - Anti-inflammatory Agents, Miscellaneous -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 995,
    "name": "CYCLOTHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1809,
    "name": "CYCRIMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 1590,
    "name": "CYPROHEPTADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382541",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1810,
    "name": "CYSTEAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 314014",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: cysteamine; WHO name: mercaptamine. Primary code: A16AA04 (cystinosis treatment). Alternative code: S01XA21 (ophthalmic). Corrected 2025-10-16."
  },
  {
    "id": 379,
    "name": "CYTARABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382222",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2254,
    "name": "Cabozantinib",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313027",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2255,
    "name": "Calaspargase pegol-mknl",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 379026",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2172,
    "name": "Canakinumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2173,
    "name": "Caplacizumab-yhdp",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AX",
    "level4_name": "Other antithrombotic agents",
    "ahfs_category": "20:12.92 - Antithrombotic Agents, Miscellaneous -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2174,
    "name": "Cemiplimab-rwlc",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318048",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2092,
    "name": "Cerliponase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 317035",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2175,
    "name": "Certolizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AB",
    "level4_name": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2176,
    "name": "Cetuximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FE",
    "level4_name": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 304006",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2303,
    "name": "Cholera Vaccine Live Oral",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 317010",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2079,
    "name": "Choriogonadotropin Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03GA",
    "level4_name": "Gonadotropins",
    "ahfs_category": "68:18.08 - Gonadotropins - 301054",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2114,
    "name": "Coagulation Factor IX (Recombinant, Human)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BD",
    "level4_name": "Blood coagulation factors",
    "ahfs_category": "20:28.16 - Hemostatics - 316036",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2256,
    "name": "Coagulation Factor X Human",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BD",
    "level4_name": "Blood coagulation factors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382289",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2093,
    "name": "Collagenase Clostridium Histolyticum",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "M09AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 311015",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2257,
    "name": "Copanlisib",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EM",
    "level4_name": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317055",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2127,
    "name": "Cytomegalovirus Immune Globulin IV",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 397030",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 906,
    "name": "DABIGATRAN ETEXILATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AE",
    "level4_name": "Direct thrombin inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 380,
    "name": "DABRAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EC",
    "level4_name": "B-Raf serine-threonine kinase (BRAF) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 381,
    "name": "DACARBAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AX",
    "level4_name": "Other alkylating agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382750",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1301,
    "name": "DACLATASVIR DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 382,
    "name": "DACOMITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 383,
    "name": "DACTINOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DA",
    "level4_name": "Actinomycines",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382224",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1302,
    "name": "DALBAVANCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XA",
    "level4_name": "Glycopeptide antibacterials",
    "ahfs_category": "8:12.28.16 - Glycopeptides - 315008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1463,
    "name": "DALFAMPRIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1811,
    "name": "DALFOPRISTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01FG",
    "level4_name": "Streptogramins",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: quinupristin/dalfopristin"
  },
  {
    "id": 907,
    "name": "DALTEPARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AB",
    "level4_name": "Heparin group",
    "ahfs_category": "20:12.04.16 - Heparins - 396006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 908,
    "name": "DANAPAROID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AB",
    "level4_name": "Heparin group",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1209,
    "name": "DANAZOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03XA",
    "level4_name": "Antigonadotropins and similar agents",
    "ahfs_category": "68:08 - Androgens - 382599",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 384,
    "name": "DANICOPAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1406,
    "name": "DANTROLENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03CA",
    "level4_name": "Dantrolene and derivatives",
    "ahfs_category": "12:20.08 - Direct-acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 763,
    "name": "DAPAGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": "68:20.18 - Sodium-glucose Cotransporter 2 (SGLT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1652,
    "name": "DAPIPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EX",
    "level4_name": "Other antiglaucoma preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 909,
    "name": "DAPRODUSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1154,
    "name": "DAPSONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AX",
    "level4_name": "Other anti-acne preparations for topical use",
    "ahfs_category": "8:16.92 - Antimycobacterials, Miscellaneous - 382128",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1303,
    "name": "DAPTOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": "8:12.28.12 - Cyclic Lipopeptides - 303042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 665,
    "name": "DARIDOREXANT",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CJ",
    "level4_name": "Orexin receptor antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1210,
    "name": "DARIFENACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.04 - Antimuscarinics - 305008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 385,
    "name": "DAROLUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1304,
    "name": "DARUNAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 306015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1812,
    "name": "DARUNAVIR ETHANOLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1305,
    "name": "DASABUVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.16 - HCV Polymerase Inhibitors - 379037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 386,
    "name": "DASATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1249,
    "name": "DASIGLUCAGON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H04AA",
    "level4_name": "Glycogenolytic hormones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 387,
    "name": "DAUNORUBICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2258,
    "name": "DAUNOrubicin and Cytarabine",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317052",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 764,
    "name": "DECAMETHONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BB",
    "level4_name": "Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Decamethonium bromide not in WHO ATC database. Neuromuscular blocking agent (depolarizing type). Discontinued/obsolete; replaced by safer alternatives like succinylcholine. Would belong to M03AA (neuromuscular blocking agents) if listed. Corrected 2025-10-16."
  },
  {
    "id": 388,
    "name": "DECITABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1813,
    "name": "DEFACTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 8, 2025 (with avutometinib) for KRAS-mutated ovarian cancer - first FAK inhibitor"
  },
  {
    "id": 1681,
    "name": "DEFERASIROX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AC",
    "level4_name": "Iron chelating agents",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 307028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1682,
    "name": "DEFERIPRONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AC",
    "level4_name": "Iron chelating agents",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 312018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1683,
    "name": "DEFEROXAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AC",
    "level4_name": "Iron chelating agents",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 382254",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 910,
    "name": "DEFIBROTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AX",
    "level4_name": "Other antithrombotic agents",
    "ahfs_category": "20:12.92 - Antithrombotic Agents, Miscellaneous -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1250,
    "name": "DEFLAZACORT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": "68:04 - Adrenals - 317009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 389,
    "name": "DEGARELIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BX",
    "level4_name": "Other hormone antagonists and related agents",
    "ahfs_category": "68:18.04 - Antigonadotropins - 309017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 5,
    "name": "DELAFLOXACIN MEGLUMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Active medication; delafloxacin meglumine (Baxdela IV) FDA-approved June 2017 for bacterial infections; fluoroquinolone antibiotic; name variant due to meglumine salt form"
  },
  {
    "id": 1306,
    "name": "DELAVIRDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1155,
    "name": "DELGOCITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1814,
    "name": "DEMECARIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EB",
    "level4_name": "Parasympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 312,
    "name": "DEMECLOCYCLINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "D06AA",
    "level4_name": "Tetracycline and derivatives",
    "ahfs_category": "8:12.24 - Tetracyclines - 382103",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1156,
    "name": "DEOXYCHOLIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 996,
    "name": "DESERPIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AA",
    "level4_name": "Rauwolfia alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1464,
    "name": "DESFLURANE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": "28:04.16 - Inhalation Anesthetics - 379039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 671,
    "name": "DESIPRAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 997,
    "name": "DESLANOSIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01AA",
    "level4_name": "Digitalis glycosides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1591,
    "name": "DESLORATADINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 302004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1251,
    "name": "DESMOPRESSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01BA",
    "level4_name": "Vasopressin and analogues",
    "ahfs_category": "68:28 - Pituitary - 382876",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 132,
    "name": "DESOGESTREL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 226,
    "name": "DESONIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AB",
    "level4_name": "Corticosteroids, moderately potent (group II)",
    "ahfs_category": "84:06.08 - Corticosteroids - 382207",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 228,
    "name": "DESOXIMETASONE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "84:06.08 - Corticosteroids - 382208",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1252,
    "name": "DESOXYCORTICOSTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AA",
    "level4_name": "Mineralocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 702,
    "name": "DESVENLAFAXINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.16 - Selective Serotonin- and Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 390,
    "name": "DEUCRAVACITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AF",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1157,
    "name": "DEURUXOLITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1465,
    "name": "DEUTETRABENAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "28:56 - Vesicular Monoamine Transporter 2 (VMAT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1592,
    "name": "DEUTIVACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 765,
    "name": "DEXAMETHASONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": "52:08.08 - Corticosteroids - 382869",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1593,
    "name": "DEXBROMPHENIRAMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1594,
    "name": "DEXCHLORPHENIRAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 766,
    "name": "DEXLANSOPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 309012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 670,
    "name": "DEXMEDETOMIDINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CM",
    "level4_name": "Other hypnotics and sedatives",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 601,
    "name": "DEXMETHYLPHENIDATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.32 - Respiratory and CNS Stimulants - 301068",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 168,
    "name": "DEXPANTHENOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11HA",
    "level4_name": "Other plain vitamin preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1684,
    "name": "DEXRAZOXANE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AF",
    "level4_name": "Detoxifying agents for antineoplastic treatment",
    "ahfs_category": "92:56 - Protective Agents - 396004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1595,
    "name": "DEXTROAMPHETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": "28:20.04 - Amphetamines - 382041",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1596,
    "name": "DEXTROMETHORPHAN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": "48:08 - Antitussives - 382492",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1597,
    "name": "DEXTROMETHORPHAN POLISTIREX",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 911,
    "name": "DEXTROSE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B05CX",
    "level4_name": "Other irrigating solutions",
    "ahfs_category": "40:20 - Caloric Agents - 382624",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 998,
    "name": "DEXTROTHYROXINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 573,
    "name": "DEZOCINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AX",
    "level4_name": "Other opioids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 6,
    "name": "DIATRIZOATE MEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AA",
    "level4_name": "Watersoluble, nephrotropic, high osmolar X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 577,
    "name": "DIAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 382047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 999,
    "name": "DIAZOXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02DA",
    "level4_name": "Thiazide derivatives",
    "ahfs_category": "68:22.92 - Antihypoglycemic Agents, Miscellaneous -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1817,
    "name": "DIBUCAINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:08 - Antipruritics and Local Anesthetics - 382421",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: dibucaine; WHO/INN name: cinchocaine"
  },
  {
    "id": 1598,
    "name": "DICHLORPHENAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AB",
    "level4_name": "Substituted alkylamines",
    "ahfs_category": "92:26 - Carbonic Anhydrase Inhibitors - 316077",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1158,
    "name": "DICLOFENAC",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1818,
    "name": "DICLOFENAC EPOLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 76,
    "name": "DICLOXACILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": "8:12.16.12 - Penicillinase-resistant Penicillins - 385017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 912,
    "name": "DICUMAROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AA",
    "level4_name": "Vitamin K antagonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 767,
    "name": "DICYCLOMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AA",
    "level4_name": "Synthetic anticholinergics, esters with tertiary amino group",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384007",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1307,
    "name": "DIDANOSINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 142,
    "name": "DIENESTROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CB",
    "level4_name": "Synthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 148,
    "name": "DIENOGEST",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03DB",
    "level4_name": "Pregnadien derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 729,
    "name": "DIETHYLCARBAMAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02CB",
    "level4_name": "Piperazine and derivatives",
    "ahfs_category": "8:08 - Anthelmintics - 379044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1819,
    "name": "DIETHYLPROPION",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "28:20.08.04 - Amphetamine Derivatives - 382037",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name (USAN): diethylpropion; WHO name (INN): amfepramone. Appetite suppressant. Mapped 2025-10-16."
  },
  {
    "id": 143,
    "name": "DIETHYLSTILBESTROL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "G03CB",
    "level4_name": "Synthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1685,
    "name": "DIFELIKEFALIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AX",
    "level4_name": "Other therapeutic products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 768,
    "name": "DIFENOXIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A07DA",
    "level4_name": "Antipropulsives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1820,
    "name": "DIFLORASONE DIACETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1466,
    "name": "DIFLUNISAL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02BA",
    "level4_name": "Salicylic acid and derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 232,
    "name": "DIFLUPREDNATE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "52:08.08 - Corticosteroids - 308031",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1000,
    "name": "DIGITOXIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01AA",
    "level4_name": "Digitalis glycosides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1001,
    "name": "DIGOXIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01AA",
    "level4_name": "Digitalis glycosides",
    "ahfs_category": "24:04.08 - Cardiotonic Agents - 382301",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 565,
    "name": "DIHYDROCODEINE BITARTRATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AA",
    "level4_name": "Natural opium alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Bitartrate salt form; WHO maps to dihydrocodeine"
  },
  {
    "id": 1467,
    "name": "DIHYDROERGOTAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CA",
    "level4_name": "Ergot alkaloids",
    "ahfs_category": "12:16.04.04 - Non-selective alpha-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1002,
    "name": "DILTIAZEM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AE",
    "level4_name": "Muscle relaxants",
    "ahfs_category": "24:28.92 - Calcium-Channel Blocking Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1599,
    "name": "DIMENHYDRINATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AA",
    "level4_name": "Aminoalkyl ethers",
    "ahfs_category": "56:22.08 - Antihistamines - 382140",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1686,
    "name": "DIMERCAPROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 382859",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 391,
    "name": "DIMETHYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 313048",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1211,
    "name": "DIMETHYL SULFOXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": "40:36 - Irrigating Solutions - 379047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1821,
    "name": "DINOPROST TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02AD",
    "level4_name": "Prostaglandins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1212,
    "name": "DINOPROSTONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02AD",
    "level4_name": "Prostaglandins",
    "ahfs_category": "76:00 - Oxytocics - 382512",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1822,
    "name": "DIPHEMANIL METHYLSULFATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1159,
    "name": "DIPHENHYDRAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382539",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 769,
    "name": "DIPHENIDOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": "56:22.92 - Antiemetics, Miscellaneous - 382875",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 770,
    "name": "DIPHENOXYLATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "A07DA",
    "level4_name": "Antipropulsives",
    "ahfs_category": "56:08 - Antidiarrhea Agents - 382679",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1600,
    "name": "DIPHENYLPYRALINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AA",
    "level4_name": "Aminoalkyl ethers",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1653,
    "name": "DIPIVEFRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EA",
    "level4_name": "Sympathomimetics in glaucoma therapy",
    "ahfs_category": "52:24 - Mydriatics - 386005",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 913,
    "name": "DIPYRIDAMOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "24:12.92 - Vasodilating Agents, Miscellaneous - 382830",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 299,
    "name": "DIRITHROMYCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01FA",
    "level4_name": "Macrolides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 392,
    "name": "DIROXIMEL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1003,
    "name": "DISOPYRAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BA",
    "level4_name": "Antiarrhythmics, class Ia",
    "ahfs_category": "24:04.04.04 - Class Ia Antiarrhythmics - 382408",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1468,
    "name": "DISULFIRAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BB",
    "level4_name": "Drugs used in alcohol dependence",
    "ahfs_category": "92:04 - Alcohol Deterrents - 382602",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1823,
    "name": "DIVALPROEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Divalproex is the sodium salt of valproic acid. WHO code N03AG01 covers valproic acid and its salts. Anticonvulsant. Mapped 2025-10-16."
  },
  {
    "id": 1004,
    "name": "DOBUTAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.08.08 - Selective beta-1-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 393,
    "name": "DOCETAXEL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CD",
    "level4_name": "Taxanes",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 224,
    "name": "DOCOSANOL",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": "84:04.06 - Antivirals - 301056",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1005,
    "name": "DOFETILIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BD",
    "level4_name": "Antiarrhythmics, class III",
    "ahfs_category": "24:04.04.20 - Class III Antiarrhythmics - 300008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 771,
    "name": "DOLASETRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AA",
    "level4_name": "Serotonin (5HT3) antagonists",
    "ahfs_category": "56:22.20 - 5-HT3 Receptor Antagonists - 301001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1308,
    "name": "DOLUTEGRAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AJ",
    "level4_name": "Integrase inhibitors",
    "ahfs_category": "8:18.08.12 - HIV Integrase Inhibitors - 314004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 710,
    "name": "DONEPEZIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1006,
    "name": "DOPAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.08.08 - Selective beta-1-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1309,
    "name": "DORAVIRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 294,
    "name": "DORIPENEM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DH",
    "level4_name": "Carbapenems",
    "ahfs_category": "8:12.07.08 - Carbapenems - 308009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1654,
    "name": "DORZOLAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EC",
    "level4_name": "Carbonic anhydrase inhibitors",
    "ahfs_category": "52:40.12 - Carbonic Anhydrase Inhibitors - 397049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1407,
    "name": "DOXACURIUM CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1601,
    "name": "DOXAPRAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AB",
    "level4_name": "Respiratory stimulants",
    "ahfs_category": "28:20.32 - Respiratory and CNS Stimulants - 382189",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1007,
    "name": "DOXAZOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "24:20 - alpha-Adrenergic Blocking Agents - 393045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1160,
    "name": "DOXEPIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D04AX",
    "level4_name": "Other antipruritics",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1253,
    "name": "DOXERCALCIFEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05BX",
    "level4_name": "Other anti-parathyroid agents",
    "ahfs_category": "88:16 - Vitamin D - 399027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 394,
    "name": "DOXORUBICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382221",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 174,
    "name": "DOXYCYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:12.24 - Tetracyclines - 382063",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1602,
    "name": "DOXYLAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AA",
    "level4_name": "Aminoalkyl ethers",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382537",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 772,
    "name": "DROMOSTANOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 773,
    "name": "DRONABINOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": "56:22.92 - Antiemetics, Miscellaneous - 306021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1008,
    "name": "DRONEDARONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BD",
    "level4_name": "Antiarrhythmics, class III",
    "ahfs_category": "24:04.04.20 - Class III Antiarrhythmics - 309025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 623,
    "name": "DROPERIDOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AD",
    "level4_name": "Butyrophenone derivatives",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 133,
    "name": "DROSPIRENONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1009,
    "name": "DROXIDOPA",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.12 - alpha- and beta-Adrenergic Agonists - 315023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 701,
    "name": "DULOXETINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.16 - Selective Serotonin- and Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 281,
    "name": "DURLOBACTAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CG",
    "level4_name": "Beta-lactamase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1213,
    "name": "DUTASTERIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04CB",
    "level4_name": "Testosterone-5-alpha reductase inhibitors",
    "ahfs_category": "92:08 - 5-alpha-Reductase Inhibitors - 302002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 395,
    "name": "DUVELISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EM",
    "level4_name": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318052",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 244,
    "name": "DYCLONINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": true,
    "level4_code": "N01BX",
    "level4_name": "Other local anesthetics",
    "ahfs_category": "52:16 - Local Anesthetics - 382500",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 147,
    "name": "DYDROGESTERONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03DB",
    "level4_name": "Pregnadien derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1603,
    "name": "DYPHYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DA",
    "level4_name": "Xanthines",
    "ahfs_category": "48:12.12 - Xanthine Derivatives - 379048",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2259,
    "name": "Daclatasvir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.24 - HCV Replication Complex Inhibitors -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2177,
    "name": "Daclizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 316073",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2178,
    "name": "Daratumumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FC",
    "level4_name": "CD38 (Clusters of Differentiation 38) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316022",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2080,
    "name": "Darbepoetin Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": "20:16 - Hematopoietic Agents - 301064",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2260,
    "name": "Dasabuvir, Ombitasvir, Paritaprevir, and Ritonavir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.40.16 - HCV Polymerase Inhibitors - 315025",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2261,
    "name": "Denileukin",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 301049",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2179,
    "name": "Denosumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 310025",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2180,
    "name": "Dinutuximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316005",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2128,
    "name": "Diphtheria Antitoxin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06AA",
    "level4_name": "Immune sera",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 382808",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2262,
    "name": "Dolutegravir and Rilpivirine",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AR",
    "level4_name": "Antivirals for treatment of HIV infections, combinations",
    "ahfs_category": "8:18.08.12 - HIV Integrase Inhibitors - 317064",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2081,
    "name": "Dornase Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R05CB",
    "level4_name": "Mucolytics",
    "ahfs_category": "48:24 - Mucolytic Agents - 394002",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2263,
    "name": "Dulaglutide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 315021",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2181,
    "name": "Dupilumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2182,
    "name": "Durvalumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317032",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 1824,
    "name": "ECAMSULE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "UV filter/sunscreen agent. Would belong to D02B (sun protection) if listed. Classified as cosmetic ingredient rather than pharmaceutical in most jurisdictions."
  },
  {
    "id": 1655,
    "name": "ECHOTHIOPHATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EB",
    "level4_name": "Parasympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 203,
    "name": "ECONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 384049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1469,
    "name": "EDARAVONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1656,
    "name": "EDETATE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 914,
    "name": "EDOXABAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AF",
    "level4_name": "Direct factor Xa inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 774,
    "name": "EDROPHONIUM CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 1310,
    "name": "EFAVIRENZ",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 211,
    "name": "EFINACONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 314025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1161,
    "name": "EFLORNITHINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 396,
    "name": "ELACESTRANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BA",
    "level4_name": "Anti-estrogens",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 775,
    "name": "ELAFIBRANOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A05AX",
    "level4_name": "Other drugs for bile therapy",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1254,
    "name": "ELAGOLIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CC",
    "level4_name": "Anti-gonadotropin-releasing hormones",
    "ahfs_category": "68:18.04 - Antigonadotropins - 318027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1311,
    "name": "ELBASVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1470,
    "name": "ELETRIPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": "28:32.28 - Selective Serotonin Agonists - 303003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1825,
    "name": "ELEXACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: ivacaftor, tezacaftor and elexacaftor"
  },
  {
    "id": 776,
    "name": "ELIGLUSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1826,
    "name": "ELTROMBOPAG CHOLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match. Thrombopoietin receptor agonist for thrombocytopenia. Mapped 2025-10-16."
  },
  {
    "id": 1827,
    "name": "ELTROMBOPAG OLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 777,
    "name": "ELUXADOLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07DA",
    "level4_name": "Antipropulsives",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 316004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1312,
    "name": "ELVITEGRAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AJ",
    "level4_name": "Integrase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1828,
    "name": "EMEDASTINE DIFUMARATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01GX",
    "level4_name": "Other antiallergics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 778,
    "name": "EMPAGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": "68:20.18 - Sodium-glucose Cotransporter 2 (SGLT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1313,
    "name": "EMTRICITABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "28:12.12 - Hydantoins - 382328",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1010,
    "name": "ENALAPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1011,
    "name": "ENALAPRILAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 397,
    "name": "ENASIDENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XM",
    "level4_name": "Isocitrate dehydrogenase (IDH) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 398,
    "name": "ENCORAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EC",
    "level4_name": "B-Raf serine-threonine kinase (BRAF) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1471,
    "name": "ENFLURANE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": "28:04.16 - Inhalation Anesthetics - 379052",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1314,
    "name": "ENFUVIRTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": "8:18.08.04 - HIV Entry and Fusion Inhibitors - 303014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 282,
    "name": "ENMETAZOBACTAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01CG",
    "level4_name": "Beta-lactamase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1315,
    "name": "ENOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 915,
    "name": "ENOXAPARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AB",
    "level4_name": "Heparin group",
    "ahfs_category": "20:12.04.16 - Heparins - 393016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 399,
    "name": "ENSARTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1829,
    "name": "ENSIFENTRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved June 27, 2024 (Ohtuvayre) for COPD"
  },
  {
    "id": 1472,
    "name": "ENTACAPONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BX",
    "level4_name": "Other dopaminergic agents",
    "ahfs_category": "28:36.12 - Catechol-O-Methyltransferase (COMT)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1316,
    "name": "ENTECAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 305015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 400,
    "name": "ENTRECTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 401,
    "name": "ENZALUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1012,
    "name": "EPHEDRINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.12 - alpha- and beta-Adrenergic Agonists - 382253",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1604,
    "name": "EPINASTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "52:02 - Antiallergic Agents - 304003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 191,
    "name": "EPINEPHRINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AD",
    "level4_name": "Other agents for local oral treatment",
    "ahfs_category": "12:12.12 - alpha- and beta-Adrenergic Agonists - 382789",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 402,
    "name": "EPIRUBICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": "10:00 - Antineoplastic Agents - 399030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1013,
    "name": "EPLERENONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03DA",
    "level4_name": "Aldosterone antagonists",
    "ahfs_category": "24:32.20 - Mineralocorticoid (Aldosterone) Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1473,
    "name": "EPLONTERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 916,
    "name": "EPOPROSTENOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "48:48 - Vasodilating Agents - 304017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1014,
    "name": "EPROSARTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": "24:32.08 - Angiotensin II Receptor Antagonists - 302013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 917,
    "name": "EPTIFIBATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 399009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 273,
    "name": "ERAVACYCLINE DIHYDROCHLORIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01AA",
    "level4_name": "Tetracyclines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 403,
    "name": "ERDAFITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EN",
    "level4_name": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 162,
    "name": "ERGOCALCIFEROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CC",
    "level4_name": "Vitamin D and analogues",
    "ahfs_category": "88:16 - Vitamin D - 382333",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1015,
    "name": "ERGOLOID MESYLATES",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C04AE",
    "level4_name": "Ergot alkaloids",
    "ahfs_category": "12:16.04.04 - Non-selective alpha-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1474,
    "name": "ERGOTAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CA",
    "level4_name": "Ergot alkaloids",
    "ahfs_category": "12:16.04.04 - Non-selective alpha-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 404,
    "name": "ERIBULIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 311019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 405,
    "name": "ERLOTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 304028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 293,
    "name": "ERTAPENEM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DH",
    "level4_name": "Carbapenems",
    "ahfs_category": "8:12.07.08 - Carbapenems - 302001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 779,
    "name": "ERTUGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": "68:20.18 - Sodium-glucose Cotransporter 2 (SGLT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1162,
    "name": "ERYTHROMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AF",
    "level4_name": "Antiinfectives for treatment of acne",
    "ahfs_category": "8:12.12.04 - Erythromycins - 382392",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1163,
    "name": "ERYTHROMYCIN LACTOBIONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AF",
    "level4_name": "Antiinfectives for treatment of acne",
    "ahfs_category": "8:12.12.04 - Erythromycins - 382845",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 688,
    "name": "ESCITALOPRAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1475,
    "name": "ESKETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AX",
    "level4_name": "Other general anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1476,
    "name": "ESLICARBAZEPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AF",
    "level4_name": "Carboxamide derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 315005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1016,
    "name": "ESMOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 387013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 780,
    "name": "ESOMEPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 301031",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 586,
    "name": "ESTAZOLAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 391003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 140,
    "name": "ESTETROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Estetrol is estrogen component. WHO lists only in combination: G03AA18 (drospirenone and estetrol). Mapped to G03CA (estrogens) category. Corrected 2025-10-16."
  },
  {
    "id": 137,
    "name": "ESTRADIOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": "68:16.04 - Estrogens - 382453",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 138,
    "name": "ESTRADIOL CYPIONATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 139,
    "name": "ESTRADIOL HEMIHYDRATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 406,
    "name": "ESTRAMUSTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 302029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 135,
    "name": "ESTROGENS",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03C",
    "level4_name": "ESTROGENS",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 141,
    "name": "ESTRONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1830,
    "name": "ESTROPIPATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03CC",
    "level4_name": "Estrogens, combinations with other drugs",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 594,
    "name": "ESZOPICLONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CF",
    "level4_name": "Benzodiazepine related drugs",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1255,
    "name": "ETELCALCETIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05BX",
    "level4_name": "Other anti-parathyroid agents",
    "ahfs_category": "68:24.04 - Antiparathyroid Agents - 317026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1408,
    "name": "ETEPLIRSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": "92:18 - Antisense Oligonucleotides - 316080",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1831,
    "name": "ETHACRYNATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CC",
    "level4_name": "Aryloxyacetic acid derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1017,
    "name": "ETHACRYNIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CC",
    "level4_name": "Aryloxyacetic acid derivatives",
    "ahfs_category": "40:28.08 - Loop Diuretics - 382857",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1317,
    "name": "ETHAMBUTOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AK",
    "level4_name": "Other drugs for treatment of tuberculosis",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382550",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1018,
    "name": "ETHANOLAMINE OLEATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05BB",
    "level4_name": "Sclerosing agents for local injection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 669,
    "name": "ETHCHLORVYNOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05CM",
    "level4_name": "Other hypnotics and sedatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1832,
    "name": "ETHINAMATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 136,
    "name": "ETHINYL ESTRADIOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03CA",
    "level4_name": "Natural and semisynthetic estrogens, plain",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Ethinylestradiol as standalone agent not in WHO ATC database. WHO lists only in combinations (G03AA). Mapped to G03CA (estrogens) category. FDA lists as single agent. Corrected 2025-10-16."
  },
  {
    "id": 1318,
    "name": "ETHIONAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AD",
    "level4_name": "Thiocarbamide derivatives",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382544",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 618,
    "name": "ETHOPROPAZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1477,
    "name": "ETHOSUXIMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AD",
    "level4_name": "Succinimide derivatives",
    "ahfs_category": "28:12.20 - Succinimides - 382327",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1478,
    "name": "ETHOTOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AB",
    "level4_name": "Hydantoin derivatives",
    "ahfs_category": "10:00 - Antineoplastic Agents - 396019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1657,
    "name": "ETHOXZOLAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EC",
    "level4_name": "Carbonic anhydrase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 781,
    "name": "ETHYLESTRENOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A14AB",
    "level4_name": "Estren derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1833,
    "name": "ETHYNODIOL DIACETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US spelling: ethynodiol; WHO spelling: etynodiol. Ester form (diacetate) is prodrug. Progestin. Mapped 2025-10-16."
  },
  {
    "id": 319,
    "name": "ETIDOCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1834,
    "name": "ETIDRONATE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Salt form removed: etidronate disodium \u2192 etidronic acid. Bisphosphonate for osteoporosis. Mapped 2025-10-16."
  },
  {
    "id": 1409,
    "name": "ETODOLAC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AB",
    "level4_name": "Acetic acid derivatives and related substances",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1479,
    "name": "ETOMIDATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N01AX",
    "level4_name": "Other general anesthetics",
    "ahfs_category": "28:04.92 - General Anesthetics, Miscellaneous - 302038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 131,
    "name": "ETONOGESTREL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 407,
    "name": "ETOPOSIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CB",
    "level4_name": "Podophyllotoxin derivatives",
    "ahfs_category": "10:00 - Antineoplastic Agents - 384055",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1835,
    "name": "ETRASIMOD ARGININE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1319,
    "name": "ETRAVIRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1164,
    "name": "ETRETINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05BB",
    "level4_name": "Retinoids for treatment of psoriasis",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 408,
    "name": "EVEROLIMUS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EG",
    "level4_name": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 309008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 409,
    "name": "EXEMESTANE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BG",
    "level4_name": "Aromatase inhibitors",
    "ahfs_category": "68:16.08 - Antiestrogens - 399038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1836,
    "name": "EXENATIDE SYNTHETIC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1019,
    "name": "EZETIMIBE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.05 - Cholesterol Absorption Inhibitors - 302039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1837,
    "name": "EZOGABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: ezogabine; WHO name: retigabine"
  },
  {
    "id": 2264,
    "name": "Ecallantide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AC",
    "level4_name": "Drugs used in hereditary angioedema",
    "ahfs_category": "92:32 - Complement Inhibitors - 311006",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2183,
    "name": "Eculizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": "92:32 - Complement Inhibitors - 307019",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2094,
    "name": "Elapegademase-lvlr",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "44:00 - Enzymes - 318053",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2265,
    "name": "Elbasvir and Grazoprevir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.24 - HCV Replication Complex Inhibitors -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2095,
    "name": "Elosulfase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 316008",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2184,
    "name": "Elotuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316023",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2266,
    "name": "Eltrombopag",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:16 - Hematopoietic Agents - 309003",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2267,
    "name": "Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.12 - HIV Integrase Inhibitors - 313034",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2185,
    "name": "Emapalumab-lzsg",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 318062",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2186,
    "name": "Emicizumab-kxwh",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 317065",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2082,
    "name": "Epoetin Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": "20:04 - Antianemia Drugs - 392034",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2083,
    "name": "Epoetin Alfa; -epbx",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": "20:16 - Hematopoietic Agents - 392034",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2187,
    "name": "Erenumab-aooe",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": "28:32.12 - Calcitonin Gene-related Peptide (CGRP)",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2188,
    "name": "Etanercept, Etanercept-szzs",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AB",
    "level4_name": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2268,
    "name": "Etidronate",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 382581",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2189,
    "name": "Evolocumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.24 - Proprotein Convertase Subtilisin Kexin Type",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2269,
    "name": "Exenatide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 305021",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 1320,
    "name": "FAMCICLOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 394038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 175,
    "name": "FAMOTIDINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A02BA",
    "level4_name": "H2-receptor antagonists",
    "ahfs_category": "56:28.12 - Histamine H2-Antagonists - 387011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1410,
    "name": "FEBUXOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M04AA",
    "level4_name": "Preparations inhibiting uric acid production",
    "ahfs_category": "92:16 - Antigout Agents - 309010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 410,
    "name": "FEDRATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EJ",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1480,
    "name": "FELBAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 393027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1020,
    "name": "FELODIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 392016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 782,
    "name": "FENFLURAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A08AA",
    "level4_name": "Centrally acting antiobesity products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1021,
    "name": "FENOFIBRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AB",
    "level4_name": "Fibrates",
    "ahfs_category": "24:06.06 - Fibric Acid Derivatives - 301038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1839,
    "name": "FENOFIBRIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AB",
    "level4_name": "Fibrates",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1022,
    "name": "FENOLDOPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "24:08.20 - Direct Vasodilators - 308018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1411,
    "name": "FENOPROFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1481,
    "name": "FENTANYL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AH",
    "level4_name": "Opioid anesthetics",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382519",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1687,
    "name": "FERRIC AMMONIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1840,
    "name": "FERRIC CARBOXYMALTOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "20:04.04 - Iron Preparations - 315011",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved July 25, 2013 (Injectafer) for iron deficiency anemia"
  },
  {
    "id": 1838,
    "name": "FERRIC CITRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "40:18.19 - Phosphate-removing Agents - 315033",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1841,
    "name": "FERRIC DERISOMALTOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 15, 2020 (Monoferric) for iron deficiency anemia"
  },
  {
    "id": 1842,
    "name": "FERRIC HEXACYANOFERRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved October 2, 2003 (Radiogardase, Prussian blue) for cesium/thallium contamination; remains in national stockpile"
  },
  {
    "id": 918,
    "name": "FERRIC MALTOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03AB",
    "level4_name": "Iron trivalent, oral preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 919,
    "name": "FERRIC OXYHYDROXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03AB",
    "level4_name": "Iron trivalent, oral preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1843,
    "name": "FERRIC PYROPHOSPHATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "20:04.04 - Iron Preparations - 379058",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved February 4, 2015 (Triferic) for iron replacement in dialysis"
  },
  {
    "id": 1688,
    "name": "FERUMOXSIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CB",
    "level4_name": "Superparamagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1844,
    "name": "FERUMOXYTOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "20:04.04 - Iron Preparations - 309018",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved June 30, 2009 (Feraheme) for iron deficiency anemia"
  },
  {
    "id": 1214,
    "name": "FESOTERODINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.04 - Antimuscarinics - 309006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 304,
    "name": "FEXINIDAZOLE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "P01CA",
    "level4_name": "Nitroimidazole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1605,
    "name": "FEXOFENADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 397035",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1215,
    "name": "FEZOLINETANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CX",
    "level4_name": "Other gynecologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 783,
    "name": "FIDAXOMICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.12.92 - Other Macrolides - 311029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1321,
    "name": "FINAFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "52:04.04 - Antibacterials - 379059",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1166,
    "name": "FINASTERIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1023,
    "name": "FINERENONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03DA",
    "level4_name": "Aldosterone antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 411,
    "name": "FINGOLIMOD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 311004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1845,
    "name": "FINGOLIMOD LAURYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1846,
    "name": "FITUSIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "RNAi therapeutic for hemophilia. Would belong to B02 (antihemorrhagics) if listed. Approved 2023; not yet in WHO ATC database (database updates lag approvals)."
  },
  {
    "id": 1216,
    "name": "FLAVOXATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.04 - Antimuscarinics - 382706",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1024,
    "name": "FLECAINIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BC",
    "level4_name": "Antiarrhythmics, class Ic",
    "ahfs_category": "24:04.04.12 - Class Ic Antiarrhythmics - 386009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1217,
    "name": "FLIBANSERIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CX",
    "level4_name": "Other gynecologicals",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1689,
    "name": "FLORBETABEN F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1690,
    "name": "FLORBETAPIR F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1691,
    "name": "FLORTAUCIPIR F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 7,
    "name": "FLOTUFOLASTAT F-18 GALLIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved flotufolastat F-18 for prostate cancer PET imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 412,
    "name": "FLOXURIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1692,
    "name": "FLUCICLOVINE F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 169,
    "name": "FLUCONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 390002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 311,
    "name": "FLUCYTOSINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "8:14.32 - Pyrimidines - 382230",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 413,
    "name": "FLUDARABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 392003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 8,
    "name": "FLUDEOXYGLUCOSE F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved F-18 FDG for PET imaging of cancer/brain/heart; name variant between FDA and WHO nomenclature (FDG-PET); active diagnostic agent - most widely used PET tracer"
  },
  {
    "id": 1256,
    "name": "FLUDROCORTISONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AA",
    "level4_name": "Mineralocorticoids",
    "ahfs_category": "68:04 - Adrenals - 382549",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1693,
    "name": "FLUMAZENIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1847,
    "name": "FLUMETHASONE PIVALATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Locorten (flumethasone pivalate 0.03% cream) topical corticosteroid approved 1969; listed as \"US Previously Marketed\"; USP proposed omitting monograph as no longer marketed in US for human use; FDA approved veterinary generic (Bimasone) April 2023 for horses/dogs/cats; still available in some countries (Canada) as Locacorten-Vioform combination"
  },
  {
    "id": 1606,
    "name": "FLUNISOLIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AD",
    "level4_name": "Corticosteroids",
    "ahfs_category": "52:08.08 - Corticosteroids - 381048",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1025,
    "name": "FLUOCINOLONE ACETONIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AA",
    "level4_name": "Corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1026,
    "name": "FLUOCINONIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AA",
    "level4_name": "Corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1658,
    "name": "FLUORESCEIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01JA",
    "level4_name": "Colouring agents",
    "ahfs_category": "36:58 - Ocular Disorders - 379064",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 155,
    "name": "FLUORIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A12CD",
    "level4_name": "Fluoride",
    "ahfs_category": "92:28 - Cariostatic Agents - 382727",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1694,
    "name": "FLUORODOPA F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1695,
    "name": "FLUOROESTRADIOL F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1027,
    "name": "FLUOROMETHOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AA",
    "level4_name": "Corticosteroids",
    "ahfs_category": "52:08.08 - Corticosteroids - 382870",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 414,
    "name": "FLUOROURACIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 682,
    "name": "FLUOXETINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 555,
    "name": "FLUOXYMESTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": "68:08 - Androgens - 382690",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 609,
    "name": "FLUPHENAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382172",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 610,
    "name": "FLUPHENAZINE DECANOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 611,
    "name": "FLUPHENAZINE ENANTHATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 784,
    "name": "FLUPREDNISOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1848,
    "name": "FLURANDRENOLIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:06.08 - Corticosteroids - 382214",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved before 1982 (Cordran) topical corticosteroid; no therapeutically equivalent version currently available in US but medication class still used"
  },
  {
    "id": 585,
    "name": "FLURAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 382051",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1412,
    "name": "FLURBIPROFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1849,
    "name": "FLURPIRIDAZ F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved September 25, 2024 for cardiac PET imaging"
  },
  {
    "id": 415,
    "name": "FLUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 397045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1696,
    "name": "FLUTEMETAMOL F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 230,
    "name": "FLUTICASONE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "52:08.08 - Corticosteroids - 395002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1607,
    "name": "FLUTICASONE FUROATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AD",
    "level4_name": "Corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1028,
    "name": "FLUVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 394010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 687,
    "name": "FLUVOXAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 185,
    "name": "FOLIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B03BB",
    "level4_name": "Folic acid and derivatives",
    "ahfs_category": "88:08 - Vitamin B Complex - 382591",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1697,
    "name": "FOMEPIZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "92:12 - Antidotes - 398015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 324,
    "name": "FOMIVIRSEN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "S01AD",
    "level4_name": "Antivirals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 920,
    "name": "FONDAPARINUX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AX",
    "level4_name": "Other antithrombotic agents",
    "ahfs_category": "20:12.04.92 - Anticoagulants, Miscellaneous - 302012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1608,
    "name": "FORMOTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1322,
    "name": "FOSAMPRENAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 303044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 9,
    "name": "FOSAPREPITANT DIMEGLUMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Active medication; fosaprepitant dimeglumine (Emend IV) FDA-approved January 2008 for chemotherapy-induced nausea/vomiting; prodrug of aprepitant; name variant due to dimeglumine salt form"
  },
  {
    "id": 1850,
    "name": "FOSCARBIDOPA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved October 16, 2024 (Vyalev, with foslevodopa) for advanced Parkinson disease - first 24-hour subcutaneous infusion"
  },
  {
    "id": 1323,
    "name": "FOSCARNET",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AD",
    "level4_name": "Phosphonic acid derivatives",
    "ahfs_category": "8:18.92 - Antivirals, Miscellaneous - 392019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 785,
    "name": "FOSDENOPTERIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1851,
    "name": "FOSFOMYCIN TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1029,
    "name": "FOSINOPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match. ACE inhibitor for hypertension/heart failure. Mapped 2025-10-16."
  },
  {
    "id": 1482,
    "name": "FOSLEVODOPA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BA",
    "level4_name": "Dopa and dopa derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1852,
    "name": "FOSNETUPITANT CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved April 19, 2018 (Akynzeo IV) with palonosetron; IV formulation still marketed"
  },
  {
    "id": 1483,
    "name": "FOSPHENYTOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AB",
    "level4_name": "Hydantoin derivatives",
    "ahfs_category": "28:12.12 - Hydantoins - 301020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1853,
    "name": "FOSPROPOFOL DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N01AX",
    "level4_name": "Other general anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1854,
    "name": "FOSTAMATINIB DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1855,
    "name": "FOSTEMSAVIR TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1484,
    "name": "FROVATRIPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": "28:32.28 - Selective Serotonin Agonists - 301065",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 416,
    "name": "FRUQUINTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EK",
    "level4_name": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 417,
    "name": "FULVESTRANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BA",
    "level4_name": "Anti-estrogens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 302019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1218,
    "name": "FURAZOLIDONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G01AX",
    "level4_name": "Other antiinfectives and antiseptics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1030,
    "name": "FUROSEMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.08 - Loop Diuretics - 382858",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 418,
    "name": "FUTIBATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EN",
    "level4_name": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2115,
    "name": "Factor IX (Human), Factor IX Complex (Human)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 382076",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2116,
    "name": "Factor IX (Recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 307039",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2117,
    "name": "Factor IX (Recombinant), Fc fusion protein",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 317012",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2118,
    "name": "Factor IX (Recombinant), glycoPEGylated",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 379056",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2119,
    "name": "Factor VIIa (Recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 301055",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2120,
    "name": "Factor XIII",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BD",
    "level4_name": "Blood coagulation factors",
    "ahfs_category": "20:28.16 - Hemostatics - 313032",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2121,
    "name": "Factor XIII A-Subunit (Recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 317013",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2084,
    "name": "Factor Xa (recombinant), inactivated-zhzo",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:28.92 - Antihemorrhagic Agents, Miscellaneous -",
    "who_mapping_type": "DRUG_CLASS_PATTERN",
    "who_mapping_notes": "Approximated based on DRUG_CLASS_PATTERN"
  },
  {
    "id": 2270,
    "name": "Faldaprevir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 379057",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2271,
    "name": "Filgrastim; -sndz, Tbo-filgrastim",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "20:16 - Hematopoietic Agents - 392033",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2085,
    "name": "Florbetaben",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2190,
    "name": "Fremanezumab-vfrm",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": "28:32.12 - Calcitonin Gene-related Peptide (CGRP)",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 1485,
    "name": "GABAPENTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02BF",
    "level4_name": "Gabapentinoids",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 394007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1486,
    "name": "GABAPENTIN ENACARBIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02BF",
    "level4_name": "Gabapentinoids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 10,
    "name": "GADOBENATE DIMEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 11,
    "name": "GADOBUTROL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1698,
    "name": "GADODIAMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1856,
    "name": "GADOFOSVESET TRISODIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 12,
    "name": "GADOPENTETATE DIMEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1699,
    "name": "GADOPICLENOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 13,
    "name": "GADOTERATE MEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1700,
    "name": "GADOTERIDOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1701,
    "name": "GADOVERSETAMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 14,
    "name": "GADOXETATE DISODIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 713,
    "name": "GALANTAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1857,
    "name": "GALLAMINE TRIETHIODIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 15,
    "name": "GALLIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 392021",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; gallium citrate Ga-67 for infection/tumor imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 16,
    "name": "GALLIUM DOTATATE GA-68",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved Ga-68 dotatate for neuroendocrine tumor PET imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 17,
    "name": "GALLIUM GA-67",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved gallium citrate Ga-67 for infection/tumor imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 18,
    "name": "GALLIUM GA-68 EDOTREOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; Ga-68 edotreotide (SomaKit TOC) for neuroendocrine tumor PET imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 19,
    "name": "GALLIUM GA-68 GOZETOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09HX",
    "level4_name": "Other diagnostic radiopharmaceuticals for inflammation and infection detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved Ga-68 gozetotide (Locametz) for prostate cancer PET imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 1487,
    "name": "GANAXOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1324,
    "name": "GANCICLOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 389014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1257,
    "name": "GANIRELIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CC",
    "level4_name": "Anti-gonadotropin-releasing hormones",
    "ahfs_category": "68:18.04 - Antigonadotropins - 399024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1325,
    "name": "GATIFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "52:04.04 - Antibacterials - 303018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 419,
    "name": "GEFITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 303025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 420,
    "name": "GEMCITABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BC",
    "level4_name": "Pyrimidine analogues",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1031,
    "name": "GEMFIBROZIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AB",
    "level4_name": "Fibrates",
    "ahfs_category": "24:06.06 - Fibric Acid Derivatives - 386002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1326,
    "name": "GEMIFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "8:12.18 - Quinolones - 303019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 314,
    "name": "GENTAMICIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "8:12.02 - Aminoglycosides - 382664",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1858,
    "name": "GENTIAN VIOLET",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:04.08.92 - Antifungals, Miscellaneous - 382656",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 700,
    "name": "GEPIRONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1327,
    "name": "GEPOTIDACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 421,
    "name": "GILTERITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318066",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1413,
    "name": "GIVINOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 786,
    "name": "GIVOSIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 422,
    "name": "GLASDEGIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XJ",
    "level4_name": "Hedgehog pathway inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318065",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 423,
    "name": "GLATIRAMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 305047",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1860,
    "name": "GLECAPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 317051",
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Glecaprevir is HCV antiviral; WHO lists only as combination J05AP57 (glecaprevir and pibrentasvir). Corrected 2025-10-16."
  },
  {
    "id": 787,
    "name": "GLIMEPIRIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 396016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 788,
    "name": "GLIPIZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 384060",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1258,
    "name": "GLUCAGON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H04AA",
    "level4_name": "Glycogenolytic hormones",
    "ahfs_category": "68:22.12 - Glycogenolytic Agents - 382480",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1702,
    "name": "GLUTATHIONE DISULFIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 658,
    "name": "GLUTETHIMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05CE",
    "level4_name": "Piperidinedione derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 789,
    "name": "GLYBURIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 384058",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 790,
    "name": "GLYCERIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A06AG",
    "level4_name": "Enemas",
    "ahfs_category": "56:12 - Cathartics and Laxatives - 379072",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 791,
    "name": "GLYCEROL PHENYLBUTYRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "40:10 - Ammonia Detoxicants - 379073",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 921,
    "name": "GLYCEROPHOSPHATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05XA",
    "level4_name": "Electrolyte solutions",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 186,
    "name": "GLYCINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B05CX",
    "level4_name": "Other irrigating solutions",
    "ahfs_category": "40:36 - Irrigating Solutions - 379074",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1863,
    "name": "GLYCOPYRROLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384022",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1167,
    "name": "GLYCOPYRRONIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AA",
    "level4_name": "Antihidrotics",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1414,
    "name": "GOLODIRSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1259,
    "name": "GONADORELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CA",
    "level4_name": "Gonadotropin-releasing hormones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 424,
    "name": "GOSERELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02AE",
    "level4_name": "Gonadotropin releasing hormone analogues",
    "ahfs_category": "68:18.08 - Gonadotropins - 302008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1609,
    "name": "GRAMICIDIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R02AB",
    "level4_name": "Antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 792,
    "name": "GRANISETRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AA",
    "level4_name": "Serotonin (5HT3) antagonists",
    "ahfs_category": "56:22.20 - 5-HT3 Receptor Antagonists - 394011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1328,
    "name": "GRAZOPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1329,
    "name": "GREPAFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 202,
    "name": "GRISEOFULVIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:14.92 - Antifungals, Miscellaneous - 382295",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 192,
    "name": "GUAIFENESIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05CA",
    "level4_name": "Expectorants",
    "ahfs_category": "48:16 - Expectorants - 382494",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1032,
    "name": "GUANABENZ",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02CC",
    "level4_name": "Guanidine derivatives",
    "ahfs_category": "24:08.16 - Central alpha-Agonists - 386003",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1864,
    "name": "GUANADREL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Antihypertensive (guanidine derivative). Would belong to C02CC (antiadrenergic agents, peripherally acting) if listed. Product discontinued; not in current WHO ATC database."
  },
  {
    "id": 1865,
    "name": "GUANETHIDINE MONOSULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Salt form (monosulfate) included in name; WHO lists as guanethidine"
  },
  {
    "id": 1033,
    "name": "GUANFACINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AC",
    "level4_name": "Imidazoline receptor agonists",
    "ahfs_category": "24:08.16 - Central alpha-Agonists - 308013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1034,
    "name": "GUANIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02CC",
    "level4_name": "Guanidine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Guanidine hydrochloride used for Lambert-Eaton myasthenic syndrome. Not in WHO ATC database. Would belong to N07XX (other nervous system drugs) if listed. Corrected 2025-10-16."
  },
  {
    "id": 2191,
    "name": "Galcanezumab-gnlm",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": "28:32.12 - Calcitonin Gene-related Peptide (CGRP)",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2096,
    "name": "Galsulfase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 305039",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2192,
    "name": "Gemtuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 300030",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2272,
    "name": "Glecaprevir And Pibrentasvir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 317051",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2193,
    "name": "Golimumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AB",
    "level4_name": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2273,
    "name": "Gonadotropin, Chorionic",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03GA",
    "level4_name": "Gonadotropins",
    "ahfs_category": "68:18.08 - Gonadotropins - 382459",
    "who_mapping_type": "COMBINATION_PRIMARY_COMPONENT",
    "who_mapping_notes": "Approximated based on COMBINATION_PRIMARY_COMPONENT"
  },
  {
    "id": 2194,
    "name": "Guselkumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 584,
    "name": "HALAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 235,
    "name": "HALCINONIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AD",
    "level4_name": "Corticosteroids, very potent (group IV)",
    "ahfs_category": "84:06.08 - Corticosteroids - 382272",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 233,
    "name": "HALOBETASOL",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "84:06.08 - Corticosteroids - 379076",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 724,
    "name": "HALOFANTRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BX",
    "level4_name": "Other antimalarials",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 621,
    "name": "HALOPERIDOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AD",
    "level4_name": "Butyrophenone derivatives",
    "ahfs_category": "28:16.08.08 - Butyrophenones - 382180",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 622,
    "name": "HALOPERIDOL DECANOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AD",
    "level4_name": "Butyrophenone derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 310,
    "name": "HALOPROGIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1488,
    "name": "HALOTHANE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": "28:04.16 - Inhalation Anesthetics - 379077",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 922,
    "name": "HEPARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AB",
    "level4_name": "Heparin group",
    "ahfs_category": "20:12.04.16 - Heparins - 382826",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 278,
    "name": "HETACILLIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 236,
    "name": "HEXACHLOROPHENE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D08AE",
    "level4_name": "Phenol and derivatives",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1867,
    "name": "HEXAFLUORENIUM BROMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; neuromuscular blocking agent fell out of clinical use decades ago (1960s-1970s); no longer commercially available"
  },
  {
    "id": 1703,
    "name": "HEXAMINOLEVULINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": "36:40 - Kidney Function - 379080",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1868,
    "name": "HEXOCYCLIUM METHYLSULFATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1869,
    "name": "HEXYLCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 425,
    "name": "HISTAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "36:06 - Allergenic Extracts - 379081",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 528,
    "name": "HISTAMINE DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 426,
    "name": "HISTRELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02AE",
    "level4_name": "Gonadotropin releasing hormone analogues",
    "ahfs_category": "68:18.08 - Gonadotropins - 304025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 793,
    "name": "HOMATROPINE METHYLBROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BB",
    "level4_name": "Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1035,
    "name": "HYDRALAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02DB",
    "level4_name": "Hydrazinophthalazine derivatives",
    "ahfs_category": "24:08.20 - Direct Vasodilators - 382246",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1036,
    "name": "HYDROCHLOROTHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": "40:28.20 - Thiazide Diuretics - 382571",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 717,
    "name": "HYDROCODONE BITARTRATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 718,
    "name": "HYDROCODONE POLISTIREX",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "R05DA",
    "level4_name": "Opium alkaloids and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1870,
    "name": "HYDROCORTAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 794,
    "name": "HYDROCORTISONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": "52:08.08 - Corticosteroids - 382871",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 795,
    "name": "HYDROCORTISONE BUTYRATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 796,
    "name": "HYDROCORTISONE CYPIONATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 227,
    "name": "HYDROCORTISONE PROBUTATE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AB",
    "level4_name": "Corticosteroids, moderately potent (group II)",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1037,
    "name": "HYDROFLUMETHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 797,
    "name": "HYDROGEN PEROXIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "52:28 - Mouthwashes and Gargles - 382354",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 562,
    "name": "HYDROMORPHONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AA",
    "level4_name": "Natural opium alkaloids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1168,
    "name": "HYDROQUINONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "84:50.04 - Depigmenting Agents - 382379",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 923,
    "name": "HYDROXOCOBALAMIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B03BA",
    "level4_name": "Vitamin B12 (cyanocobalamin and analogues)",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1871,
    "name": "HYDROXYAMPHETAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Sympathomimetic used in ophthalmology; WHO category S01FB"
  },
  {
    "id": 115,
    "name": "HYDROXYCHLOROQUINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 382319",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 144,
    "name": "HYDROXYPROGESTERONE CAPROATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03DA",
    "level4_name": "Pregnen (4) derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1872,
    "name": "HYDROXYPROPYL CELLULOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 379083",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved (Lacrisert) for dry eye; sterile ophthalmic insert still marketed by Bausch & Lomb"
  },
  {
    "id": 1873,
    "name": "HYDROXYSTILBAMIDINE ISETHIONATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; antiprotozoal for blastomycosis and leishmaniasis; replaced by amphotericin B"
  },
  {
    "id": 427,
    "name": "HYDROXYUREA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382004",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 647,
    "name": "HYDROXYZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BB",
    "level4_name": "Diphenylmethane derivatives",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 648,
    "name": "HYDROXYZINE PAMOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BB",
    "level4_name": "Diphenylmethane derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2304,
    "name": "Haemophilus b Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AG",
    "level4_name": "Haemophilus influenzae B vaccines",
    "ahfs_category": "80:12 - Vaccines - 386010",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2274,
    "name": "Hematopoietic Progenitor Cells, Cord Blood",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "26:04 - Cellular Therapy - 379079",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2305,
    "name": "Hepatitis A Virus Vaccine Inactivated",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BC",
    "level4_name": "Hepatitis vaccines",
    "ahfs_category": "80:12 - Vaccines - 395003",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2129,
    "name": "Hepatitis B Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 381051",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2306,
    "name": "Hepatitis B Vaccine Recombinant",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BC",
    "level4_name": "Hepatitis vaccines",
    "ahfs_category": "80:12 - Vaccines - 381052",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2307,
    "name": "Human Papillomavirus Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BM",
    "level4_name": "Papillomavirus vaccines",
    "ahfs_category": "80:12 - Vaccines - 306016",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 1876,
    "name": "IBANDRONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BA",
    "level4_name": "Bisphosphonates",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 305018",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 301,
    "name": "IBREXAFUNGERP",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J02AX",
    "level4_name": "Other antimycotics for systemic use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 428,
    "name": "IBRUTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EL",
    "level4_name": "Bruton's tyrosine kinase (BTK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 158,
    "name": "IBUPROFEN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1038,
    "name": "IBUTILIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BD",
    "level4_name": "Antiarrhythmics, class III",
    "ahfs_category": "24:04.04.20 - Class III Antiarrhythmics - 396017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 924,
    "name": "ICATIBANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AC",
    "level4_name": "Drugs used in hereditary angioedema",
    "ahfs_category": "92:32 - Complement Inhibitors - 312007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1877,
    "name": "ICODEXTRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved December 20, 2002 (Extraneal) for peritoneal dialysis"
  },
  {
    "id": 1878,
    "name": "ICOSAPENT ETHYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.92 - Antilipemic Agents, Miscellaneous - 313008",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 429,
    "name": "IDARUBICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": "10:00 - Antineoplastic Agents - 303037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 430,
    "name": "IDELALISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EM",
    "level4_name": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 316,
    "name": "IDOXURIDINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 431,
    "name": "IFOSFAMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 395023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 642,
    "name": "ILOPERIDONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 310007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 925,
    "name": "ILOPROST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "48:48 - Vasodilating Agents - 305042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 432,
    "name": "IMATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 301024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 433,
    "name": "IMETELSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 715,
    "name": "IMIPENEM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Active moiety is imipenem; WHO lists only as combination with cilastatin (always used together)"
  },
  {
    "id": 672,
    "name": "IMIPRAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 673,
    "name": "IMIPRAMINE PAMOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 223,
    "name": "IMIQUIMOD",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": "68:20.08.16 - Long-acting Insulins - 306011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1039,
    "name": "INAMRINONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01CE",
    "level4_name": "Phosphodiesterase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1879,
    "name": "INAVOLISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved November 27, 2024 for PIK3CA-mutated breast cancer"
  },
  {
    "id": 1040,
    "name": "INCLISIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1610,
    "name": "INDACATEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1041,
    "name": "INDAPAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03BA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.24 - Thiazide-like Diuretics - 384062",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1042,
    "name": "INDECAINIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BC",
    "level4_name": "Antiarrhythmics, class Ic",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1330,
    "name": "INDINAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 396028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1881,
    "name": "INDIUM IN-111 CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1882,
    "name": "INDIUM IN-111 OXYQUINOLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1883,
    "name": "INDIUM IN-111 PENTETATE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AX",
    "level4_name": "Other central nervous system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1704,
    "name": "INDIUM IN-111 PENTETREOTIDE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IB",
    "level4_name": "Indium (111In) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1705,
    "name": "INDOCYANINE GREEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": "36:18 - Cardiac Function - 382740",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1043,
    "name": "INDOMETHACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 434,
    "name": "INFIGRATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EN",
    "level4_name": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1169,
    "name": "INGENOL MEBUTATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BX",
    "level4_name": "Other chemotherapeutics",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1489,
    "name": "INOTERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "92:18 - Antisense Oligonucleotides - 318055",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 187,
    "name": "INULIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "V04CH",
    "level4_name": "Tests for renal function and ureteral injuries",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1044,
    "name": "INVERT SUGAR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05BB",
    "level4_name": "Sclerosing agents for local injection",
    "ahfs_category": "40:20 - Caloric Agents - 382623",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1706,
    "name": "IOBENGUANE I-123",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1707,
    "name": "IOBENGUANE I-131",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318029",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1708,
    "name": "IOCETAMIC ACID",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AC",
    "level4_name": "Watersoluble, hepatotropic X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 20,
    "name": "IODAMIDE MEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AA",
    "level4_name": "Watersoluble, nephrotropic, high osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 21,
    "name": "IODIPAMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AC",
    "level4_name": "Watersoluble, hepatotropic X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Iodipamide not in WHO ATC database. Contrast agent for cholecystography/cholangiography. Discontinued due to safer alternatives. Would belong to V08AC (cholecystographic contrast media) if listed. Corrected 2025-10-16."
  },
  {
    "id": 22,
    "name": "IODIPAMIDE MEGLUMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AC",
    "level4_name": "Watersoluble, hepatotropic X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Iodipamide meglumine not in WHO ATC database. Salt form of iodipamide. Contrast agent for cholecystography. Discontinued. Would belong to V08AC if listed. Corrected 2025-10-16."
  },
  {
    "id": 1709,
    "name": "IODIXANOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1884,
    "name": "IODOHIPPURATE I-123",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; I-123 iodohippurate approved 1984 for renal imaging; discontinued from US market after introduction of Tc-99m MAG3; no longer commercially available"
  },
  {
    "id": 1885,
    "name": "IODOHIPPURATE I-131",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Hippuran I-131 (ortho-iodohippurate) was gold standard for renal imaging since 1960; discontinued after introduction of Tc-99m MAG3; no longer diagnostically used"
  },
  {
    "id": 23,
    "name": "IODOXAMATE MEGLUMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Endobil (meglumine iodoxamate) was intravenous cholecystographic (biliary) contrast agent developed in 1970s; distinct from but similar to iodipamide meglumine (Cholografin); both iodoxamate and iodipamide are discontinued; intravenous cholangiography obsolete due to ultrasound and safer imaging techniques"
  },
  {
    "id": 1886,
    "name": "IOFETAMINE I-123",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; radiopharmaceutical for brain SPECT imaging (Spectamine, approved 1987); discontinued in USA"
  },
  {
    "id": 1887,
    "name": "IOFLUPANE I-123",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 14, 2011 (DaTscan) for Parkinson imaging"
  },
  {
    "id": 24,
    "name": "IOHEXOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1710,
    "name": "IOMEPROL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 25,
    "name": "IOPAMIDOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 26,
    "name": "IOPANOIC ACID",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AC",
    "level4_name": "Watersoluble, hepatotropic X-ray contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1711,
    "name": "IOPHENDYLATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AD",
    "level4_name": "Non-watersoluble X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1712,
    "name": "IOPROMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1888,
    "name": "IOTHALAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09CX",
    "level4_name": "Other renal system diagnostic radiopharmaceuticals",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1889,
    "name": "IOTHALAMATE I-125",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved (Glofil-125) for glomerular filtration rate measurement; limited production (monthly batches) but still available"
  },
  {
    "id": 27,
    "name": "IOTHALAMATE MEGLUMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AA",
    "level4_name": "Watersoluble, nephrotropic, high osmolar X-ray contrast media",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 307015",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Iothalamate meglumine (non-radioactive contrast agent) not in WHO ATC database. WHO lists only radioactive form: V09CX03 sodium iothalamate (125I). Would belong to V08AA (iodinated X-ray contrast media) if listed. Corrected 2025-10-16."
  },
  {
    "id": 1713,
    "name": "IOTROLAN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1714,
    "name": "IOVERSOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1890,
    "name": "IOXAGLATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Ioxaglate not in WHO ATC database. Low-osmolality ionic contrast agent. Discontinued in most markets; replaced by non-ionic alternatives. Would belong to V08AB (iodinated X-ray contrast media) if listed. Corrected 2025-10-16."
  },
  {
    "id": 28,
    "name": "IOXAGLATE MEGLUMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Ioxaglate meglumine not in WHO ATC database. Salt form of ioxaglate. Discontinued contrast agent. Would belong to V08AB if listed. Corrected 2025-10-16."
  },
  {
    "id": 1715,
    "name": "IOXILAN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1611,
    "name": "IPRATROPIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AX",
    "level4_name": "Other nasal preparations",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 395021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 435,
    "name": "IPTACOPAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1045,
    "name": "IRBESARTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": "24:32.08 - Angiotensin II Receptor Antagonists - 398009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 436,
    "name": "IRINOTECAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CE",
    "level4_name": "Topoisomerase 1 (TOP1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 396034",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 719,
    "name": "ISAVUCONAZONIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J02AC",
    "level4_name": "Triazole and tetrazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 315031",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 689,
    "name": "ISOCARBOXAZID",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AF",
    "level4_name": "Monoamine oxidase inhibitors, non-selective",
    "ahfs_category": "28:16.04.12 - Monoamine Oxidase Inhibitors - 379093",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1612,
    "name": "ISOETHARINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1490,
    "name": "ISOFLURANE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1491,
    "name": "ISOFLUROPHATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1331,
    "name": "ISONIAZID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AC",
    "level4_name": "Hydrazides",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382401",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 798,
    "name": "ISOPROPAMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1892,
    "name": "ISOPROTERENOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.08.04 - Non-selective beta-Adrenergic Agonists -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1893,
    "name": "ISOSORBIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AE",
    "level4_name": "Muscle relaxants",
    "ahfs_category": "24:12.08 - Nitrates and Nitrites - 382348",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1046,
    "name": "ISOSORBIDE DINITRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01DA",
    "level4_name": "Organic nitrates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1047,
    "name": "ISOSORBIDE MONONITRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01DA",
    "level4_name": "Organic nitrates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1894,
    "name": "ISOSULFAN BLUE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "36:46 - Lymphatic System - 379094",
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Diagnostic dye; WHO category V04CZ (other diagnostic agents)"
  },
  {
    "id": 253,
    "name": "ISOTRETINOIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D10AD",
    "level4_name": "Retinoids for topical use in acne",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1048,
    "name": "ISRADIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 393048",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1492,
    "name": "ISTRADEFYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04CX",
    "level4_name": "Other antiparkinson drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 103,
    "name": "ITRACONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AC",
    "level4_name": "Triazole and tetrazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 392049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1049,
    "name": "IVABRADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": "24:04.92 - Cardiac Drugs, Miscellaneous - 316041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1613,
    "name": "IVACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": "48:14.12 - Cystic Fibrosis Transmembrane",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1170,
    "name": "IVERMECTIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "8:08 - Anthelmintics - 304023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 437,
    "name": "IVOSIDENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XM",
    "level4_name": "Isocitrate dehydrogenase (IDH) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 438,
    "name": "IXABEPILONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DC",
    "level4_name": "Other cytotoxic antibiotics",
    "ahfs_category": "10:00 - Antineoplastic Agents - 308027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 439,
    "name": "IXAZOMIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XG",
    "level4_name": "Proteasome inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2195,
    "name": "Ibalizumab-uiyk",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": "8:18.08.04 - HIV Entry and Fusion Inhibitors - 318012",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2196,
    "name": "Ibritumomab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V10XX",
    "level4_name": "Various therapeutic radiopharmaceuticals",
    "ahfs_category": "10:00 - Antineoplastic Agents - 302022",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2097,
    "name": "Idursulfase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 310011",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2098,
    "name": "Imiglucerase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 304024",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2130,
    "name": "Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 382815",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2308,
    "name": "Influenza Vaccine Live Intranasal",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AG",
    "level4_name": "Haemophilus influenzae B vaccines",
    "ahfs_category": "80:12 - Vaccines - 303031",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2309,
    "name": "Influenza Vaccine Recombinant",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AG",
    "level4_name": "Haemophilus influenzae B vaccines",
    "ahfs_category": "80:12 - Vaccines - 313010",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2310,
    "name": "Influenza Virus Vaccine Inactivated",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AG",
    "level4_name": "Haemophilus influenzae B vaccines",
    "ahfs_category": "80:12 - Vaccines - 395026",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2197,
    "name": "Inotuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FB",
    "level4_name": "CD22 (Clusters of Differentiation 22) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317054",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2137,
    "name": "Insulin Aspart",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AB",
    "level4_name": "Insulins and analogues for injection, fast-acting",
    "ahfs_category": "68:20.08.04 - Rapid-acting Insulins - 300048",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2138,
    "name": "Insulin Aspart Protamine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AB",
    "level4_name": "Insulins and analogues for injection, fast-acting",
    "ahfs_category": "68:20.08.12 - Intermediate-acting Insulins - 379085",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2139,
    "name": "Insulin Degludec",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AE",
    "level4_name": "Insulins and analogues for injection, long-acting",
    "ahfs_category": "68:20.08.16 - Long-acting Insulins - 316061",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2140,
    "name": "Insulin Glargine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AE",
    "level4_name": "Insulins and analogues for injection, long-acting",
    "ahfs_category": "68:20.08.16 - Long-acting Insulins - 300027",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2141,
    "name": "Insulin Glulisine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AB",
    "level4_name": "Insulins and analogues for injection, fast-acting",
    "ahfs_category": "68:20.08.04 - Rapid-acting Insulins - 306009",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2142,
    "name": "Insulin Human",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AF",
    "level4_name": "Insulins and analogues for inhalation",
    "ahfs_category": "68:20.08.08 - Short-acting Insulins - 384041",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2143,
    "name": "Insulin Human, Isophane",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AF",
    "level4_name": "Insulins and analogues for inhalation",
    "ahfs_category": "68:20.08.12 - Intermediate-acting Insulins - 384041",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2144,
    "name": "Insulin Lispro",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AB",
    "level4_name": "Insulins and analogues for injection, fast-acting",
    "ahfs_category": "68:20.08.04 - Rapid-acting Insulins - 397021",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2145,
    "name": "Insulin Lispro Protamine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AB",
    "level4_name": "Insulins and analogues for injection, fast-acting",
    "ahfs_category": "68:20.08.12 - Intermediate-acting Insulins - 379086",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2146,
    "name": "Insulin Zinc",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A10AF",
    "level4_name": "Insulins and analogues for inhalation",
    "ahfs_category": "68:20.08.12 - Intermediate-acting Insulins - 382612",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2147,
    "name": "Interferon Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "8:18.20 - Interferons - 301061",
    "who_mapping_type": "INTERFERON",
    "who_mapping_notes": null
  },
  {
    "id": 2148,
    "name": "Interferon Beta",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 393040",
    "who_mapping_type": "INTERFERON",
    "who_mapping_notes": null
  },
  {
    "id": 2149,
    "name": "Interferon Gamma",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AB",
    "level4_name": "Interferons",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 303020",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2198,
    "name": "Ipilimumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 311018",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2199,
    "name": "Ixekizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2311,
    "name": "Japanese Encephalitis Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 393014",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 799,
    "name": "KANAMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1493,
    "name": "KETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AX",
    "level4_name": "Other general anesthetics",
    "ahfs_category": "28:04.92 - General Anesthetics, Miscellaneous - 319005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 206,
    "name": "KETOCONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 382816",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1415,
    "name": "KETOPROFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1895,
    "name": "KETOROLAC TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AB",
    "level4_name": "Acetic acid derivatives and related substances",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1614,
    "name": "KETOTIFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "52:02 - Antiallergic Agents - 399018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1896,
    "name": "KRYPTON GAS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 176,
    "name": "L-GLUTAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AA",
    "level4_name": "Amino acids and derivatives",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1050,
    "name": "LABETALOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AG",
    "level4_name": "Alpha and beta blocking agents",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 385034",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1494,
    "name": "LACOSAMIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 310008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1219,
    "name": "LACTIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G01AD",
    "level4_name": "Organic acids",
    "ahfs_category": "84:24.04 - Basic Lotions and Liniments - 379096",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 800,
    "name": "LACTITOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AD",
    "level4_name": "Osmotically acting laxatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 801,
    "name": "LACTULOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AD",
    "level4_name": "Osmotically acting laxatives",
    "ahfs_category": "40:10 - Ammonia Detoxicants - 382338",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1332,
    "name": "LAMIVUDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1495,
    "name": "LAMOTRIGINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 395007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1051,
    "name": "LANDIOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1260,
    "name": "LANREOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CB",
    "level4_name": "Somatostatin and analogues",
    "ahfs_category": "68:29.04 - Somatostatin Agonists - 308003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 802,
    "name": "LANSOPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 395020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1716,
    "name": "LANTHANUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AE",
    "level4_name": "Drugs for treatment of hyperkalemia and hyperphosphatemia",
    "ahfs_category": "40:18.19 - Phosphate-removing Agents - 304026",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1898,
    "name": "LAPATINIB DITOSYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EH",
    "level4_name": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1717,
    "name": "LAPYRIUM CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Lapyrium chloride (laurolinium chloride) not in WHO ATC database. Antiseptic/disinfectant. Quaternary ammonium compound. Would belong to D08AJ (quaternary ammonium compounds) if listed. Corrected 2025-10-16."
  },
  {
    "id": 440,
    "name": "LAROTRECTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318064",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1496,
    "name": "LASMIDITAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1659,
    "name": "LATANOPROST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": "52:40.28 - Prostaglandin Analogs - 397003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1660,
    "name": "LATANOPROSTENE BUNOD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": "52:40.28 - Prostaglandin Analogs - 317061",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 441,
    "name": "LAZERTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1899,
    "name": "LEDIPASVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Ledipasvir is HCV antiviral; WHO lists only as combination J05AP51 (sofosbuvir and ledipasvir). Corrected 2025-10-16."
  },
  {
    "id": 1333,
    "name": "LEFAMULIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 442,
    "name": "LEFLUNOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AK",
    "level4_name": "Dihydroorotate dehydrogenase (DHODH) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 664,
    "name": "LEMBOREXANT",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CJ",
    "level4_name": "Orexin receptor antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1334,
    "name": "LENACAPAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 443,
    "name": "LENALIDOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 444,
    "name": "LENIOLISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 445,
    "name": "LENVATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1416,
    "name": "LESINURAD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M04AB",
    "level4_name": "Preparations increasing uric acid excretion",
    "ahfs_category": "40:40 - Uricosuric Agents - 316072",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1335,
    "name": "LETERMOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": "8:18.92 - Antivirals, Miscellaneous - 317062",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 446,
    "name": "LETROZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BG",
    "level4_name": "Aromatase inhibitors",
    "ahfs_category": "68:16.08 - Antiestrogens - 398004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1900,
    "name": "LEUCOVORIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": "92:12 - Antidotes - 382336",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1901,
    "name": "LEUPROLIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "68:18.08 - Gonadotropins - 385040",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name (USAN): leuprolide; WHO name (INN): leuprorelin. GnRH agonist for prostate cancer/endometriosis. Mapped 2025-10-16."
  },
  {
    "id": 1497,
    "name": "LEVACETYLLEUCINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07CA",
    "level4_name": "Antivertigo preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1615,
    "name": "LEVALBUTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1902,
    "name": "LEVALLORPHAN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; opioid antagonist (Lorfan) replaced by naloxone in clinical practice; no longer commonly used"
  },
  {
    "id": 730,
    "name": "LEVAMISOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02CE",
    "level4_name": "Imidazothiazole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1052,
    "name": "LEVAMLODIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1498,
    "name": "LEVETIRACETAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 300021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1053,
    "name": "LEVOBETAXOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1661,
    "name": "LEVOBUNOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01ED",
    "level4_name": "Beta blocking agents",
    "ahfs_category": "52:40.08 - beta-Adrenergic Blocking Agents - 386011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 321,
    "name": "LEVOBUPIVACAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1616,
    "name": "LEVOCABASTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AC",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 803,
    "name": "LEVOCARNITINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AA",
    "level4_name": "Amino acids and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1617,
    "name": "LEVOCETIRIZINE DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AE",
    "level4_name": "Piperazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1499,
    "name": "LEVODOPA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BA",
    "level4_name": "Dopa and dopa derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1336,
    "name": "LEVOFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "8:12.18 - Quinolones - 397040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1261,
    "name": "LEVOKETOCONAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02CA",
    "level4_name": "Anticorticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1903,
    "name": "LEVOLEUCOVORIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": "92:12 - Antidotes - 308025",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 606,
    "name": "LEVOMEPROMAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AA",
    "level4_name": "Phenothiazines with aliphatic side-chain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1500,
    "name": "LEVOMETHADYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BC",
    "level4_name": "Drugs used in opioid dependence",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 705,
    "name": "LEVOMILNACIPRAN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.16 - Selective Serotonin- and Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1905,
    "name": "LEVONORDEFRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1952 as vasoconstrictor in dental anesthetics; only available as 1:20,000 with 2% mepivacaine; still actively used"
  },
  {
    "id": 126,
    "name": "LEVONORGESTREL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": "68:12 - Contraceptives - 379097",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1906,
    "name": "LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; antitussive (Novrad) removed from market in 1970s; optical isomer of dextropropoxyphene"
  },
  {
    "id": 1907,
    "name": "LEVORPHANOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "28:08.08 - Opiate Agonists - 382020",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved opioid analgesic; still marketed but rarely used due to availability of alternatives"
  },
  {
    "id": 149,
    "name": "LEVOTHYROXINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H03AA",
    "level4_name": "Thyroid hormones",
    "ahfs_category": "68:36.04 - Thyroid Agents - 382461",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1054,
    "name": "LIDOCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": true,
    "level4_code": "C01BB",
    "level4_name": "Antiarrhythmics, class Ib",
    "ahfs_category": "24:04.04.08 - Class Ib Antiarrhythmics - 382234",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1662,
    "name": "LIFITEGRAST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": "52:08.92 - Anti-inflammatory Agents, Miscellaneous -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 804,
    "name": "LINACLOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 314006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 805,
    "name": "LINAGLIPTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BH",
    "level4_name": "Dipeptidyl peptidase 4 (DPP-4) inhibitors",
    "ahfs_category": "68:20.05 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1337,
    "name": "LINCOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01FF",
    "level4_name": "Lincosamides",
    "ahfs_category": "8:12.28.20 - Lincomycins - 382400",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 323,
    "name": "LINDANE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "P03AB",
    "level4_name": "Chlorine containing products",
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 382651",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1338,
    "name": "LINEZOLID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": "8:12.28.24 - Oxazolidinones - 300022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 150,
    "name": "LIOTHYRONINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H03AA",
    "level4_name": "Thyroid hormones",
    "ahfs_category": "68:36.04 - Thyroid Agents - 382462",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1908,
    "name": "LIOTRIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "68:36.04 - Thyroid Agents - 382463",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Thyroid hormone combination (levothyroxine + liothyronine in 4:1 ratio). Would belong to H03AA (thyroid preparations) if listed. Not in current WHO ATC database."
  },
  {
    "id": 806,
    "name": "LIRAGLUTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 311002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 602,
    "name": "LISDEXAMFETAMINE DIMESYLATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1055,
    "name": "LISINOPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1171,
    "name": "LITHIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "ANTIPSYCHOTICS",
    "level4_name": "N05AN",
    "ahfs_category": "28:28 - Antimanic Agents - 381039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1909,
    "name": "LODOXAMIDE TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01GX",
    "level4_name": "Other antiallergics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1501,
    "name": "LOFEXIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BC",
    "level4_name": "Drugs used in opioid dependence",
    "ahfs_category": "12:12.04 - alpha-Adrenergic Agonists - 318020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1339,
    "name": "LOMEFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1056,
    "name": "LOMITAPIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.92 - Antilipemic Agents, Miscellaneous - 314017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 447,
    "name": "LOMUSTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AD",
    "level4_name": "Nitrosoureas",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382297",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 807,
    "name": "LONAFARNIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 808,
    "name": "LOPERAMIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A07DA",
    "level4_name": "Antipropulsives",
    "ahfs_category": "56:08 - Antidiarrhea Agents - 382280",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1910,
    "name": "LOPINAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Lopinavir is active moiety; WHO lists only as combination J05AR10 (lopinavir and ritonavir). Always boosted with ritonavir. Corrected 2025-10-16."
  },
  {
    "id": 285,
    "name": "LORACARBEF",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01DC",
    "level4_name": "Second-generation cephalosporins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1618,
    "name": "LORATADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:08 - Second Generation Antihistamines - 397038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 580,
    "name": "LORAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 382053",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 448,
    "name": "LORLATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01ED",
    "level4_name": "Anaplastic lymphoma kinase (ALK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318060",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1057,
    "name": "LOSARTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": "24:32.08 - Angiotensin II Receptor Antagonists - 395008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1911,
    "name": "LOTEPREDNOL ETABONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01BA",
    "level4_name": "Corticosteroids, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1058,
    "name": "LOVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 388006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 631,
    "name": "LOXAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": "28:16.08.92 - Antipsychotics, Miscellaneous - 382311",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 809,
    "name": "LUBIPROSTONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 306008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1912,
    "name": "LUCINACTANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "48:36 - Pulmonary Surfactants - 379099",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved March 6, 2012 (Surfaxin) for neonatal respiratory distress syndrome"
  },
  {
    "id": 210,
    "name": "LULICONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 314024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1913,
    "name": "LUMACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: ivacaftor and lumacaftor"
  },
  {
    "id": 810,
    "name": "LUMASIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 624,
    "name": "LUMATEPERONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AD",
    "level4_name": "Butyrophenone derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1914,
    "name": "LUMEFANTRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BF",
    "level4_name": "Artemisinin and derivatives, combinations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 627,
    "name": "LURASIDONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AE",
    "level4_name": "Indole derivatives",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 311013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 449,
    "name": "LURBINECTEDIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 926,
    "name": "LUSUTROMBOPAG",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:16 - Hematopoietic Agents - 379100",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 29,
    "name": "LUTETIUM LU 177 DOTATATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "10:00 - Antineoplastic Agents - 318008",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 26, 2018 (Lutathera) for neuroendocrine tumors"
  },
  {
    "id": 30,
    "name": "LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved March 23, 2022 (Pluvicto) for metastatic prostate cancer"
  },
  {
    "id": 1262,
    "name": "LYPRESSIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "H01BA",
    "level4_name": "Vasopressin and analogues",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 2200,
    "name": "Lanadelumab-flyo",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AC",
    "level4_name": "Drugs used in hereditary angioedema",
    "ahfs_category": "92:32 - Complement Inhibitors - 318042",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2275,
    "name": "Lapatinib",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EH",
    "level4_name": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 307006",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2099,
    "name": "Laronidase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 303024",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2276,
    "name": "Ledipasvir and Sofosbuvir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.24 - HCV Replication Complex Inhibitors -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2277,
    "name": "Lixisenatide",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 316060",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2278,
    "name": "Lopinavir and Ritonavir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AR",
    "level4_name": "Antivirals for treatment of HIV infections, combinations",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 300043",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2086,
    "name": "Lutropin Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03GA",
    "level4_name": "Gonadotropins",
    "ahfs_category": "68:18.08 - Gonadotropins - 304027",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 1718,
    "name": "MACIMORELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CD",
    "level4_name": "Tests for pituitary function",
    "ahfs_category": "36:66 - Pituitary Function - 379101",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1059,
    "name": "MACITENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KX",
    "level4_name": "Antihypertensives for pulmonary arterial hypertension",
    "ahfs_category": "48:48 - Vasodilating Agents - 314009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1172,
    "name": "MAFENIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BA",
    "level4_name": "Sulfonamides",
    "ahfs_category": "84:04.92 - Local Anti-infectives, Miscellaneous - 382263",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 248,
    "name": "MALATHION",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "P03AX",
    "level4_name": "Other ectoparasiticides, incl. scabicides",
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 384040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1916,
    "name": "MANGAFODIPIR TRISODIUM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CA",
    "level4_name": "Paramagnetic contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 177,
    "name": "MANNITOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A06AD",
    "level4_name": "Osmotically acting laxatives",
    "ahfs_category": "36:40 - Kidney Function - 382646",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 681,
    "name": "MAPROTILINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 811,
    "name": "MARALIXIBAT CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A05AX",
    "level4_name": "Other drugs for bile therapy",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1340,
    "name": "MARAVIROC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": "8:18.08.04 - HIV Entry and Fusion Inhibitors - 307027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1341,
    "name": "MARIBAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 450,
    "name": "MASOPROCOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1060,
    "name": "MAVACAMTEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 451,
    "name": "MAVORIXAFOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 812,
    "name": "MAZINDOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A08AA",
    "level4_name": "Centrally acting antiobesity products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 122,
    "name": "MEBENDAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P02CA",
    "level4_name": "Benzimidazole derivatives",
    "ahfs_category": "8:08 - Anthelmintics - 382315",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 650,
    "name": "MEBUTAMATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BC",
    "level4_name": "Carbamates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1061,
    "name": "MECAMYLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02BB",
    "level4_name": "Secondary and tertiary amines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 452,
    "name": "MECHLORETHAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382223",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1619,
    "name": "MECLIZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AE",
    "level4_name": "Piperazine derivatives",
    "ahfs_category": "56:22.08 - Antihistamines - 382548",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1917,
    "name": "MECLOCYCLINE SULFOSALICYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 708,
    "name": "MECLOFENAMATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BX",
    "level4_name": "Other psychostimulants and nootropics",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 130,
    "name": "MEDROXYPROGESTERONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": "68:32 - Progestins - 382470",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1663,
    "name": "MEDRYSONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01BA",
    "level4_name": "Corticosteroids, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1417,
    "name": "MEFENAMIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AG",
    "level4_name": "Fenamates",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 119,
    "name": "MEFLOQUINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BC",
    "level4_name": "Methanolquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 397039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 129,
    "name": "MEGESTROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": "68:32 - Progestins - 382003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 32,
    "name": "MEGLUMINE METRIZOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AA",
    "level4_name": "Watersoluble, nephrotropic, high osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1418,
    "name": "MELOXICAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AC",
    "level4_name": "Oxicams",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 453,
    "name": "MELPHALAN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01AA",
    "level4_name": "Nitrogen mustard analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382220",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 714,
    "name": "MEMANTINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DX",
    "level4_name": "Other anti-dementia drugs",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1919,
    "name": "MENADIOL DIPHOSPHATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; vitamin K analog (Kappadione) discontinued in North America due to carcinogenic potential and hemolytic anemia risk"
  },
  {
    "id": 927,
    "name": "MENADIONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BA",
    "level4_name": "Vitamin K",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1920,
    "name": "MENTHOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Topical analgesic/cooling agent with multiple therapeutic uses. Could belong to M02 (topical products for joint/muscular pain), R05 (cough/cold), or other categories. Not listed as standalone in WHO ATC; typically used in combinations."
  },
  {
    "id": 1921,
    "name": "MEPENZOLATE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384012",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 566,
    "name": "MEPERIDINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AB",
    "level4_name": "Phenylpiperidine derivatives",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382117",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1062,
    "name": "MEPHENTERMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1502,
    "name": "MEPHENYTOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AB",
    "level4_name": "Hydantoin derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 241,
    "name": "MEPIVACAINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": "72:00 - Local Anesthetics - 382702",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1263,
    "name": "MEPREDNISONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 649,
    "name": "MEPROBAMATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BC",
    "level4_name": "Carbamates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1173,
    "name": "MEQUINOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 454,
    "name": "MERCAPTOPURINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382653",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 292,
    "name": "MEROPENEM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01DH",
    "level4_name": "Carbapenems",
    "ahfs_category": "8:12.07.08 - Carbapenems - 396038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1063,
    "name": "MERSALYL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C03BC",
    "level4_name": "Mercurial diuretics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 813,
    "name": "MESALAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EC",
    "level4_name": "Aminosalicylic acid and similar agents",
    "ahfs_category": "56:36 - Anti-inflammatory Agents - 388021",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1620,
    "name": "MESNA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R05CB",
    "level4_name": "Mucolytics",
    "ahfs_category": "92:56 - Protective Agents - 395034",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 620,
    "name": "MESORIDAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AC",
    "level4_name": "Phenothiazines with piperidine structure",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1064,
    "name": "MESTRANOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Mestranol is a synthetic estrogen; WHO lists under G03CA (estrogens); specific Level 5 code may not exist"
  },
  {
    "id": 1922,
    "name": "METAPROTERENOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AB",
    "level4_name": "Non-selective beta-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1923,
    "name": "METARAMINOL BITARTRATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 666,
    "name": "METAXALONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CM",
    "level4_name": "Other hypnotics and sedatives",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 814,
    "name": "METFORMIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BA",
    "level4_name": "Biguanides",
    "ahfs_category": "68:20.04 - Biguanides - 396005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1924,
    "name": "METHACHOLINE CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 66,
    "name": "METHACYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01AA",
    "level4_name": "Tetracyclines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1503,
    "name": "METHADONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N07BC",
    "level4_name": "Drugs used in opioid dependence",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382134",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 596,
    "name": "METHAMPHETAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.04 - Amphetamines - 382184",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1925,
    "name": "METHANTHELINE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1504,
    "name": "METHARBITAL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AA",
    "level4_name": "Barbiturates and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1664,
    "name": "METHAZOLAMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "S01EC",
    "level4_name": "Carbonic anhydrase inhibitors",
    "ahfs_category": "52:40.12 - Carbonic Anhydrase Inhibitors - 382754",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1621,
    "name": "METHDILAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AD",
    "level4_name": "Phenothiazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1926,
    "name": "METHENAMINE HIPPURATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 280,
    "name": "METHICILLIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1264,
    "name": "METHIMAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H03BB",
    "level4_name": "Sulfur-containing imidazole derivatives",
    "ahfs_category": "68:36.08 - Antithyroid Agents - 382464",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1505,
    "name": "METHIXENE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N04AA",
    "level4_name": "Tertiary amines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Methixene is synonym for pimethixene. WHO name: pimethixene. Antihistamine/anticholinergic. Corrected 2025-10-16."
  },
  {
    "id": 1419,
    "name": "METHOCARBAMOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BA",
    "level4_name": "Carbamic acid esters",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1506,
    "name": "METHOHEXITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AF",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": "28:04.04 - Barbiturates - 382092",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 455,
    "name": "METHOTREXATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BA",
    "level4_name": "Folic acid analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1065,
    "name": "METHOXAMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1174,
    "name": "METHOXSALEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AD",
    "level4_name": "Psoralens for topical use",
    "ahfs_category": "84:50.06 - Pigmenting Agents - 382384",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1927,
    "name": "METHSCOPOLAMINE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01FA",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384014",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1507,
    "name": "METHSUXIMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N03AD",
    "level4_name": "Succinimide derivatives",
    "ahfs_category": "28:12.20 - Succinimides - 382028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1066,
    "name": "METHYCLOTHIAZIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": "40:28.20 - Thiazide Diuretics - 382569",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 456,
    "name": "METHYL AMINOLEVULINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XD",
    "level4_name": "Sensitizers used in photodynamic/radiation therapy",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1220,
    "name": "METHYL SALICYLATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Methyl salicylate not in WHO ATC database. Topical counterirritant/analgesic. Mapped to M02AC category (topical salicylic acid derivatives). Corrected 2025-10-16."
  },
  {
    "id": 1067,
    "name": "METHYLDOPA",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AB",
    "level4_name": "Methyldopa",
    "ahfs_category": "24:08.16 - Central alpha-Agonists - 382242",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1068,
    "name": "METHYLDOPATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AB",
    "level4_name": "Methyldopa",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Methyldopate is prodrug ester of methyldopa. Mapped to C02AB02 (racemic methyldopa). Corrected 2025-10-16."
  },
  {
    "id": 1719,
    "name": "METHYLENE BLUE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "92:12 - Antidotes - 382747",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: methylene blue; WHO name: methylthioninium chloride. Antidote and diagnostic dye. Corrected 2025-10-16."
  },
  {
    "id": 1221,
    "name": "METHYLERGONOVINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02AB",
    "level4_name": "Ergot alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: methylergonovine; WHO name: methylergometrine. Oxytocic agent for postpartum hemorrhage. Corrected 2025-10-16."
  },
  {
    "id": 815,
    "name": "METHYLNALTREXONE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AH",
    "level4_name": "Peripheral opioid receptor antagonists",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 308033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 597,
    "name": "METHYLPHENIDATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.32 - Respiratory and CNS Stimulants - 382188",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 733,
    "name": "METHYLPREDNISOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D07AA",
    "level4_name": "Corticosteroids, weak (group I)",
    "ahfs_category": "68:04 - Adrenals - 382795",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 556,
    "name": "METHYLTESTOSTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": "68:08 - Androgens - 382689",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 659,
    "name": "METHYPRYLON",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05CE",
    "level4_name": "Piperidinedione derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1508,
    "name": "METHYSERGIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CA",
    "level4_name": "Ergot alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1665,
    "name": "METIPRANOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01ED",
    "level4_name": "Beta blocking agents",
    "ahfs_category": "52:40.08 - beta-Adrenergic Blocking Agents - 379116",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 816,
    "name": "METOCLOPRAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03FA",
    "level4_name": "Propulsives",
    "ahfs_category": "56:32 - Prokinetic Agents - 384035",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1928,
    "name": "METOCURINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AA",
    "level4_name": "Curare alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1069,
    "name": "METOLAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03BA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.24 - Thiazide-like Diuretics - 382345",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1070,
    "name": "METOPROLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 382864",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1720,
    "name": "METRIZAMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V08AB",
    "level4_name": "Watersoluble, nephrotropic, low osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 306,
    "name": "METRIZOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02BB",
    "level4_name": "Organophosphorous compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1721,
    "name": "METRIZOIC ACID",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AA",
    "level4_name": "Watersoluble, nephrotropic, high osmolar X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 817,
    "name": "METRONIDAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 382244",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1722,
    "name": "METYRAPONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "V04CD",
    "level4_name": "Tests for pituitary function",
    "ahfs_category": "36:66 - Pituitary Function - 382239",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1071,
    "name": "METYROSINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C02KB",
    "level4_name": "Tyrosine hydroxylase inhibitors",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1072,
    "name": "MEXILETINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BB",
    "level4_name": "Antiarrhythmics, class Ib",
    "ahfs_category": "24:04.04.08 - Class Ib Antiarrhythmics - 303012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 73,
    "name": "MEZLOCILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 108,
    "name": "MICAFUNGIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AX",
    "level4_name": "Other antimycotics for systemic use",
    "ahfs_category": "8:14.16 - Echinocandins - 305017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 818,
    "name": "MICONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "84:04.08.08 - Azoles - 382616",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 589,
    "name": "MIDAZOLAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 387008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1073,
    "name": "MIDODRINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.04 - alpha-Adrenergic Agonists - 396042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 457,
    "name": "MIDOSTAURIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317034",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1222,
    "name": "MIFEPRISTONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03XB",
    "level4_name": "Progesterone receptor modulators",
    "ahfs_category": "76:00 - Oxytocics - 300042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 819,
    "name": "MIGALASTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 820,
    "name": "MIGLITOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BF",
    "level4_name": "Alpha glucosidase inhibitors",
    "ahfs_category": "68:20.02 - alpha-Glucosidase Inhibitors - 307002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 821,
    "name": "MIGLUSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 699,
    "name": "MILNACIPRAN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:40 - Fibromyalgia Agents - 309009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1074,
    "name": "MILRINONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01CE",
    "level4_name": "Phosphodiesterase inhibitors",
    "ahfs_category": "24:04.08 - Cardiotonic Agents - 303013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 726,
    "name": "MILTEFOSINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01CX",
    "level4_name": "Other agents against leishmaniasis and trypanosomiasis",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 316003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 178,
    "name": "MINOCYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:12.24 - Tetracyclines - 382101",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1075,
    "name": "MINOXIDIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": true,
    "level4_code": "C02DC",
    "level4_name": "Pyrimidine derivatives",
    "ahfs_category": "24:08.20 - Direct Vasodilators - 382608",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1076,
    "name": "MIPOMERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": "24:06.92 - Antilipemic Agents, Miscellaneous - 314018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1223,
    "name": "MIRABEGRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.08.12 - Selective beta-3 Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 458,
    "name": "MIRDAMETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EE",
    "level4_name": "Mitogen-activated protein kinase (MEK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 696,
    "name": "MIRTAZAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.92 - Antidepressants, Miscellaneous - 397009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 822,
    "name": "MISOPROSTOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BB",
    "level4_name": "Prostaglandins",
    "ahfs_category": "56:28.28 - Prostaglandins - 389009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 928,
    "name": "MITAPIVAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AX",
    "level4_name": "Other hematological agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 459,
    "name": "MITOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DC",
    "level4_name": "Other cytotoxic antibiotics",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382415",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 460,
    "name": "MITOTANE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382380",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 461,
    "name": "MITOXANTRONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": "10:00 - Antineoplastic Agents - 396040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1420,
    "name": "MIVACURIUM CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 379119",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 462,
    "name": "MOBOCERTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 599,
    "name": "MODAFINIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": "28:20.80 - Wakefulness-promoting Agents - 399047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1077,
    "name": "MOEXIPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 625,
    "name": "MOLINDONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AE",
    "level4_name": "Indole derivatives",
    "ahfs_category": "28:16.08.92 - Antipsychotics, Miscellaneous - 382238",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 463,
    "name": "MOMELOTINIB DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EJ",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1929,
    "name": "MOMETASONE FUROATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BA",
    "level4_name": "Glucocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1175,
    "name": "MONOBENZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "84:50.04 - Depigmenting Agents - 382378",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1930,
    "name": "MONOCTANOIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Moctanin (monoctanoin) approved October 29, 1985 for dissolving retained cholesterol gallstones; no longer available in United States"
  },
  {
    "id": 823,
    "name": "MONOFLUOROPHOSPHATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AA",
    "level4_name": "Caries prophylactic agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1622,
    "name": "MONTELUKAST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DC",
    "level4_name": "Leukotriene receptor antagonists",
    "ahfs_category": "48:10.24 - Leukotriene Modifiers - 300014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1078,
    "name": "MORICIZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BG",
    "level4_name": "Other antiarrhythmics, class I and III",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 561,
    "name": "MORPHINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AA",
    "level4_name": "Natural opium alkaloids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382133",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 464,
    "name": "MOTIXAFORTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1932,
    "name": "MOXALACTAM DISODIUM",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; oxacephem antibiotic (latamoxef) withdrawn from U.S. market due to serious bleeding complications and coagulopathy"
  },
  {
    "id": 308,
    "name": "MOXIDECTIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "P02CX",
    "level4_name": "Other antinematodals",
    "ahfs_category": "8:08 - Anthelmintics - 379122",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1342,
    "name": "MOXIFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "8:12.18 - Quinolones - 300002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 219,
    "name": "MUPIROCIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "8:12.16.04 - Natural Penicillins - 385904",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1933,
    "name": "MYCOPHENOLATE MOFETIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Mycophenolate mofetil is prodrug ester of mycophenolic acid. WHO code L04AA06 covers both forms. Immunosuppressant. Mapped 2025-10-16."
  },
  {
    "id": 465,
    "name": "MYCOPHENOLIC",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2312,
    "name": "Measles Virus Vaccine Live",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 382559",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2313,
    "name": "Meningococcal Group B Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AH",
    "level4_name": "Meningococcal vaccines",
    "ahfs_category": "80:12 - Vaccines - 317007",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2314,
    "name": "Meningococcal Groups A, C, Y, and W-135 Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AH",
    "level4_name": "Meningococcal vaccines",
    "ahfs_category": "80:12 - Vaccines - 397004",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2201,
    "name": "Mepolizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DX",
    "level4_name": "Other systemic drugs for obstructive airway diseases",
    "ahfs_category": "48:10.20 - Interleukin Antagonists - 316051",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2202,
    "name": "Mogamulizumab-kpkc",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318034",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2203,
    "name": "Moxetumomab-tdfk",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XY",
    "level4_name": "Combinations of antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318056",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2315,
    "name": "Mumps Virus Vaccine Live",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BD",
    "level4_name": "Measles vaccines",
    "ahfs_category": "80:12 - Vaccines - 382561",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 824,
    "name": "NABILONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": "56:22.92 - Antiemetics, Miscellaneous - 306022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1421,
    "name": "NABUMETONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AX",
    "level4_name": "Other antiinflammatory and antirheumatic agents, non-steroids",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1079,
    "name": "NADOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 382666",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1265,
    "name": "NAFARELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CA",
    "level4_name": "Gonadotropin-releasing hormones",
    "ahfs_category": "68:18.08 - Gonadotropins - 302011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 79,
    "name": "NAFCILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": "8:12.16.12 - Penicillinase-resistant Penicillins - 385019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 215,
    "name": "NAFTIFINE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "84:04.08.04 - Allylamines - 388020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 571,
    "name": "NALBUPHINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AF",
    "level4_name": "Morphinan derivatives",
    "ahfs_category": "28:08.12 - Opiate Partial Agonists - 382668",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 825,
    "name": "NALDEMEDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AH",
    "level4_name": "Peripheral opioid receptor antagonists",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 317027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1343,
    "name": "NALIDIXIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MB",
    "level4_name": "Other quinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1509,
    "name": "NALMEFENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BB",
    "level4_name": "Drugs used in alcohol dependence",
    "ahfs_category": "28:10 - Opiate Antagonists - 395009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 826,
    "name": "NALOXEGOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AH",
    "level4_name": "Peripheral opioid receptor antagonists",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 316002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 827,
    "name": "NALOXONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AH",
    "level4_name": "Peripheral opioid receptor antagonists",
    "ahfs_category": "28:10 - Opiate Antagonists - 382232",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1510,
    "name": "NALTREXONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N07BB",
    "level4_name": "Drugs used in alcohol dependence",
    "ahfs_category": "28:10 - Opiate Antagonists - 385041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 828,
    "name": "NANDROLONE DECANOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "A14AB",
    "level4_name": "Estren derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1623,
    "name": "NAPHAZOLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01AA",
    "level4_name": "Sympathomimetics, plain",
    "ahfs_category": "52:32 - Vasoconstrictors - 382268",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1224,
    "name": "NAPROXEN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
    "level4_name": "M01AE",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1511,
    "name": "NARATRIPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": "28:32.28 - Selective Serotonin Agonists - 301032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 829,
    "name": "NATAMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "52:04.16 - Antifungals - 382219",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 830,
    "name": "NATEGLINIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BX",
    "level4_name": "Other blood glucose lowering drugs, excl. insulins",
    "ahfs_category": "68:20.16 - Meglitinides - 301007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1080,
    "name": "NEBIVOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AB",
    "level4_name": "Beta blocking agents, selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 308012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1624,
    "name": "NEDOCROMIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AC",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": "52:02 - Antiallergic Agents - 301053",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 831,
    "name": "NEDOSIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 694,
    "name": "NEFAZODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.24 - Serotonin Modulators - 395005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 466,
    "name": "NELARABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1344,
    "name": "NELFINAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 397034",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 832,
    "name": "NEOMYCIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "8:12.02 - Aminoglycosides - 382662",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1934,
    "name": "NEOSTIGMINE METHYLSULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07AA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1666,
    "name": "NEPAFENAC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01BC",
    "level4_name": "Antiinflammatory agents, non-steroids",
    "ahfs_category": "52:08.20 - Nonsteroidal Anti-inflammatory Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 467,
    "name": "NERATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EH",
    "level4_name": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317050",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1081,
    "name": "NESIRITIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01DX",
    "level4_name": "Other vasodilators used in cardiac diseases",
    "ahfs_category": "24:12.92 - Vasodilating Agents, Miscellaneous - 301051",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1667,
    "name": "NETARSUDIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EX",
    "level4_name": "Other antiglaucoma preparations",
    "ahfs_category": "52:40.32 - Rho Kinase Inhibitors - 318002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1668,
    "name": "NETARSUDIL DIMESYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EX",
    "level4_name": "Other antiglaucoma preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1345,
    "name": "NETILMICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01GB",
    "level4_name": "Other aminoglycosides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1935,
    "name": "NETUPITANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved October 10, 2014 (Akynzeo) with palonosetron for chemotherapy-induced nausea/vomiting; still marketed"
  },
  {
    "id": 1346,
    "name": "NEVIRAPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 188,
    "name": "NIACIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C04AC",
    "level4_name": "Nicotinic acid and derivatives",
    "ahfs_category": "24:06.92 - Antilipemic Agents, Miscellaneous - 382518",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 166,
    "name": "NIACINAMIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11HA",
    "level4_name": "Other plain vitamin preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1082,
    "name": "NICARDIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 395032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 731,
    "name": "NICLOSAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02DA",
    "level4_name": "Salicylic acid derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 193,
    "name": "NICOTINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N07BA",
    "level4_name": "Drugs used in nicotine dependence",
    "ahfs_category": "12:92 - Autonomic Drugs, Miscellaneous - 384056",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 200,
    "name": "NICOTINE POLACRILEX",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N07BA",
    "level4_name": "Drugs used in nicotine dependence",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1083,
    "name": "NIFEDIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "86:12.04 - Antimuscarinics - 382141",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 305,
    "name": "NIFURTIMOX",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "P01CC",
    "level4_name": "Nitrofuran derivatives",
    "ahfs_category": "8:92 - Anti-infectives, Miscellaneous - 379125",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 468,
    "name": "NILOTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 308017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 469,
    "name": "NILOTINIB D-",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 470,
    "name": "NILUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BB",
    "level4_name": "Anti-androgens",
    "ahfs_category": "10:00 - Antineoplastic Agents - 397044",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1084,
    "name": "NIMODIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 389010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1936,
    "name": "NINTEDANIB ESYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 471,
    "name": "NIRAPARIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XK",
    "level4_name": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1347,
    "name": "NIRMATRELVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 472,
    "name": "NIROGACESTAT",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1085,
    "name": "NISOLDIPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08CA",
    "level4_name": "Dihydropyridine derivatives",
    "ahfs_category": "24:28.08 - Dihydropyridines - 396009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 112,
    "name": "NITAZOXANIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01AX",
    "level4_name": "Other agents against amoebiasis and other protozoal diseases",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 303004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 833,
    "name": "NITISINONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1625,
    "name": "NITRIC OXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": "24:12.08 - Nitrates and Nitrites - 301043",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1348,
    "name": "NITROFURANTOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XE",
    "level4_name": "Nitrofuran derivatives",
    "ahfs_category": "8:36 - Urinary Anti-infectives - 382291",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 929,
    "name": "NITROFURAZONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05CA",
    "level4_name": "Antiinfectives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1086,
    "name": "NITROGLYCERIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01DA",
    "level4_name": "Organic nitrates",
    "ahfs_category": "24:12.08 - Nitrates and Nitrites - 382346",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1087,
    "name": "NITROPRUSSIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02DD",
    "level4_name": "Nitroferricyanide derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 834,
    "name": "NIZATIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BA",
    "level4_name": "H2-receptor antagonists",
    "ahfs_category": "56:28.12 - Histamine H2-Antagonists - 394030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1939,
    "name": "NORELGESTROMIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03DC",
    "level4_name": "Estren derivatives",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Norelgestromin is progestin component. WHO lists only in combination: G03AA13 (norelgestromin and ethinylestradiol). Mapped to G03DC (progestogens) category. Corrected 2025-10-16."
  },
  {
    "id": 199,
    "name": "NOREPINEPHRINE BITARTRATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 835,
    "name": "NORETHINDRONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": "68:32 - Progestins - 382473",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1940,
    "name": "NORETHYNODREL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03DC",
    "level4_name": "Estren derivatives",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Approximation: Mapped to WHO category code; specific substance code may not exist"
  },
  {
    "id": 1349,
    "name": "NORFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1941,
    "name": "NORGESTIMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03DC",
    "level4_name": "Estren derivatives",
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Norgestimate is progestin component. WHO lists only in combination: G03AA11 (norgestimate and ethinylestradiol). Mapped to G03DC (progestogens) category. Corrected 2025-10-16."
  },
  {
    "id": 127,
    "name": "NORGESTREL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 678,
    "name": "NORTRIPTYLINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1422,
    "name": "NUSINERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": "92:18 - Antisense Oligonucleotides - 317002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 179,
    "name": "NYSTATIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:14.28 - Polyenes - 382790",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2204,
    "name": "Natalizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 304030",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2205,
    "name": "Necitumumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FE",
    "level4_name": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316025",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2206,
    "name": "Nivolumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315022",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 836,
    "name": "OBETICHOLIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A05AA",
    "level4_name": "Bile acids and derivatives",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 316059",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1176,
    "name": "OCTINOXATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D02BA",
    "level4_name": "Protectives against UV-radiation for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1266,
    "name": "OCTREOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CB",
    "level4_name": "Somatostatin and analogues",
    "ahfs_category": "68:29.04 - Somatostatin Agonists - 393049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 837,
    "name": "ODEVIXIBAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A05AX",
    "level4_name": "Other drugs for bile therapy",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1350,
    "name": "OFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": "8:12.18 - Quinolones - 391005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 633,
    "name": "OLANZAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 397011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 634,
    "name": "OLANZAPINE PAMOATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 473,
    "name": "OLAPARIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XK",
    "level4_name": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1943,
    "name": "OLEZARSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Antisense oligonucleotide for hypertriglyceridemia. Would belong to C10AX (other lipid modifying agents) if listed. Approved 2024; not yet in WHO ATC database."
  },
  {
    "id": 575,
    "name": "OLICERIDINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AX",
    "level4_name": "Other opioids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1088,
    "name": "OLMESARTAN MEDOXOMIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1626,
    "name": "OLODATEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1627,
    "name": "OLOPATADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R01AC",
    "level4_name": "Antiallergic agents, excl. corticosteroids",
    "ahfs_category": "52:02 - Antiallergic Agents - 399006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 838,
    "name": "OLSALAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EC",
    "level4_name": "Aminosalicylic acid and similar agents",
    "ahfs_category": "56:36 - Anti-inflammatory Agents - 304018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 474,
    "name": "OLUTASIDENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XM",
    "level4_name": "Isocitrate dehydrogenase (IDH) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 475,
    "name": "OMACETAXINE MEPESUCCINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 68,
    "name": "OMADACYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01AA",
    "level4_name": "Tetracyclines",
    "ahfs_category": "8:12.24.04 - Aminomethylcyclines - 318054",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1512,
    "name": "OMAVELOXOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1944,
    "name": "OMBITASVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Ombitasvir is HCV antiviral; WHO lists as combination J05AP53 (ombitasvir, paritaprevir and ritonavir). Corrected 2025-10-16."
  },
  {
    "id": 839,
    "name": "OMEPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 393050",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1945,
    "name": "OMIDENEPAG ISOPROPYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EX",
    "level4_name": "Other antiglaucoma preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 840,
    "name": "ONDANSETRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AA",
    "level4_name": "Serotonin (5HT3) antagonists",
    "ahfs_category": "56:22.20 - 5-HT3 Receptor Antagonists - 392023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1513,
    "name": "OPICAPONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BX",
    "level4_name": "Other dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1946,
    "name": "ORITAVANCIN DIPHOSPHATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XA",
    "level4_name": "Glycopeptide antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 841,
    "name": "ORLISTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A08AB",
    "level4_name": "Peripherally acting antiobesity products",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 399010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1423,
    "name": "ORPHENADRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BC",
    "level4_name": "Ethers, chemically close to antihistamines",
    "ahfs_category": "12:20.92 - Skeletal Muscle Relaxants, Miscellaneous -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1351,
    "name": "OSELTAMIVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AH",
    "level4_name": "Neuraminidase inhibitors",
    "ahfs_category": "8:18.28 - Neuraminidase Inhibitors - 399040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1267,
    "name": "OSILODROSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02CA",
    "level4_name": "Anticorticosteroids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 476,
    "name": "OSIMERTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EB",
    "level4_name": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1225,
    "name": "OSPEMIFENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03XC",
    "level4_name": "Selective estrogen receptor modulators",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 314005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 106,
    "name": "OTESECONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AC",
    "level4_name": "Triazole and tetrazole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 78,
    "name": "OXACILLIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CF",
    "level4_name": "Beta-lactamase resistant penicillins",
    "ahfs_category": "8:12.16.12 - Penicillinase-resistant Penicillins - 385020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 477,
    "name": "OXALIPLATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XA",
    "level4_name": "Platinum compounds",
    "ahfs_category": "10:00 - Antineoplastic Agents - 302033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 727,
    "name": "OXAMNIQUINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02BA",
    "level4_name": "Quinoline derivatives and related substances",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 842,
    "name": "OXANDROLONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": "68:08 - Androgens - 308011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1424,
    "name": "OXAPROZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 579,
    "name": "OXAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 382050",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1514,
    "name": "OXCARBAZEPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AF",
    "level4_name": "Carboxamide derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 301030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 208,
    "name": "OXICONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 389004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1723,
    "name": "OXIGLUTATIONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1089,
    "name": "OXPRENOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1948,
    "name": "OXTRIPHYLLINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "48:12.12 - Xanthine Derivatives - 379129",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; choline theophyllinate (Choledyl SA) for asthma/COPD; no longer available in United States"
  },
  {
    "id": 1949,
    "name": "OXYBATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1226,
    "name": "OXYBUTYNIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1951,
    "name": "OXYBUTYNIN CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 563,
    "name": "OXYCODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AA",
    "level4_name": "Natural opium alkaloids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382132",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1952,
    "name": "OXYCODONE TEREPHTHALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 1177,
    "name": "OXYMETAZOLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D11AX",
    "level4_name": "Other dermatologicals",
    "ahfs_category": "52:32 - Vasoconstrictors - 382562",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 843,
    "name": "OXYMETHOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": "68:08 - Androgens - 379130",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 564,
    "name": "OXYMORPHONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AA",
    "level4_name": "Natural opium alkaloids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 382131",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1425,
    "name": "OXYPHENBUTAZONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "M01AA",
    "level4_name": "Butylpyrazolidines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 844,
    "name": "OXYPHENCYCLIMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "A03AA",
    "level4_name": "Synthetic anticholinergics, esters with tertiary amino group",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1953,
    "name": "OXYPHENONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 845,
    "name": "OXYTETRACYCLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1268,
    "name": "OXYTOCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01BB",
    "level4_name": "Oxytocin and analogues",
    "ahfs_category": "76:00 - Oxytocics - 382685",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 478,
    "name": "OZANIMOD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 221,
    "name": "OZENOXACIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "84:04.04 - Antibacterials - 318005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2207,
    "name": "Obiltoxaximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J06BC",
    "level4_name": "Antibacterial monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 316064",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2208,
    "name": "Obinutuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FA",
    "level4_name": "CD20 (Clusters of Differentiation 20) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 314013",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2209,
    "name": "Ocrelizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 317024",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2210,
    "name": "Ofatumumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FA",
    "level4_name": "CD20 (Clusters of Differentiation 20) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 310003",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2211,
    "name": "Olaratumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FX",
    "level4_name": "Other monoclonal antibodies and antibody drug conjugates",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316081",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2279,
    "name": "Omacetaxine",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313028",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2212,
    "name": "Omalizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DX",
    "level4_name": "Other systemic drugs for obstructive airway diseases",
    "ahfs_category": "48:92 - Respiratory Tract Agents, Miscellaneous -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2280,
    "name": "Ombitasvir, Paritaprevir, Ritonavir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.40.24 - HCV Replication Complex Inhibitors -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2281,
    "name": "Omega-3-acid Ethyl Esters",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "24:06.92 - Antilipemic Agents, Miscellaneous - 306002",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2282,
    "name": "Oprelvekin",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AC",
    "level4_name": "Interleukins",
    "ahfs_category": "20:16 - Hematopoietic Agents - 308005",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 479,
    "name": "PACLITAXEL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CD",
    "level4_name": "Taxanes",
    "ahfs_category": "10:00 - Antineoplastic Agents - 398035",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 480,
    "name": "PACRITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EJ",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1724,
    "name": "PAFOLACIANINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CX",
    "level4_name": "Other diagnostic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 481,
    "name": "PALBOCICLIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EF",
    "level4_name": "Cyclin-dependent kinase (CDK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 641,
    "name": "PALIPERIDONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 307003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 846,
    "name": "PALONOSETRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AA",
    "level4_name": "Serotonin (5HT3) antagonists",
    "ahfs_category": "56:22.20 - 5-HT3 Receptor Antagonists - 303038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 259,
    "name": "PALOPEGTERIPARATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05AA",
    "level4_name": "Parathyroid hormones and analogues",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Automatically mapped via exact search on 2025-10-16"
  },
  {
    "id": 1426,
    "name": "PALOVAROTENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1955,
    "name": "PAMIDRONATE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BA",
    "level4_name": "Bisphosphonates",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1427,
    "name": "PANCURONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 382552",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Pancuronium bromide; salt form included in active moiety name"
  },
  {
    "id": 482,
    "name": "PANOBINOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XH",
    "level4_name": "Histone deacetylase (HDAC) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315035",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 847,
    "name": "PANTOPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 300049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1956,
    "name": "PANTOTHENIC ACID",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "88:08 - Vitamin B Complex - 382589",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Also known as vitamin B5; dexpanthenol is the WHO-listed form"
  },
  {
    "id": 1515,
    "name": "PARAMETHADIONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N03AC",
    "level4_name": "Oxazolidine derivatives",
    "ahfs_category": "28:12.16 - Oxazolidinediones - 379131",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1269,
    "name": "PARAMETHASONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1090,
    "name": "PARGYLINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C02KC",
    "level4_name": "MAO inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1270,
    "name": "PARICALCITOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05BX",
    "level4_name": "Other anti-parathyroid agents",
    "ahfs_category": "88:16 - Vitamin D - 301071",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1352,
    "name": "PARITAPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 379133",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 848,
    "name": "PAROMOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:30.04 - Amebicides - 382152",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 684,
    "name": "PAROXETINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1957,
    "name": "PASIREOTIDE DIASPARTATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CB",
    "level4_name": "Somatostatin and analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1271,
    "name": "PASIREOTIDE PAMOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01CB",
    "level4_name": "Somatostatin and analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1958,
    "name": "PATIROMER SORBITEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AE",
    "level4_name": "Drugs for treatment of hyperkalemia and hyperphosphatemia",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1516,
    "name": "PATISIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 483,
    "name": "PAZOPANIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 310010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 260,
    "name": "PEGAPTANIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01LA",
    "level4_name": "Antineovascularisation agents",
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 305011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Automatically mapped via exact search on 2025-10-16"
  },
  {
    "id": 261,
    "name": "PEGCETACOPLAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Automatically mapped via exact search on 2025-10-16"
  },
  {
    "id": 262,
    "name": "PEGINESATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Automatically mapped via exact search on 2025-10-16"
  },
  {
    "id": 263,
    "name": "PEGULICIANINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Pharmaceutical excipient/inactive ingredient; not classified in WHO ATC (therapeutic agents only)"
  },
  {
    "id": 484,
    "name": "PEMETREXED",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BA",
    "level4_name": "Folic acid analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 304005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1959,
    "name": "PEMETREXED DIPOTASSIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BA",
    "level4_name": "Folic acid analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1960,
    "name": "PEMETREXED DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BA",
    "level4_name": "Folic acid analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1961,
    "name": "PEMETREXED DITROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 485,
    "name": "PEMIGATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EN",
    "level4_name": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 486,
    "name": "PEMIROLAST",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L04AA",
    "level4_name": "Selective immunosuppressants",
    "ahfs_category": "52:02 - Antiallergic Agents - 301018",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Pemirolast not in WHO ATC database. Antiallergic agent/mast cell stabilizer for allergic conjunctivitis. Would belong to S01GX (other antiallergics) if listed. Completely different from apremilast (immunosuppressant). Corrected 2025-10-16."
  },
  {
    "id": 598,
    "name": "PEMOLINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1091,
    "name": "PENBUTOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 222,
    "name": "PENCICLOVIR",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": "84:04.06 - Antivirals - 397027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1428,
    "name": "PENICILLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01CC",
    "level4_name": "Penicillamine and similar agents",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 382290",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 74,
    "name": "PENICILLIN G",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CE",
    "level4_name": "Beta-lactamase sensitive penicillins",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1962,
    "name": "PENICILLIN G BENZATHINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Approximation: Mapped to WHO category code; specific substance code may not exist"
  },
  {
    "id": 1963,
    "name": "PENICILLIN G PROCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "8:12.16.04 - Natural Penicillins - 385014",
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Approximation: Mapped to WHO category code; specific substance code may not exist"
  },
  {
    "id": 75,
    "name": "PENICILLIN V",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CE",
    "level4_name": "Beta-lactamase sensitive penicillins",
    "ahfs_category": "8:12.16.04 - Natural Penicillins - 385015",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1725,
    "name": "PENTAGASTRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CG",
    "level4_name": "Tests for gastric secretion",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 725,
    "name": "PENTAMIDINE ISETHIONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01CX",
    "level4_name": "Other agents against leishmaniasis and trypanosomiasis",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 568,
    "name": "PENTAZOCINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AD",
    "level4_name": "Benzomorphan derivatives",
    "ahfs_category": "28:08.12 - Opiate Partial Agonists - 382324",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1964,
    "name": "PENTETATE TRISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved 2004 (Ca-DTPA) for internal contamination with plutonium/americium/curium"
  },
  {
    "id": 1965,
    "name": "PENTETATE TRISODIUM YB-169",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Pentetate Calcium Trisodium Yb-169 (3M, marketed 1976); Yb-169 DTPA complex for imaging; no longer commercially available"
  },
  {
    "id": 653,
    "name": "PENTOBARBITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CA",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": "28:24.04 - Barbiturates - 382416",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 849,
    "name": "PENTOLINIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03BB",
    "level4_name": "Belladonna alkaloids, semisynthetic, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Pentolinium not in WHO ATC database. Ganglionic blocking agent for severe hypertension. Obsolete/discontinued; replaced by safer antihypertensives. Would belong to C02BB (ganglionic blocking agents) if listed. Corrected 2025-10-16."
  },
  {
    "id": 1092,
    "name": "PENTOSAN POLYSULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05BA",
    "level4_name": "Heparins or heparinoids for topical use",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 487,
    "name": "PENTOSTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 392004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1093,
    "name": "PENTOXIFYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C04AD",
    "level4_name": "Purine derivatives",
    "ahfs_category": "20:24 - Hemorrheologic Agents - 385027",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1353,
    "name": "PERAMIVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AH",
    "level4_name": "Neuraminidase inhibitors",
    "ahfs_category": "8:18.28 - Neuraminidase Inhibitors - 315026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1517,
    "name": "PERAMPANEL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 315002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1966,
    "name": "PERFLEXANE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Imagent (perflexane lipid microspheres) approved June 3, 2002 for echocardiography; discontinued and no longer commercially available as of June 2005"
  },
  {
    "id": 1726,
    "name": "PERFLUBRON",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CX",
    "level4_name": "Other magnetic resonance imaging contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1967,
    "name": "PERFLUOROHEXYLOCTANE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 19, 2023 (Miebo) for dry eye disease"
  },
  {
    "id": 1727,
    "name": "PERFLUTREN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08CX",
    "level4_name": "Other magnetic resonance imaging contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1518,
    "name": "PERGOLIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BC",
    "level4_name": "Dopamine agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1969,
    "name": "PERINDOPRIL ARGININE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1970,
    "name": "PERINDOPRIL ERBUMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 245,
    "name": "PERMETHRIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "P03AC",
    "level4_name": "Pyrethrines, incl. synthetic compounds",
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 398037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 613,
    "name": "PERPHENAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382165",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 488,
    "name": "PEXIDARTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1519,
    "name": "PHENACEMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1227,
    "name": "PHENAZOPYRIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": "84:08 - Antipruritics and Local Anesthetics - 382231",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1971,
    "name": "PHENDIMETRAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "28:20.08.04 - Amphetamine Derivatives - 382186",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1976 (Bontril) for obesity; Schedule III controlled substance; still marketed for short-term (12 weeks) weight management"
  },
  {
    "id": 690,
    "name": "PHENELZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AF",
    "level4_name": "Monoamine oxidase inhibitors, non-selective",
    "ahfs_category": "28:16.04.12 - Monoamine Oxidase Inhibitors - 382089",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 930,
    "name": "PHENINDIONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "B01AA",
    "level4_name": "Vitamin K antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1178,
    "name": "PHENIRAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 691,
    "name": "PHENMETRAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AF",
    "level4_name": "Monoamine oxidase inhibitors, non-selective",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Phenmetrazine not in WHO ATC database. Appetite suppressant (anorectic agent). Withdrawn due to abuse potential and cardiovascular risks. Would belong to A08AA (centrally acting antiobesity products) if listed. Completely different from phenelzine (antidepressant). Corrected 2025-10-16."
  },
  {
    "id": 1520,
    "name": "PHENOBARBITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N03AA",
    "level4_name": "Barbiturates and derivatives",
    "ahfs_category": "28:12.04 - Barbiturates - 382007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1094,
    "name": "PHENOXYBENZAMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C04AX",
    "level4_name": "Other peripheral vasodilators",
    "ahfs_category": "12:16.04.04 - Non-selective alpha-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 931,
    "name": "PHENPROCOUMON",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "B01AA",
    "level4_name": "Vitamin K antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1521,
    "name": "PHENSUXIMIDE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N03AD",
    "level4_name": "Succinimide derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 850,
    "name": "PHENTERMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A08AA",
    "level4_name": "Centrally acting antiobesity products",
    "ahfs_category": "28:20.08.04 - Amphetamine Derivatives - 382187",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1972,
    "name": "PHENTERMINE RESIN COMPLEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Phentermine resin complex is extended-release formulation. Maps to A08AA01 (phentermine). Appetite suppressant. Mapped 2025-10-16."
  },
  {
    "id": 1095,
    "name": "PHENTOLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C04AB",
    "level4_name": "Imidazoline derivatives",
    "ahfs_category": "12:16.04.04 - Non-selective alpha-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1228,
    "name": "PHENYL AMINOSALICYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1973,
    "name": "PHENYLACETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1429,
    "name": "PHENYLBUTAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AA",
    "level4_name": "Butylpyrazolidines",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 851,
    "name": "PHENYLBUTYRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1096,
    "name": "PHENYLEPHRINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": "12:12.04 - alpha-Adrenergic Agonists - 382252",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1974,
    "name": "PHENYLEPHRINE BITARTRATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C01CA",
    "level4_name": "Adrenergic and dopaminergic agents",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1628,
    "name": "PHENYLPROPANOLAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01BA",
    "level4_name": "Sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1522,
    "name": "PHENYTOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AB",
    "level4_name": "Hydantoin derivatives",
    "ahfs_category": "28:12.12 - Hydantoins - 382022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 932,
    "name": "PHYTONADIONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BA",
    "level4_name": "Vitamin K",
    "ahfs_category": "88:24 - Vitamin K Activity - 382659",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1976,
    "name": "PIBRENTASVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "8:18.40.24 - HCV Replication Complex Inhibitors -",
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Pibrentasvir is HCV antiviral; WHO lists only as combination J05AP57 (glecaprevir and pibrentasvir). Corrected 2025-10-16."
  },
  {
    "id": 1728,
    "name": "PICOSULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1729,
    "name": "PIFLUFOLASTAT F-18",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09IX",
    "level4_name": "Other diagnostic radiopharmaceuticals for tumour detection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1523,
    "name": "PILOCARPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07AX",
    "level4_name": "Other parasympathomimetics",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 645,
    "name": "PIMAVANSERIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 316047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1179,
    "name": "PIMECROLIMUS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 630,
    "name": "PIMOZIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AG",
    "level4_name": "Diphenylbutylpiperidine derivatives",
    "ahfs_category": "28:16.08.92 - Antipsychotics, Miscellaneous - 386018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1097,
    "name": "PINACIDIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02DG",
    "level4_name": "Guanidine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1098,
    "name": "PINDOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 384032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 852,
    "name": "PIOGLITAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BG",
    "level4_name": "Thiazolidinediones",
    "ahfs_category": "68:20.28 - Thiazolidinediones - 399016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1430,
    "name": "PIPECURONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 307,
    "name": "PIPERACETAZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 277,
    "name": "PIPERACILLIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 124,
    "name": "PIPERAZINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P02CB",
    "level4_name": "Piperazine and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 489,
    "name": "PIPOBROMAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AX",
    "level4_name": "Other alkylating agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1629,
    "name": "PIRBUTEROL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 490,
    "name": "PIRFENIDONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "48:02 - Antifibrotic Agents - 315043",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1431,
    "name": "PIROXICAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AC",
    "level4_name": "Oxicams",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 491,
    "name": "PIRTOBRUTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EL",
    "level4_name": "Bruton's tyrosine kinase (BTK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1099,
    "name": "PITAVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 311003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1524,
    "name": "PITOLISANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 71,
    "name": "PIVMECILLINAM",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1354,
    "name": "PLAZOMICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01GB",
    "level4_name": "Other aminoglycosides",
    "ahfs_category": "8:12.02 - Aminoglycosides - 318024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 853,
    "name": "PLECANATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 317011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 492,
    "name": "PLERIXAFOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "20:16 - Hematopoietic Agents - 309002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 493,
    "name": "PLICAMYCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "L01DC",
    "level4_name": "Other cytotoxic antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1978,
    "name": "PODOFILOX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1990 (Condylox) for genital warts treatment; still FDA-approved and available"
  },
  {
    "id": 1100,
    "name": "POLIDOCANOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05BB",
    "level4_name": "Sclerosing agents for local injection",
    "ahfs_category": "24:16 - Sclerosing Agents - 313019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 494,
    "name": "POLYESTRADIOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L02AA",
    "level4_name": "Estrogens",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 264,
    "name": "POLYETHYLENE GLYCOL 3350",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: polyethylene glycol 3350; WHO name: macrogol. Osmotic laxative."
  },
  {
    "id": 854,
    "name": "POLYMYXIN B",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.28.28 - Polymyxins - 382314",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1730,
    "name": "POLYSTYRENE SULFONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AE",
    "level4_name": "Drugs for treatment of hyperkalemia and hyperphosphatemia",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1101,
    "name": "POLYTHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": "40:28.20 - Thiazide Diuretics - 382568",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 495,
    "name": "POMALIDOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 496,
    "name": "PONATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EA",
    "level4_name": "BCR-ABL tyrosine kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 497,
    "name": "PONESIMOD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1980,
    "name": "PORFIMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XD",
    "level4_name": "Sensitizers used in photodynamic/radiation therapy",
    "ahfs_category": "10:00 - Antineoplastic Agents - 379139",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 105,
    "name": "POSACONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AC",
    "level4_name": "Triazole and tetrazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 306026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 498,
    "name": "PRALATREXATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BA",
    "level4_name": "Folic acid analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 310001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1982,
    "name": "PRALIDOXIME CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "92:12 - Antidotes - 382517",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 499,
    "name": "PRALSETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1525,
    "name": "PRAMIPEXOLE DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BC",
    "level4_name": "Dopamine agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 855,
    "name": "PRAMLINTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BX",
    "level4_name": "Other blood glucose lowering drugs, excl. insulins",
    "ahfs_category": "68:20.03 - Amylinomimetics - 305022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1102,
    "name": "PRAMOXINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "C05AD",
    "level4_name": "Local anesthetics",
    "ahfs_category": "84:08 - Antipruritics and Local Anesthetics - 382429",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 856,
    "name": "PRASTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": "68:04 - Adrenals - 317041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 933,
    "name": "PRASUGREL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 309019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1103,
    "name": "PRAVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 392025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 582,
    "name": "PRAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05BA",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 121,
    "name": "PRAZIQUANTEL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P02BA",
    "level4_name": "Quinoline derivatives and related substances",
    "ahfs_category": "8:08 - Anthelmintics - 384064",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1104,
    "name": "PRAZOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "24:20 - alpha-Adrenergic Blocking Agents - 382245",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 231,
    "name": "PREDNICARBATE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D07AC",
    "level4_name": "Corticosteroids, potent (group III)",
    "ahfs_category": "84:06.08 - Corticosteroids - 394036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 857,
    "name": "PREDNISOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": "52:08.08 - Corticosteroids - 382873",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1983,
    "name": "PREDNISOLONE TEBUTATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Ester form (tebutate); WHO lists as prednisolone"
  },
  {
    "id": 858,
    "name": "PREDNISONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EA",
    "level4_name": "Corticosteroids acting locally",
    "ahfs_category": "68:04 - Adrenals - 382796",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1526,
    "name": "PREGABALIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02BF",
    "level4_name": "Gabapentinoids",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 305048",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1355,
    "name": "PRETOMANID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AK",
    "level4_name": "Other drugs for treatment of tuberculosis",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 242,
    "name": "PRILOCAINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": "72:00 - Local Anesthetics - 382697",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 720,
    "name": "PRIMAQUINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 382320",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1527,
    "name": "PRIMIDONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AA",
    "level4_name": "Barbiturates and derivatives",
    "ahfs_category": "28:12.04 - Barbiturates - 382023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1432,
    "name": "PROBENECID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M04AB",
    "level4_name": "Preparations increasing uric acid excretion",
    "ahfs_category": "40:40 - Uricosuric Agents - 382395",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1105,
    "name": "PROBUCOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C10AX",
    "level4_name": "Other lipid modifying agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1106,
    "name": "PROCAINAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BA",
    "level4_name": "Antiarrhythmics, class Ia",
    "ahfs_category": "24:04.04.04 - Class Ia Antiarrhythmics - 382398",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1107,
    "name": "PROCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AD",
    "level4_name": "Local anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1984,
    "name": "PROCAINE MERETHOXYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01HA",
    "level4_name": "Local anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 500,
    "name": "PROCARBAZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "L01XB",
    "level4_name": "Methylhydrazines",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382094",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 614,
    "name": "PROCHLORPERAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382116",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 615,
    "name": "PROCHLORPERAZINE EDISYLATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1528,
    "name": "PROCYCLIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04AA",
    "level4_name": "Tertiary amines",
    "ahfs_category": "28:36.08 - Anticholinergic Agents - 382161",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 145,
    "name": "PROGESTERONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03DA",
    "level4_name": "Pregnen (4) derivatives",
    "ahfs_category": "68:32 - Progestins - 382472",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 117,
    "name": "PROGUANIL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BB",
    "level4_name": "Biguanides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 607,
    "name": "PROMAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AA",
    "level4_name": "Phenothiazines with aliphatic side-chain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1180,
    "name": "PROMETHAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382752",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1108,
    "name": "PROPAFENONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BC",
    "level4_name": "Antiarrhythmics, class Ic",
    "ahfs_category": "24:04.04.12 - Class Ic Antiarrhythmics - 398002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1985,
    "name": "PROPANTHELINE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384020",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1109,
    "name": "PROPARACAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AD",
    "level4_name": "Local anesthetics",
    "ahfs_category": "52:16 - Local Anesthetics - 382371",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1986,
    "name": "PROPIOLACTONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; beta-propiolactone discontinued due to carcinogenic properties (IARC Group 2B); production ceased"
  },
  {
    "id": 667,
    "name": "PROPIOMAZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05CM",
    "level4_name": "Other hypnotics and sedatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1529,
    "name": "PROPOFOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AX",
    "level4_name": "Other general anesthetics",
    "ahfs_category": "28:04.92 - General Anesthetics, Miscellaneous - 302025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1110,
    "name": "PROPOXYCAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AD",
    "level4_name": "Local anesthetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 567,
    "name": "PROPOXYPHENE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N02AC",
    "level4_name": "Diphenylpropylamine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1987,
    "name": "PROPOXYPHENE NAPSYLATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N02AC",
    "level4_name": "Diphenylpropylamine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1111,
    "name": "PROPRANOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 382607",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1731,
    "name": "PROPYLIODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08AD",
    "level4_name": "Non-watersoluble X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1273,
    "name": "PROPYLTHIOURACIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H03BA",
    "level4_name": "Thiouracils",
    "ahfs_category": "68:36.08 - Antithyroid Agents - 382465",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1732,
    "name": "PROTAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "20:28.08 - Antiheparin Agents - 382278",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 934,
    "name": "PROTEIN HYDROLYSATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B05BA",
    "level4_name": "Solutions for parenteral nutrition",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1733,
    "name": "PROTIRELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CJ",
    "level4_name": "Tests for thyreoidea function",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1988,
    "name": "PROTOKYLOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 679,
    "name": "PROTRIPTYLINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 859,
    "name": "PRUCALOPRIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": "56:32 - Prokinetic Agents - 319001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 194,
    "name": "PSEUDOEPHEDRINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01BA",
    "level4_name": "Sympathomimetics",
    "ahfs_category": "12:12.12 - alpha- and beta-Adrenergic Agonists - 382619",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 195,
    "name": "PSEUDOEPHEDRINE POLISTIREX",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01BA",
    "level4_name": "Sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1356,
    "name": "PYRAZINAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AK",
    "level4_name": "Other drugs for treatment of tuberculosis",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382402",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 246,
    "name": "PYRETHRINS",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "P03AC",
    "level4_name": "Pyrethrines, incl. synthetic compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1990,
    "name": "PYRIDOSTIGMINE BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07AA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1991,
    "name": "PYRIDOXINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "88:08 - Vitamin B Complex - 382587",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 170,
    "name": "PYRILAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R06AC",
    "level4_name": "Substituted ethylene diamines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 120,
    "name": "PYRIMETHAMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BD",
    "level4_name": "Diaminopyrimidines",
    "ahfs_category": "8:30.08 - Antimalarials - 382321",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 660,
    "name": "PYRITHIONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CE",
    "level4_name": "Piperidinedione derivatives",
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 125,
    "name": "PYRVINIUM PAMOATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P02CX",
    "level4_name": "Other antinematodals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2213,
    "name": "Palivizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "8:18.24 - Monoclonal Antibodies - 398034",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2283,
    "name": "Pamidronate",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 392024",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2214,
    "name": "Panitumumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FE",
    "level4_name": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 307004",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2100,
    "name": "Pegademase bovine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "44:00 - Enzymes - 379134",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2284,
    "name": "Pegaspargase",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 395031",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2285,
    "name": "Pegfilgrastim; -jmdb; -cbqv",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "20:16 - Hematopoietic Agents - 302006",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2150,
    "name": "Peginterferon Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "8:18.20 - Interferons - 301060",
    "who_mapping_type": "INTERFERON",
    "who_mapping_notes": null
  },
  {
    "id": 2151,
    "name": "Peginterferon Beta-1a",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AB",
    "level4_name": "Interferons",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 315049",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2101,
    "name": "Pegvaliase-pqpz",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 318018",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2215,
    "name": "Pembrolizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FF",
    "level4_name": "PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315018",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2216,
    "name": "Pertuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FD",
    "level4_name": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313007",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2316,
    "name": "Pneumococcal Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 382657",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2317,
    "name": "Poliovirus Vaccine Inactivated",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 395016",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2087,
    "name": "Poractant Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "48:36 - Pulmonary Surfactants - 300050",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 590,
    "name": "QUAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 390009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 635,
    "name": "QUETIAPINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 398019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1112,
    "name": "QUINAPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 128,
    "name": "QUINESTROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AC",
    "level4_name": "Progestogens",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1113,
    "name": "QUINETHAZONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C03BA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1114,
    "name": "QUINIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BA",
    "level4_name": "Antiarrhythmics, class Ia",
    "ahfs_category": "24:04.04.04 - Class Ia Antiarrhythmics - 382396",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1992,
    "name": "QUINIDINE POLYGALACTURONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BA",
    "level4_name": "Antiarrhythmics, class Ia",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 118,
    "name": "QUININE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BC",
    "level4_name": "Methanolquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 382322",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1993,
    "name": "QUINUPRISTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01FG",
    "level4_name": "Streptogramins",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: quinupristin/dalfopristin"
  },
  {
    "id": 501,
    "name": "QUIZARTINIB DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 860,
    "name": "RABEPRAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": "56:28.36 - Proton-pump Inhibitors - 399033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1734,
    "name": "RADIUM RA-223 DICHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V10XX",
    "level4_name": "Various therapeutic radiopharmaceuticals",
    "ahfs_category": "78:00 - Radioactive Agents - 379145",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1229,
    "name": "RALOXIFENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03XC",
    "level4_name": "Selective estrogen receptor modulators",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 398007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1357,
    "name": "RALTEGRAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AJ",
    "level4_name": "Integrase inhibitors",
    "ahfs_category": "8:18.08.12 - HIV Integrase Inhibitors - 307032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 661,
    "name": "RAMELTEON",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CH",
    "level4_name": "Melatonin receptor agonists",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1115,
    "name": "RAMIPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "24:32.04 - Angiotensin-Converting Enzyme Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 861,
    "name": "RANITIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BA",
    "level4_name": "H2-receptor antagonists",
    "ahfs_category": "56:28.12 - Histamine H2-Antagonists - 384046",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 862,
    "name": "RANITIDINE BISMUTH",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BA",
    "level4_name": "H2-receptor antagonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1116,
    "name": "RANOLAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": "24:04.92 - Cardiac Drugs, Miscellaneous - 306010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1433,
    "name": "RAPACURONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1530,
    "name": "RASAGILINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BD",
    "level4_name": "Monoamine oxidase B inhibitors",
    "ahfs_category": "28:36.32 - Monoamine Oxidase B Inhibitors - 306024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1994,
    "name": "RAUWOLFIA SERPENTINA ROOT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AA",
    "level4_name": "Rauwolfia alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1117,
    "name": "REGADENOSON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01EB",
    "level4_name": "Other cardiac preparations",
    "ahfs_category": "36:18 - Cardiac Function - 309005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 502,
    "name": "REGORAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1995,
    "name": "RELEBACTAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01DH",
    "level4_name": "Carbapenems",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: imipenem, cilastatin and relebactam"
  },
  {
    "id": 503,
    "name": "RELUGOLIX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BX",
    "level4_name": "Other hormone antagonists and related agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1358,
    "name": "REMDESIVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1531,
    "name": "REMIFENTANIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AH",
    "level4_name": "Opioid anesthetics",
    "ahfs_category": "28:08.08 - Opiate Agonists - 308001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 591,
    "name": "REMIMAZOLAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 863,
    "name": "REPAGLINIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BX",
    "level4_name": "Other blood glucose lowering drugs, excl. insulins",
    "ahfs_category": "68:20.16 - Meglitinides - 300010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 504,
    "name": "REPOTRECTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1118,
    "name": "RESCINNAMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "C02AA",
    "level4_name": "Rauwolfia alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1119,
    "name": "RESERPINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02AA",
    "level4_name": "Rauwolfia alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1996,
    "name": "RESMETIROM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved March 2024 (Rezdiffra) for NASH - first NASH treatment"
  },
  {
    "id": 220,
    "name": "RETAPAMULIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06AX",
    "level4_name": "Other antibiotics for topical use",
    "ahfs_category": "84:04.04 - Antibacterials - 307012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1630,
    "name": "REVEFENACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 318059",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1997,
    "name": "REVUMENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved December 27, 2024 (Revuforj) for NPM1-mutant ALS"
  },
  {
    "id": 302,
    "name": "REZAFUNGIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J02AX",
    "level4_name": "Other antimycotics for systemic use",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1359,
    "name": "RIBAVIRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 386021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 505,
    "name": "RIBOCICLIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EF",
    "level4_name": "Cyclin-dependent kinase (CDK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1669,
    "name": "RIBOFLAVIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": "88:08 - Vitamin B Complex - 382585",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1670,
    "name": "RIBOFLAVIN 5'-",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1360,
    "name": "RIFABUTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 393009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 201,
    "name": "RIFAMPIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 382403",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 864,
    "name": "RIFAMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.28.30 - Rifamycins - 319008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1361,
    "name": "RIFAPENTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:16.04 - Antituberculosis Agents - 398033",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 180,
    "name": "RIFAXIMIN",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.28.30 - Rifamycins - 304016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1362,
    "name": "RILPIVIRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AG",
    "level4_name": "Non-nucleoside reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.16 - HIV Nonnucleoside Reverse Transcriptase",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1532,
    "name": "RILUZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "28:92 - Central Nervous System Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1363,
    "name": "RIMANTADINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AC",
    "level4_name": "Cyclic amines",
    "ahfs_category": "8:18.04 - Adamantanes - 398029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1533,
    "name": "RIMEGEPANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1274,
    "name": "RIMEXOLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": "52:08.08 - Corticosteroids - 396035",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1120,
    "name": "RIOCIGUAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KX",
    "level4_name": "Antihypertensives for pulmonary arterial hypertension",
    "ahfs_category": "48:48 - Vasodilating Agents - 314008",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 506,
    "name": "RIPRETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1434,
    "name": "RISDIPLAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1998,
    "name": "RISEDRONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BA",
    "level4_name": "Bisphosphonates",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 301004",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 639,
    "name": "RISPERIDONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AX",
    "level4_name": "Other antipsychotics",
    "ahfs_category": "28:16.08.04 - Atypical Antipsychotics - 394015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 507,
    "name": "RITLECITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AF",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1230,
    "name": "RITODRINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G02CA",
    "level4_name": "Sympathomimetics, labour repressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1364,
    "name": "RITONAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 396029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 935,
    "name": "RIVAROXABAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AF",
    "level4_name": "Direct factor Xa inhibitors",
    "ahfs_category": "20:12.04.14 - Direct Factor Xa Inhibitors - 312005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 711,
    "name": "RIVASTIGMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": "12:04 - Parasympathomimetic (Cholinergic) Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1534,
    "name": "RIZATRIPTAN BENZOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": "28:32.28 - Selective Serotonin Agonists - 301033",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1435,
    "name": "ROCURONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 394016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1436,
    "name": "ROFECOXIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AH",
    "level4_name": "Coxibs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1181,
    "name": "ROFLUMILAST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AX",
    "level4_name": "Other antipsoriatics for topical use",
    "ahfs_category": "48:32 - Phosphodiesterase Type 4 Inhibitors - 311030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 865,
    "name": "ROLAPITANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": "56:22.32 - Neurokinin-1 Receptor Antagonists - 316057",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 508,
    "name": "ROMIDEPSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XH",
    "level4_name": "Histone deacetylase (HDAC) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 310004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1535,
    "name": "ROPINIROLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N04BC",
    "level4_name": "Dopamine agonists",
    "ahfs_category": "28:36.20.08 - Nonergot-derivative Dopamine Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 320,
    "name": "ROPIVACAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N01BB",
    "level4_name": "Amides",
    "ahfs_category": "72:00 - Local Anesthetics - 319004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1999,
    "name": "ROSE BENGAL I-131",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Substance not found in WHO ATC database - may be too new, discontinued, regional, diagnostic agent, or excipient"
  },
  {
    "id": 866,
    "name": "ROSIGLITAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BG",
    "level4_name": "Thiazolidinediones",
    "ahfs_category": "68:20.28 - Thiazolidinediones - 399023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1121,
    "name": "ROSUVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 303040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1536,
    "name": "ROTIGOTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BC",
    "level4_name": "Dopamine agonists",
    "ahfs_category": "28:36.20.08 - Nonergot-derivative Dopamine Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 33,
    "name": "RUBIDIUM CHLORIDE RB-82",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09GX",
    "level4_name": "Other cardiovascular system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved Rb-82 chloride for cardiac PET imaging; name variant between FDA and WHO nomenclature; active diagnostic agent generated from Sr-82/Rb-82 generator (CardioGen-82)"
  },
  {
    "id": 2000,
    "name": "RUCAPARIB CAMSYLATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XK",
    "level4_name": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1537,
    "name": "RUFINAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AF",
    "level4_name": "Carboxamide derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 309011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1182,
    "name": "RUXOLITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2131,
    "name": "Rabies Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 381041",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2318,
    "name": "Rabies Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 381042",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2217,
    "name": "Ramucirumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FG",
    "level4_name": "VEGF/VEGFR (Vascular Endothelial Growth Factor / -Receptor) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315007",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2218,
    "name": "Ranibizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01LA",
    "level4_name": "Antineovascularisation agents",
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 306023",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2102,
    "name": "Rasburicase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "V03AF",
    "level4_name": "Detoxifying agents for antineoplastic treatment",
    "ahfs_category": "44:00 - Enzymes - 302031",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2219,
    "name": "Ravulizumab-cwvz",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": "92:32 - Complement Inhibitors - 319002",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2220,
    "name": "Raxibacumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J06BC",
    "level4_name": "Antibacterial monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 316019",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2221,
    "name": "Reslizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DX",
    "level4_name": "Other systemic drugs for obstructive airway diseases",
    "ahfs_category": "48:10.20 - Interleukin Antagonists - 316052",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2286,
    "name": "Reteplase",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AD",
    "level4_name": "Enzymes",
    "ahfs_category": "20:12.20 - Thrombolytic Agents - 301057",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2132,
    "name": "Rho(D) Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 382806",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2222,
    "name": "Rilonacept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2223,
    "name": "RimabotulinumtoxinB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2319,
    "name": "Rotavirus Vaccine Live Oral",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 306006",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2320,
    "name": "Rubella Virus Vaccine Live",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BD",
    "level4_name": "Measles vaccines",
    "ahfs_category": "80:12 - Vaccines - 382560",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2287,
    "name": "Rucaparib",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XK",
    "level4_name": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 317001",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2001,
    "name": "SACUBITRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09DX",
    "level4_name": "Angiotensin II receptor blockers (ARBs), other combinations",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: valsartan and sacubitril"
  },
  {
    "id": 2002,
    "name": "SAFFLOWER OIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AB",
    "level4_name": "Contact laxatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1538,
    "name": "SAFINAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BD",
    "level4_name": "Monoamine oxidase B inhibitors",
    "ahfs_category": "28:36.32 - Monoamine Oxidase B Inhibitors - 317037",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2003,
    "name": "SALMETEROL XINAFOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 34,
    "name": "SAMARIUM SM-153 LEXIDRONAM PENTASODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved March 16, 1997 (Quadramet) for bone pain from metastases"
  },
  {
    "id": 2004,
    "name": "SAMIDORPHAN L-MALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N05AH",
    "level4_name": "Diazepines, oxazepines, thiazepines and oxepines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 867,
    "name": "SAPROPTERIN DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1365,
    "name": "SAQUINAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 396001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 509,
    "name": "SARALASIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "L01XA",
    "level4_name": "Platinum compounds",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Saralasin not in WHO ATC database. Angiotensin II receptor antagonist peptide. Used diagnostically to detect renin-dependent hypertension. Obsolete; replaced by modern ARBs. Would belong to C09CA (angiotensin II receptor antagonists) if listed. Completely different from satraplatin (platinum chemotherapy). Corrected 2025-10-16."
  },
  {
    "id": 67,
    "name": "SARECYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01AA",
    "level4_name": "Tetracyclines",
    "ahfs_category": "8:12.24.04 - Aminomethylcyclines - 318051",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 868,
    "name": "SAXAGLIPTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BH",
    "level4_name": "Dipeptidyl peptidase 4 (DPP-4) inhibitors",
    "ahfs_category": "68:20.05 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 869,
    "name": "SCOPOLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A04AD",
    "level4_name": "Other antiemetics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 384023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 936,
    "name": "SEBETRALSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AC",
    "level4_name": "Drugs used in hereditary angioedema",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 110,
    "name": "SECNIDAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01AB",
    "level4_name": "Nitroimidazole derivatives",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 317057",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 656,
    "name": "SECOBARBITAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CA",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": "28:24.04 - Barbiturates - 382386",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1735,
    "name": "SECRETIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CK",
    "level4_name": "Tests for pancreatic function",
    "ahfs_category": "36:61 - Pancreatic Function - 382175",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2005,
    "name": "SECRETIN SYNTHETIC HUMAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CK",
    "level4_name": "Tests for pancreatic function",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 2006,
    "name": "SECRETIN SYNTHETIC PORCINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CK",
    "level4_name": "Tests for pancreatic function",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 146,
    "name": "SEGESTERONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03DA",
    "level4_name": "Pregnen (4) derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2007,
    "name": "SELADELPAR LYSINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A05AX",
    "level4_name": "Other drugs for bile therapy",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1539,
    "name": "SELEGILINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BD",
    "level4_name": "Monoamine oxidase B inhibitors",
    "ahfs_category": "28:36.32 - Monoamine Oxidase B Inhibitors - 397046",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2008,
    "name": "SELENIOUS ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "40:12 - Replacement Preparations - 317053",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved 2019 for selenium supplementation in parenteral nutrition"
  },
  {
    "id": 212,
    "name": "SELENIUM SULFIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "84:04.92 - Local Anti-infectives, Miscellaneous - 382258",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2009,
    "name": "SELENOMETHIONINE SE-75",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 937,
    "name": "SELEXIPAG",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "48:48 - Vasodilating Agents - 316054",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 510,
    "name": "SELINEXOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 511,
    "name": "SELPERCATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 512,
    "name": "SELUMETINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EE",
    "level4_name": "Mitogen-activated protein kinase (MEK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 870,
    "name": "SEMAGLUTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BJ",
    "level4_name": "Glucagon-like peptide-1 (GLP-1) analogues",
    "ahfs_category": "68:20.06 - Incretin Mimetics - 317067",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2010,
    "name": "SEPIAPTERIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved July 28, 2025 (Sephience) for phenylketonuria"
  },
  {
    "id": 2011,
    "name": "SERDEXMETHYLPHENIDATE CHLORIDE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1275,
    "name": "SERMORELIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01AC",
    "level4_name": "Somatropin and somatropin agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 209,
    "name": "SERTACONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 305002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 685,
    "name": "SERTRALINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": "28:16.04.20 - Selective Serotonin-reuptake Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 871,
    "name": "SETMELANOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A08AA",
    "level4_name": "Centrally acting antiobesity products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1736,
    "name": "SEVELAMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AE",
    "level4_name": "Drugs for treatment of hyperkalemia and hyperphosphatemia",
    "ahfs_category": "40:18.19 - Phosphate-removing Agents - 301070",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match. Phosphate binder for chronic kidney disease. Mapped 2025-10-16."
  },
  {
    "id": 1540,
    "name": "SEVOFLURANE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AB",
    "level4_name": "Halogenated hydrocarbons",
    "ahfs_category": "28:04.16 - Inhalation Anesthetics - 379153",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 872,
    "name": "SIBUTRAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A08AA",
    "level4_name": "Centrally acting antiobesity products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1231,
    "name": "SILDENAFIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BE",
    "level4_name": "Drugs used in erectile dysfunction",
    "ahfs_category": "24:12.12 - Phosphodiesterase Type 5 Inhibitors - 399015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1232,
    "name": "SILODOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "12:16.04.12 - Selective alpha-1-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1183,
    "name": "SILVER SULFADIAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BA",
    "level4_name": "Sulfonamides",
    "ahfs_category": "84:04.92 - Local Anti-infectives, Miscellaneous - 382598",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1366,
    "name": "SIMEPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 314011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 171,
    "name": "SIMETHICONE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P03AX",
    "level4_name": "Other ectoparasiticides, incl. scabicides",
    "ahfs_category": "56:10 - Antiflatulents - 382683",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2012,
    "name": "SIMETHICONE-CELLULOSE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Simethicone with cellulose carrier; WHO lists as simethicone"
  },
  {
    "id": 1122,
    "name": "SIMVASTATIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C10AA",
    "level4_name": "HMG CoA reductase inhibitors",
    "ahfs_category": "24:06.08 - HMG-CoA Reductase Inhibitors - 392030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1737,
    "name": "SINCALIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V04CC",
    "level4_name": "Tests for bile duct patency",
    "ahfs_category": "36:34 - Gallbladder Function - 382192",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 225,
    "name": "SINECATECHINS",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D06BB",
    "level4_name": "Antivirals",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 513,
    "name": "SIPONIMOD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AE",
    "level4_name": "Sphingosine-1-phosphate (S1P) receptor modulators",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 514,
    "name": "SIROLIMUS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EG",
    "level4_name": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
    "ahfs_category": "92:44 - Immunosuppressive Agents - 300009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 873,
    "name": "SITAGLIPTIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BH",
    "level4_name": "Dipeptidyl peptidase 4 (DPP-4) inhibitors",
    "ahfs_category": "68:20.05 - Dipeptidyl Peptidase-4 (DPP-4) Inhibitors -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1367,
    "name": "SOFOSBUVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.16 - HCV Polymerase Inhibitors - 314012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 874,
    "name": "SOFPIRONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1233,
    "name": "SOLIFENACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.04 - Antimuscarinics - 305007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 604,
    "name": "SOLRIAMFETOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06BA",
    "level4_name": "Centrally acting sympathomimetics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 515,
    "name": "SONIDEGIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XJ",
    "level4_name": "Hedgehog pathway inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 516,
    "name": "SORAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 306001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 875,
    "name": "SORBITOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A06AD",
    "level4_name": "Osmotically acting laxatives",
    "ahfs_category": "40:24 - Salt and Sugar Substitutes - 379167",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 876,
    "name": "SOTAGLIFLOZIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BK",
    "level4_name": "Sodium-glucose co-transporter 2 (SGLT2) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1123,
    "name": "SOTALOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 393010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 517,
    "name": "SOTORASIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1368,
    "name": "SPARFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1124,
    "name": "SPARSENTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09XX",
    "level4_name": "Other agents acting on the renin-angiotensin system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1369,
    "name": "SPECTINOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2013,
    "name": "SPINOSAD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "84:04.12 - Scabicides and Pediculicides - 311033",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 12, 2011 (Natroba) for head lice treatment"
  },
  {
    "id": 1125,
    "name": "SPIRAPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1126,
    "name": "SPIRONOLACTONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03DA",
    "level4_name": "Aldosterone antagonists",
    "ahfs_category": "24:32.20 - Mineralocorticoid (Aldosterone) Receptor",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 877,
    "name": "STANOZOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A14AA",
    "level4_name": "Androstan derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1370,
    "name": "STAVUDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1541,
    "name": "STIRIPENTOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 318040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 326,
    "name": "STREPTOMYCIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.02 - Aminoglycosides - 382665",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 518,
    "name": "STREPTOZOCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AD",
    "level4_name": "Nitrosoureas",
    "ahfs_category": "10:00 - Antineoplastic Agents - 384053",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2014,
    "name": "STRONTIUM CHLORIDE SR-89",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved June 18, 1993 (Metastron) for bone pain from metastases; brand discontinued but generic may be available"
  },
  {
    "id": 2015,
    "name": "SUCCIMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09CA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 392031",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 2016,
    "name": "SUCCINYLCHOLINE CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AB",
    "level4_name": "Choline derivatives",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 382554",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 196,
    "name": "SUCRALFATE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A02BX",
    "level4_name": "Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)",
    "ahfs_category": "56:28.32 - Protectants - 381049",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1542,
    "name": "SUFENTANIL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AH",
    "level4_name": "Opioid anesthetics",
    "ahfs_category": "28:08.08 - Opiate Agonists - 384066",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1738,
    "name": "SUGAMMADEX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "92:12 - Antidotes - 316070",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 80,
    "name": "SULBACTAM",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J01CG",
    "level4_name": "Beta-lactamase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 207,
    "name": "SULCONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 398018",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1184,
    "name": "SULFACETAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AF",
    "level4_name": "Antiinfectives for treatment of acne",
    "ahfs_category": "52:04.04 - Antibacterials - 382045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2017,
    "name": "SULFACYTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Short-acting sulfonamide antibiotic; would be in J01EB if listed (discontinued)"
  },
  {
    "id": 1371,
    "name": "SULFADIAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01EC",
    "level4_name": "Intermediate-acting sulfonamides",
    "ahfs_category": "8:12.20 - Sulfonamides - 382130",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1372,
    "name": "SULFADOXINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01ED",
    "level4_name": "Long-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1185,
    "name": "SULFAMERAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BA",
    "level4_name": "Sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2018,
    "name": "SULFAMETER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "approximation",
    "who_mapping_notes": "Short-acting sulfonamide antibiotic; would be in J01EB if listed (discontinued)"
  },
  {
    "id": 938,
    "name": "SULFAMETHIZOLE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05CA",
    "level4_name": "Antiinfectives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1373,
    "name": "SULFAMETHOXAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01EC",
    "level4_name": "Intermediate-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1186,
    "name": "SULFANILAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BA",
    "level4_name": "Sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1374,
    "name": "SULFAPHENAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01ED",
    "level4_name": "Long-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1375,
    "name": "SULFAPYRIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01EB",
    "level4_name": "Short-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 878,
    "name": "SULFASALAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07EC",
    "level4_name": "Aminosalicylic acid and similar agents",
    "ahfs_category": "8:12.20 - Sulfonamides - 382204",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1437,
    "name": "SULFINPYRAZONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "M04AB",
    "level4_name": "Preparations increasing uric acid excretion",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 2019,
    "name": "SULFISOXAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: sulfisoxazole; INN name: sulfafurazole"
  },
  {
    "id": 2020,
    "name": "SULFISOXAZOLE ACETYL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Brand discontinued; Gantrisin (sulfisoxazole acetyl pediatric suspension) brand discontinued; sulfonamide antibiotic first approved 1948; some formulations marketed until 1982; brand name no longer available though generic versions may exist"
  },
  {
    "id": 2021,
    "name": "SULFISOXAZOLE DIOLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: sulfisoxazole diolamine (salt form); INN name: sulfafurazole"
  },
  {
    "id": 1376,
    "name": "SULFOXONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01EC",
    "level4_name": "Intermediate-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Sulfoxone not in WHO ATC database. Sulfonamide antibiotic for leprosy/dermatitis herpetiformis. Largely replaced by dapsone and other agents. Would belong to J04BA (drugs for treatment of leprosy) if listed. Different from sulfamoxole (sulfonamide for UTI). Corrected 2025-10-16."
  },
  {
    "id": 1187,
    "name": "SULFUR",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "D10AB",
    "level4_name": "Preparations containing sulfur",
    "ahfs_category": "84:28 - Keratolytic Agents - 382726",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1739,
    "name": "SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "V08DA",
    "level4_name": "Ultrasound contrast media",
    "ahfs_category": "36:68 - Roentgenographic and Other Imaging Agents -",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Ultrasound contrast agent. WHO code V08DA05 includes phospholipid microsphere formulation. Corrected 2025-10-16."
  },
  {
    "id": 1438,
    "name": "SULINDAC",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AB",
    "level4_name": "Acetic acid derivatives and related substances",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2022,
    "name": "SULOPENEM ETZADROXIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved October 25, 2024 (Orlynvah) for uncomplicated UTI - first oral penem in US"
  },
  {
    "id": 1543,
    "name": "SUMATRIPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": "28:32.28 - Selective Serotonin Agonists - 396023",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2023,
    "name": "SUNITINIB MALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2024,
    "name": "SUNVOZERTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved July 2, 2025 (Zegfrovy) for EGFR exon 20+ NSCLC"
  },
  {
    "id": 1439,
    "name": "SUPROFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AE",
    "level4_name": "Propionic acid derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 663,
    "name": "SUVOREXANT",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CJ",
    "level4_name": "Orexin receptor antagonists",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2025,
    "name": "SUZETRIGINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved January 30, 2025 (Journavx) for acute pain - first new pain mechanism in 20 years"
  },
  {
    "id": 2103,
    "name": "Sacrosidase",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 301036",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2288,
    "name": "Sargramostim",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AA",
    "level4_name": "Colony stimulating factors",
    "ahfs_category": "20:16 - Hematopoietic Agents - 393005",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2224,
    "name": "Sarilumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2104,
    "name": "Sebelipase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 316050",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2225,
    "name": "Secukinumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2226,
    "name": "Siltuximab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 315037",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2289,
    "name": "Sipuleucel-T",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L03AX",
    "level4_name": "Other immunostimulants",
    "ahfs_category": "26:04 - Cellular Therapy - 379155",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2133,
    "name": "Smallpox Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 379156",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2290,
    "name": "Sofosbuvir and Velpatasvir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.16 - HCV Polymerase Inhibitors - 317003",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2291,
    "name": "Sofosbuvir, Velpatasvir, Voxilaprevir",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": "8:18.40.16 - HCV Polymerase Inhibitors - 317048",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 709,
    "name": "TACRINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06DA",
    "level4_name": "Anticholinesterases",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1188,
    "name": "TACROLIMUS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D11AH",
    "level4_name": "Agents for dermatitis, excluding corticosteroids",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1234,
    "name": "TADALAFIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BE",
    "level4_name": "Drugs used in erectile dysfunction",
    "ahfs_category": "24:12.12 - Phosphodiesterase Type 5 Inhibitors - 303047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1544,
    "name": "TAFAMIDIS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 35,
    "name": "TAFAMIDIS MEGLUMINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Active medication; tafamidis meglumine (Vyndaqel) FDA-approved May 2019 for transthyretin amyloid cardiomyopathy; name variant due to meglumine salt form"
  },
  {
    "id": 116,
    "name": "TAFENOQUINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "P01BA",
    "level4_name": "Aminoquinolines",
    "ahfs_category": "8:30.08 - Antimalarials - 319007",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1671,
    "name": "TAFLUPROST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": "52:40.28 - Prostaglandin Analogs - 312022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 519,
    "name": "TALAZOPARIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XK",
    "level4_name": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 318057",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 657,
    "name": "TALBUTAL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05CA",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 2026,
    "name": "TALETRECTINIB ADIPATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 8, 2025 (Televory) for ROS1+ NSCLC"
  },
  {
    "id": 520,
    "name": "TAMOXIFEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BA",
    "level4_name": "Anti-estrogens",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 382414",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1235,
    "name": "TAMSULOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "12:16.04.12 - Selective alpha-1-Adrenergic Blocking",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1127,
    "name": "TANNIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CC",
    "level4_name": "Aryloxyacetic acid derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 574,
    "name": "TAPENTADOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AX",
    "level4_name": "Other opioids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 310002",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1189,
    "name": "TAPINAROF",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AX",
    "level4_name": "Other antipsoriatics for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 662,
    "name": "TASIMELTEON",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CH",
    "level4_name": "Melatonin receptor agonists",
    "ahfs_category": "28:24.92 - Anxiolytics, Sedatives, and Hypnotics;",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 939,
    "name": "TAUROLIDINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "B05CA",
    "level4_name": "Antiinfectives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2028,
    "name": "TAURURSODIOL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; Relyvrio (sodium phenylbutyrate and taurursodiol) approved September 29, 2022 for ALS; voluntarily withdrawn April 4, 2024 after Phase 3 PHOENIX trial failed to demonstrate benefit vs placebo"
  },
  {
    "id": 217,
    "name": "TAVABOROLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "84:04.08.24 - Oxaboroles - 314026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1190,
    "name": "TAZAROTENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AX",
    "level4_name": "Other antipsoriatics for topical use",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 521,
    "name": "TAZEMETOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 283,
    "name": "TAZOBACTAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01CG",
    "level4_name": "Beta-lactamase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 36,
    "name": "TECHNETIUM TC-99M APCITIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved for imaging (AcuTect); name variant between FDA and WHO nomenclature; active diagnostic agent used in hospital/nuclear medicine settings"
  },
  {
    "id": 37,
    "name": "TECHNETIUM TC-99M BICISATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved brain imaging kit (Neurolite); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 38,
    "name": "TECHNETIUM TC-99M DEPREOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved for pulmonary imaging (NeoTect); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 39,
    "name": "TECHNETIUM TC-99M DISOFENIN KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09DA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved hepatobiliary imaging kit (Hepatolite); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 40,
    "name": "TECHNETIUM TC-99M ETIDRONATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved bone imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 41,
    "name": "TECHNETIUM TC-99M EXAMETAZIME KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved brain/infection imaging kit (Ceretec); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 42,
    "name": "TECHNETIUM TC-99M FERPENTETATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 43,
    "name": "TECHNETIUM TC-99M GLUCEPTATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal/brain imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 44,
    "name": "TECHNETIUM TC-99M LABELED CARBON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; radiolabeled carbon compound for imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 45,
    "name": "TECHNETIUM TC-99M LIDOFENIN KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; hepatobiliary imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 46,
    "name": "TECHNETIUM TC-99M MEBROFENIN KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved hepatobiliary imaging kit (Choletec); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 47,
    "name": "TECHNETIUM TC-99M MEDRONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved bone imaging agent; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 48,
    "name": "TECHNETIUM TC-99M MEDRONATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved bone imaging kit (MDP kit); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 49,
    "name": "TECHNETIUM TC-99M MERTIATIDE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal imaging kit (MAG3, TechneScan MAG3); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 50,
    "name": "TECHNETIUM TC-99M OXIDRONATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved bone imaging kit (HDP kit, TechneScan HDP); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 51,
    "name": "TECHNETIUM TC-99M PENTETATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal/brain imaging kit (DTPA); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 52,
    "name": "TECHNETIUM TC-99M PERTECHNETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved multi-purpose imaging agent; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 53,
    "name": "TECHNETIUM TC-99M PERTECHNETATE GENERATOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical generator; FDA-approved Mo-99/Tc-99m generator system; name variant between FDA and WHO nomenclature; active device"
  },
  {
    "id": 54,
    "name": "TECHNETIUM TC-99M POLYPHOSPHATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09BA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; bone imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 55,
    "name": "TECHNETIUM TC-99M PYRO",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; pyrophosphate for bone/cardiac imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 56,
    "name": "TECHNETIUM TC-99M PYROPHOSPHATE KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09BA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved bone/cardiac imaging kit (TechneScan PYP); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 57,
    "name": "TECHNETIUM TC-99M RED BLOOD CELL KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved RBC labeling kit for imaging; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 58,
    "name": "TECHNETIUM TC-99M SESTAMIBI KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09GA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved cardiac/parathyroid imaging kit (Cardiolite); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 59,
    "name": "TECHNETIUM TC-99M SUCCIMER",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09CA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal imaging agent (DMSA); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 60,
    "name": "TECHNETIUM TC-99M SUCCIMER KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09CA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved renal imaging kit (DMSA kit); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 61,
    "name": "TECHNETIUM TC-99M SULFUR COLLOID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09DB",
    "level4_name": "Technetium (99mTc), particles and colloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved liver/spleen/bone marrow imaging agent; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 62,
    "name": "TECHNETIUM TC-99M SULFUR COLLOID KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09DB",
    "level4_name": "Technetium (99mTc), particles and colloids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved liver/spleen imaging kit; name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 63,
    "name": "TECHNETIUM TC-99M TEBOROXIME KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved cardiac imaging kit (CardioTec); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 64,
    "name": "TECHNETIUM TC-99M TETROFOSMIN KIT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09GA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved cardiac imaging kit (Myoview); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 65,
    "name": "TECHNETIUM TC-99M TILMANOCEPT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09AA",
    "level4_name": "Technetium (99mTc) compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Diagnostic radiopharmaceutical; FDA-approved lymphatic mapping agent (Lymphoseek); name variant between FDA and WHO nomenclature; active diagnostic agent"
  },
  {
    "id": 1377,
    "name": "TECOVIRIMAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AX",
    "level4_name": "Other antivirals",
    "ahfs_category": "84:04.08.08 - Azoles - 388022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1378,
    "name": "TEDIZOLID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XX",
    "level4_name": "Other antibacterials",
    "ahfs_category": "8:12.28.24 - Oxazolidinones - 315010",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 879,
    "name": "TEDUGLUTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 313026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 880,
    "name": "TEGASEROD",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 302032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1379,
    "name": "TELAPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AP",
    "level4_name": "Antivirals for treatment of HCV infections",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1380,
    "name": "TELAVANCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01XA",
    "level4_name": "Glycopeptide antibacterials",
    "ahfs_category": "8:12.28.16 - Glycopeptides - 310005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1381,
    "name": "TELBIVUDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 307005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 300,
    "name": "TELITHROMYCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01FA",
    "level4_name": "Macrolides",
    "ahfs_category": "8:12.12.12 - Ketolides - 304011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1128,
    "name": "TELMISARTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": "24:32.08 - Angiotensin II Receptor Antagonists - 302016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2029,
    "name": "TELOTRISTAT ETIPRATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 588,
    "name": "TEMAZEPAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 384003",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 522,
    "name": "TEMOZOLOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AX",
    "level4_name": "Other alkylating agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 399025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 523,
    "name": "TEMSIROLIMUS",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EG",
    "level4_name": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 307013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 881,
    "name": "TENAPANOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A06AX",
    "level4_name": "Other drugs for constipation",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 524,
    "name": "TENIPOSIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CB",
    "level4_name": "Podophyllotoxin derivatives",
    "ahfs_category": "10:00 - Antineoplastic Agents - 392045",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1382,
    "name": "TENOFOVIR ALAFENAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1383,
    "name": "TENOFOVIR DISOPROXIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": "8:18.08.20 - HIV Nucleoside and Nucleotide Reverse",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 525,
    "name": "TEPOTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1236,
    "name": "TERAZOSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04CA",
    "level4_name": "Alpha-adrenoreceptor antagonists",
    "ahfs_category": "24:20 - alpha-Adrenergic Blocking Agents - 393046",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 214,
    "name": "TERBINAFINE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AE",
    "level4_name": "Other antifungals for topical use",
    "ahfs_category": "8:14.04 - Allylamines - 396039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1631,
    "name": "TERBUTALINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AC",
    "level4_name": "Selective beta-2-adrenoreceptor agonists",
    "ahfs_category": "12:12.08.12 - Selective beta-2-Adrenergic Agonists -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1237,
    "name": "TERCONAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G01AG",
    "level4_name": "Triazole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 526,
    "name": "TERIFLUNOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AK",
    "level4_name": "Dihydroorotate dehydrogenase (DHODH) inhibitors",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 313047",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1276,
    "name": "TERIPARATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H05AA",
    "level4_name": "Parathyroid hormones and analogues",
    "ahfs_category": "68:24.08 - Parathyroid Agents - 302043",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match. Recombinant human parathyroid hormone fragment for osteoporosis. Mapped 2025-10-16."
  },
  {
    "id": 1277,
    "name": "TERLIPRESSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01BA",
    "level4_name": "Vasopressin and analogues",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2030,
    "name": "TESTOLACTONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; aromatase inhibitor (Teslac) for breast cancer; discontinued in 2008 due to moderate clinical response; replaced by newer agents"
  },
  {
    "id": 557,
    "name": "TESTOSTERONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": "68:08 - Androgens - 382684",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 558,
    "name": "TESTOSTERONE CYPIONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 559,
    "name": "TESTOSTERONE ENANTHATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 560,
    "name": "TESTOSTERONE UNDECANOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G03BA",
    "level4_name": "3-oxoandrosten (4) derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1545,
    "name": "TETRABENAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "28:56 - Vesicular Monoamine Transporter 2 (VMAT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1129,
    "name": "TETRACAINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05AD",
    "level4_name": "Local anesthetics",
    "ahfs_category": "52:16 - Local Anesthetics - 382486",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 181,
    "name": "TETRACYCLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A01AB",
    "level4_name": "Antiinfectives and antiseptics for local oral treatment",
    "ahfs_category": "84:04.04 - Antibacterials - 382383",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2032,
    "name": "TETRADECYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C05BB",
    "level4_name": "Sclerosing agents for local injection",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1632,
    "name": "TETRAHYDROZOLINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R01AA",
    "level4_name": "Sympathomimetics, plain",
    "ahfs_category": "52:32 - Vasoconstrictors - 382563",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2034,
    "name": "TEZACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: ivacaftor and tezacaftor"
  },
  {
    "id": 527,
    "name": "THALIDOMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AX",
    "level4_name": "Other immunosuppressants",
    "ahfs_category": "92:20 - Immunomodulatory Agents - 399032",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2035,
    "name": "THALLOUS CHLORIDE TL-201",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09GX",
    "level4_name": "Other cardiovascular system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1633,
    "name": "THEOPHYLLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DA",
    "level4_name": "Xanthines",
    "ahfs_category": "86:16 - Respiratory Smooth Muscle Relaxants - 381006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2036,
    "name": "THEOPHYLLINE GLYCINATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DA",
    "level4_name": "Xanthines",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 204,
    "name": "THIABENDAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2037,
    "name": "THIAMYLAL",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "28:04.04 - Barbiturates - 379180",
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 1634,
    "name": "THIETHYLPERAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AD",
    "level4_name": "Phenothiazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1635,
    "name": "THIETHYLPERAZINE MALATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AD",
    "level4_name": "Phenothiazine derivatives",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 529,
    "name": "THIOGUANINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01BB",
    "level4_name": "Purine analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382099",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1546,
    "name": "THIOPENTAL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N01AF",
    "level4_name": "Barbiturates, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 619,
    "name": "THIORIDAZINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AC",
    "level4_name": "Phenothiazines with piperidine structure",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382119",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1740,
    "name": "THIOSULFATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 530,
    "name": "THIOTEPA",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "L01AC",
    "level4_name": "Ethylene imines",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382821",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 629,
    "name": "THIOTHIXENE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N05AF",
    "level4_name": "Thioxanthene derivatives",
    "ahfs_category": "28:16.08.32 - Thioxanthenes - 382867",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1636,
    "name": "THONZONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R05DB",
    "level4_name": "Other cough suppressants",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1547,
    "name": "TIAGABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AG",
    "level4_name": "Fatty acid derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 398014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 940,
    "name": "TICAGRELOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 312030",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2038,
    "name": "TICARCILLIN DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01CA",
    "level4_name": "Penicillins with extended spectrum",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 941,
    "name": "TICLOPIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 395036",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 272,
    "name": "TIGECYCLINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01AA",
    "level4_name": "Tetracyclines",
    "ahfs_category": "8:12.24.12 - Glycylcyclines - 305040",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2039,
    "name": "TILUDRONATE DISODIUM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BA",
    "level4_name": "Bisphosphonates",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1130,
    "name": "TIMOLOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C07AA",
    "level4_name": "Beta blocking agents, non-selective",
    "ahfs_category": "24:24 - beta-Adrenergic Blocking Agents - 384029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1238,
    "name": "TINIDAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G01AF",
    "level4_name": "Imidazole derivatives",
    "ahfs_category": "8:30.92 - Antiprotozoals, Miscellaneous - 304014",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 942,
    "name": "TINZAPARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AB",
    "level4_name": "Heparin group",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 205,
    "name": "TIOCONAZOLE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D01AC",
    "level4_name": "Imidazole and triazole derivatives",
    "ahfs_category": "84:04.08.08 - Azoles - 398017",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1239,
    "name": "TIOPRONIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BX",
    "level4_name": "Other urologicals",
    "ahfs_category": "92:92 - Other Miscellaneous Therapeutic Agents -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1637,
    "name": "TIOTROPIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 304004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2040,
    "name": "TIPIRACIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved September 22, 2015 (Lonsurf, with trifluridine) for metastatic colorectal cancer"
  },
  {
    "id": 1384,
    "name": "TIPRANAVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AE",
    "level4_name": "Protease inhibitors",
    "ahfs_category": "8:18.08.08 - HIV Protease Inhibitors - 305041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1191,
    "name": "TIRBANIBULIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D06BX",
    "level4_name": "Other chemotherapeutics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 943,
    "name": "TIROFIBAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 399039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 882,
    "name": "TIRZEPATIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BX",
    "level4_name": "Other blood glucose lowering drugs, excl. insulins",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 531,
    "name": "TIVOZANIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EK",
    "level4_name": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1440,
    "name": "TIZANIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03BX",
    "level4_name": "Other centrally acting agents",
    "ahfs_category": "12:20.04 - Centrally Acting Skeletal Muscle Relaxants -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 327,
    "name": "TOBRAMYCIN",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "J01GB",
    "level4_name": "Other aminoglycosides",
    "ahfs_category": "8:12.02 - Aminoglycosides - 382660",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1131,
    "name": "TOCAINIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01BB",
    "level4_name": "Antiarrhythmics, class Ib",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2041,
    "name": "TOCOPHEROL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 532,
    "name": "TOFACITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AF",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1548,
    "name": "TOFERSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 883,
    "name": "TOLAZAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 382482",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1132,
    "name": "TOLAZOLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C04AB",
    "level4_name": "Imidazoline derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 884,
    "name": "TOLBUTAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BB",
    "level4_name": "Sulfonylureas",
    "ahfs_category": "68:20.20 - Sulfonylureas - 382481",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1549,
    "name": "TOLCAPONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04BX",
    "level4_name": "Other dopaminergic agents",
    "ahfs_category": "28:36.12 - Catechol-O-Methyltransferase (COMT)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1441,
    "name": "TOLMETIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AB",
    "level4_name": "Acetic acid derivatives and related substances",
    "ahfs_category": "28:08.04.92 - Other Nonsteroidal Anti-inflammatory",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1240,
    "name": "TOLTERODINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": "86:12.04 - Antimuscarinics - 399026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1133,
    "name": "TOLVAPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03XA",
    "level4_name": "Vasopressin antagonists",
    "ahfs_category": "40:28.28 - Vasopressin Antagonists - 309026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1550,
    "name": "TOPIRAMATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 397012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 533,
    "name": "TOPOTECAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CE",
    "level4_name": "Topoisomerase 1 (TOP1) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 397006",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 534,
    "name": "TOREMIFENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02BA",
    "level4_name": "Anti-estrogens",
    "ahfs_category": "68:16.12 - Estrogen Agonists-Antagonists - 398005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1134,
    "name": "TORSEMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03CA",
    "level4_name": "Sulfonamides, plain",
    "ahfs_category": "40:28.08 - Loop Diuretics - 394018",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 535,
    "name": "TOVORAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 536,
    "name": "TRABECTEDIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CX",
    "level4_name": "Other plant alkaloids and natural products",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316029",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 572,
    "name": "TRAMADOL",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N02AX",
    "level4_name": "Other opioids",
    "ahfs_category": "28:08.08 - Opiate Agonists - 395011",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2042,
    "name": "TRAMETINIB DIMETHYL SULFOXIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EE",
    "level4_name": "Mitogen-activated protein kinase (MEK) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 313040",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1135,
    "name": "TRANDOLAPRIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09AA",
    "level4_name": "ACE inhibitors, plain",
    "ahfs_category": "52:92 - EENT Drugs, Miscellaneous - 300012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 944,
    "name": "TRANEXAMIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02AA",
    "level4_name": "Amino acids",
    "ahfs_category": "20:28.16 - Hemostatics - 379197",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 692,
    "name": "TRANYLCYPROMINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AF",
    "level4_name": "Monoamine oxidase inhibitors, non-selective",
    "ahfs_category": "28:16.04.12 - Monoamine Oxidase Inhibitors - 382088",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1672,
    "name": "TRAVOPROST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": "52:40.28 - Prostaglandin Analogs - 301016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 693,
    "name": "TRAZODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.24 - Serotonin Modulators - 381038",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 537,
    "name": "TREOSULFAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01AB",
    "level4_name": "Alkyl sulfonates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 945,
    "name": "TREPROSTINIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "48:48 - Vasodilating Agents - 302021",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 946,
    "name": "TREPROSTINIL DIOLAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 254,
    "name": "TRETINOIN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D10AD",
    "level4_name": "Retinoids for topical use in acne",
    "ahfs_category": "10:00 - Antineoplastic Agents - 303005",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 885,
    "name": "TRIAMCINOLONE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": "52:08.08 - Corticosteroids - 301019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 886,
    "name": "TRIAMCINOLONE ACETONIDE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2043,
    "name": "TRIAMCINOLONE DIACETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A01AC",
    "level4_name": "Corticosteroids for local oral treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2044,
    "name": "TRIAMCINOLONE HEXACETONIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Ester form (hexacetonide); WHO lists as triamcinolone"
  },
  {
    "id": 1136,
    "name": "TRIAMTERENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03DB",
    "level4_name": "Other potassium-sparing agents",
    "ahfs_category": "40:28.16 - Potassium-sparing Diuretics - 382337",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 587,
    "name": "TRIAZOLAM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CD",
    "level4_name": "Benzodiazepine derivatives",
    "ahfs_category": "28:24.08 - Benzodiazepines - 384004",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1137,
    "name": "TRICHLORMETHIAZIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C03AA",
    "level4_name": "Thiazides, plain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 728,
    "name": "TRICLABENDAZOLE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P02BX",
    "level4_name": "Other antitrematodal agents",
    "ahfs_category": "8:08 - Anthelmintics - 379185",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 668,
    "name": "TRICLOFOS",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CM",
    "level4_name": "Other hypnotics and sedatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 237,
    "name": "TRICLOSAN",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "D08AE",
    "level4_name": "Phenol and derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2045,
    "name": "TRIDIHEXETHYL CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A03AB",
    "level4_name": "Synthetic anticholinergics, quaternary ammonium compounds",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 887,
    "name": "TRIENTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "64:00 - Heavy Metal Antagonists - 317042",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2046,
    "name": "TRIENTINE TETRAHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1192,
    "name": "TRIFAROTENE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D10AD",
    "level4_name": "Retinoids for topical use in acne",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 616,
    "name": "TRIFLUOPERAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AB",
    "level4_name": "Phenothiazines with piperazine structure",
    "ahfs_category": "28:16.08.24 - Phenothiazines - 382121",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 608,
    "name": "TRIFLUPROMAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AA",
    "level4_name": "Phenothiazines with aliphatic side-chain",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 250,
    "name": "TRIFLURIDINE",
    "status": "ALLOWED",
    "topical_only": true,
    "level4_code": "S01AD",
    "level4_name": "Antivirals",
    "ahfs_category": "52:04.20 - Antivirals - 382276",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 888,
    "name": "TRIHEPTANOIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1551,
    "name": "TRIHEXYPHENIDYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N04AA",
    "level4_name": "Tertiary amines",
    "ahfs_category": "28:36.08 - Anticholinergic Agents - 382160",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1741,
    "name": "TRILACICLIB DIHYDROCHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AF",
    "level4_name": "Detoxifying agents for antineoplastic treatment",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 675,
    "name": "TRIMEPRAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name: trimeprazine; WHO/INN name: alimemazine. Antihistamine/sedative (phenothiazine derivative). Completely different from trimipramine (antidepressant). Corrected 2025-10-16."
  },
  {
    "id": 2047,
    "name": "TRIMETA PHOSPHATES KIT",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Historical bone imaging agent; Technetium Tc-99M Trimeta Phosphates (sodium trimetaphosphate with Tc-99m and stannous ion) studied as bone-visualizing agent in 1970s animal studies; largely superseded by modern bone scanning agents (Tc-99m MDP/HDP) which became standard; no current FDA-approved product found; historical radiopharmaceutical no longer in clinical use"
  },
  {
    "id": 1552,
    "name": "TRIMETHADIONE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N03AC",
    "level4_name": "Oxazolidine derivatives",
    "ahfs_category": "28:12.16 - Oxazolidinediones - 379186",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 2048,
    "name": "TRIMETHAPHAN CAMSYLATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; no longer in WHO ATC database"
  },
  {
    "id": 1638,
    "name": "TRIMETHOBENZAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AA",
    "level4_name": "Aminoalkyl ethers",
    "ahfs_category": "56:22.08 - Antihistamines - 382693",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1385,
    "name": "TRIMETHOPRIM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01EA",
    "level4_name": "Trimethoprim and derivatives",
    "ahfs_category": "8:36 - Urinary Anti-infectives - 384025",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2049,
    "name": "TRIMETREXATE GLUCURONATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "P01AX",
    "level4_name": "Other agents against amoebiasis and other protozoal diseases",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 676,
    "name": "TRIMIPRAMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "N06AA",
    "level4_name": "Non-selective monoamine reuptake inhibitors",
    "ahfs_category": "28:16.04.28 - Tricyclics and Other Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1193,
    "name": "TRIOXSALEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D05AD",
    "level4_name": "Psoralens for topical use",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1194,
    "name": "TRIPELENNAMINE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1639,
    "name": "TRIPROLIDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R06AX",
    "level4_name": "Other antihistamines for systemic use",
    "ahfs_category": "4:04 - First Generation Antihistamines - 382533",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 538,
    "name": "TRIPTORELIN PAMOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02AE",
    "level4_name": "Gonadotropin releasing hormone analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1386,
    "name": "TRISULFAPYRIMIDINES",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01EB",
    "level4_name": "Short-acting sulfonamides",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1553,
    "name": "TROFINETIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 889,
    "name": "TROGLITAZONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A10BG",
    "level4_name": "Thiazolidinediones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2052,
    "name": "TROLAMINE POLYPEPTIDE OLEATE CONDENSATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D03AX",
    "level4_name": "Other cicatrizants",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 298,
    "name": "TROLEANDOMYCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J01FA",
    "level4_name": "Macrolides",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 1195,
    "name": "TROMETHAMINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "D04AA",
    "level4_name": "Antihistamines for topical use",
    "ahfs_category": "40:08 - Alkalinizing Agents - 382171",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1673,
    "name": "TROPICAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01FA",
    "level4_name": "Anticholinergics",
    "ahfs_category": "52:24 - Mydriatics - 382353",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 154,
    "name": "TROSPIUM CHLORIDE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A12CA",
    "level4_name": "Sodium",
    "ahfs_category": "86:12.04 - Antimuscarinics - 304019",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Salt form (chloride) removed for WHO mapping"
  },
  {
    "id": 1387,
    "name": "TROVAFLOXACIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01MA",
    "level4_name": "Fluoroquinolones",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1674,
    "name": "TRYPAN BLUE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01KX",
    "level4_name": "Other surgical aids",
    "ahfs_category": "36:58 - Ocular Disorders - 379188",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2053,
    "name": "TUBOCURARINE CHLORIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AA",
    "level4_name": "Curare alkaloids",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 539,
    "name": "TUCATINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EH",
    "level4_name": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1640,
    "name": "TYLOXAPOL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "R05CA",
    "level4_name": "Expectorants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2054,
    "name": "TYROPANOATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V08AC",
    "level4_name": "Watersoluble, hepatotropic X-ray contrast media",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 2055,
    "name": "TYROSINE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H03BX",
    "level4_name": "Other antithyroid preparations",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 2292,
    "name": "Tagraxofusp-erzs",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 319006",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2105,
    "name": "Taliglucerase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 313018",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2293,
    "name": "Talimogene Laherparepvec",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XL",
    "level4_name": "Antineoplastic cell and gene therapy",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316007",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2294,
    "name": "Tenecteplase",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AD",
    "level4_name": "Enzymes",
    "ahfs_category": "20:12.20 - Thrombolytic Agents - 300037",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2134,
    "name": "Tetanus Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 382804",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2088,
    "name": "Thrombin Alfa",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BC",
    "level4_name": "Local hemostatics",
    "ahfs_category": "20:28.16 - Hemostatics - 308035",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2328,
    "name": "Thyroid, Desiccated",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "H03AA",
    "level4_name": "Thyroid hormones",
    "ahfs_category": "68:36.04 - Thyroid Agents",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2227,
    "name": "Tildrakizumab-asmn",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2295,
    "name": "Tiludronate",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": "92:24 - Bone Resorption Inhibitors - 379182",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2228,
    "name": "Tocilizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2229,
    "name": "Trastuzumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FD",
    "level4_name": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 399019",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2296,
    "name": "Trifluridine and Tipiracil",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01AD",
    "level4_name": "Antivirals",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316030",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2297,
    "name": "Triptorelin",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L02AE",
    "level4_name": "Gonadotropin releasing hormone analogues",
    "ahfs_category": "68:18.08 - Gonadotropins - 300033",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2321,
    "name": "Typhoid Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07AE",
    "level4_name": "Cholera vaccines",
    "ahfs_category": "80:12 - Vaccines - 382812",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 1554,
    "name": "UBROGEPANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 134,
    "name": "ULIPRISTAL",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "G03AD",
    "level4_name": "Emergency contraceptives",
    "ahfs_category": "68:12 - Contraceptives - 310026",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 540,
    "name": "UMBRALISIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1641,
    "name": "UMECLIDINIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03BB",
    "level4_name": "Anticholinergics",
    "ahfs_category": "12:08.08 - Antimuscarinics/Antispasmodics - 315039",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2058,
    "name": "UNDECOYLIUM CHLORIDE COMPLEX",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Antiseptic ingredient with limited FDA approval; undecoylium chloride iodine complex is cationic detergent/topical antigermicidal agent first approved 1964; subject to FDA final rule on consumer antiseptics; not demonstrated eligible for OTC Drug Review as hand rub or surgical scrub; limited to specific antiseptic uses requiring separate approval; largely obsolete"
  },
  {
    "id": 2059,
    "name": "UNOPROSTONE ISOPROPYL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01EE",
    "level4_name": "Prostaglandin analogues",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 541,
    "name": "UPADACITINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AF",
    "level4_name": "Janus-associated kinase (JAK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2060,
    "name": "URACIL MUSTARD",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; alkylating chemotherapy agent (uramustine) for lymphomas; discontinued by FDA in 1999"
  },
  {
    "id": 2062,
    "name": "UREA C-13",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1996 for Helicobacter pylori breath test; still used but limited availability"
  },
  {
    "id": 890,
    "name": "URIDINE TRIACETATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A16AX",
    "level4_name": "Various alimentary tract and metabolism products",
    "ahfs_category": "92:12 - Antidotes - 317028",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2063,
    "name": "URSODIOL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "56:14 - Cholelitholytic Agents - 308020",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "US name (USAN): ursodiol; WHO name (INN): ursodeoxycholic acid. Bile acid for gallstones. Mapped 2025-10-16."
  },
  {
    "id": 2230,
    "name": "Ustekinumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AC",
    "level4_name": "Interleukin inhibitors",
    "ahfs_category": "84:92 - Skin and Mucous Membrane Agents,",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2064,
    "name": "VABORBACTAM",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J01DH",
    "level4_name": "Carbapenems",
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Found in WHO as combination product: meropenem and vaborbactam"
  },
  {
    "id": 947,
    "name": "VADADUSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B03XA",
    "level4_name": "Other antianemic preparations",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1388,
    "name": "VALACYCLOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 395010",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1555,
    "name": "VALBENAZINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": "28:56 - Vesicular Monoamine Transporter 2 (VMAT2)",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1442,
    "name": "VALDECOXIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M01AH",
    "level4_name": "Coxibs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1389,
    "name": "VALGANCICLOVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": "8:18.32 - Nucleosides and Nucleotides - 301022",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 686,
    "name": "VALPROATE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AB",
    "level4_name": "Selective serotonin reuptake inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1556,
    "name": "VALPROIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AG",
    "level4_name": "Fatty acid derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 542,
    "name": "VALRUBICIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01DB",
    "level4_name": "Anthracyclines and related substances",
    "ahfs_category": "10:00 - Antineoplastic Agents - 300020",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1138,
    "name": "VALSARTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C09CA",
    "level4_name": "Angiotensin II receptor blockers (ARBs), plain",
    "ahfs_category": "24:32.08 - Angiotensin II Receptor Antagonists - 397015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1279,
    "name": "VAMOROLONE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H02AB",
    "level4_name": "Glucocorticoids",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 891,
    "name": "VANCOMYCIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A07AA",
    "level4_name": "Antibiotics",
    "ahfs_category": "8:12.28.16 - Glycopeptides - 382751",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 543,
    "name": "VANDETANIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EX",
    "level4_name": "Other protein kinase inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 311024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1642,
    "name": "VANZACAFTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R07AX",
    "level4_name": "Other respiratory system products",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1241,
    "name": "VARDENAFIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BE",
    "level4_name": "Drugs used in erectile dysfunction",
    "ahfs_category": "24:12.12 - Phosphodiesterase Type 5 Inhibitors - 303041",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1557,
    "name": "VARENICLINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07BA",
    "level4_name": "Drugs used in nicotine dependence",
    "ahfs_category": "12:92 - Autonomic Drugs, Miscellaneous - 306019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1280,
    "name": "VASOPRESSIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "H01BA",
    "level4_name": "Vasopressin and analogues",
    "ahfs_category": "68:28 - Pituitary - 382596",
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 2065,
    "name": "VASOPRESSIN TANNATE",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Discontinued medication; vasopressin tannate in oil (Pitressin Tannate) for diabetes insipidus; withdrawn from market in 1998 (commercial reasons, not safety)"
  },
  {
    "id": 1443,
    "name": "VECURONIUM BROMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M03AC",
    "level4_name": "Other quaternary ammonium compounds",
    "ahfs_category": "12:20.20 - Neuromuscular Blocking Agents - 385026",
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 2066,
    "name": "VELPATASVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Velpatasvir is an active component; WHO lists as part of triple combination therapy"
  },
  {
    "id": 544,
    "name": "VEMURAFENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EC",
    "level4_name": "B-Raf serine-threonine kinase (BRAF) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312001",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 545,
    "name": "VENETOCLAX",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "10:00 - Antineoplastic Agents - 316031",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 698,
    "name": "VENLAFAXINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.16 - Selective Serotonin- and Norepinephrine-",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1139,
    "name": "VERAPAMIL",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C08DA",
    "level4_name": "Phenylalkylamine derivatives",
    "ahfs_category": "24:28.92 - Calcium-Channel Blocking Agents,",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2067,
    "name": "VERATRUM VIRIDE ROOT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C02KA",
    "level4_name": "Alkaloids, excl. rauwolfia",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 1140,
    "name": "VERICIGUAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "C01DX",
    "level4_name": "Other vasodilators used in cardiac diseases",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1675,
    "name": "VERTEPORFIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01LA",
    "level4_name": "Antineovascularisation agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1242,
    "name": "VIBEGRON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "G04BD",
    "level4_name": "Drugs for urinary frequency and incontinence",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1390,
    "name": "VIDARABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AB",
    "level4_name": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1558,
    "name": "VIGABATRIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AG",
    "level4_name": "Fatty acid derivatives",
    "ahfs_category": "28:12.92 - Anticonvulsants, Miscellaneous - 310015",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2068,
    "name": "VILANTEROL TRIFENATATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03AK",
    "level4_name": "Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Automatically mapped via name_variant search on 2025-10-16"
  },
  {
    "id": 703,
    "name": "VILAZODONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.24 - Serotonin Modulators - 311016",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 695,
    "name": "VILOXAZINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1444,
    "name": "VILTOLARSEN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M09AX",
    "level4_name": "Other drugs for disorders of the musculo-skeletal system",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2069,
    "name": "VIMSELTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved May 8, 2025 (Turalio) for TGCT"
  },
  {
    "id": 546,
    "name": "VINBLASTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CA",
    "level4_name": "Vinca alkaloids and analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382848",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 547,
    "name": "VINCRISTINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CA",
    "level4_name": "Vinca alkaloids and analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 382822",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 548,
    "name": "VINORELBINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01CA",
    "level4_name": "Vinca alkaloids and analogues",
    "ahfs_category": "10:00 - Antineoplastic Agents - 395013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1391,
    "name": "VIOMYCIN",
    "status": "DISCONTINUED",
    "topical_only": false,
    "level4_code": "J04AB",
    "level4_name": "Antibiotics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Discontinued medication; WHO ATC code preserved for historical reference"
  },
  {
    "id": 549,
    "name": "VISMODEGIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XJ",
    "level4_name": "Hedgehog pathway inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 312012",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 948,
    "name": "VITAMIN A",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11CA",
    "level4_name": "Vitamin A, plain",
    "ahfs_category": "88:04 - Vitamin A - 382592",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 949,
    "name": "VITAMIN E",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A11HA",
    "level4_name": "Other plain vitamin preparations",
    "ahfs_category": "88:20 - Vitamin E - 382584",
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 950,
    "name": "VITAMIN K",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "B02BA",
    "level4_name": "Vitamin K",
    "ahfs_category": null,
    "who_mapping_type": "corrected_direct_match",
    "who_mapping_notes": "Corrected by validation script on 2025-10-16"
  },
  {
    "id": 550,
    "name": "VOCLOSPORIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AD",
    "level4_name": "Calcineurin inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 892,
    "name": "VONOPRAZAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "A02BC",
    "level4_name": "Proton pump inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 951,
    "name": "VORAPAXAR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AC",
    "level4_name": "Platelet aggregation inhibitors excl. heparin",
    "ahfs_category": "20:12.18 - Platelet-aggregation Inhibitors - 316013",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 551,
    "name": "VORASIDENIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XM",
    "level4_name": "Isocitrate dehydrogenase (IDH) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 104,
    "name": "VORICONAZOLE",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J02AC",
    "level4_name": "Triazole and tetrazole derivatives",
    "ahfs_category": "8:14.08 - Azoles - 302024",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 552,
    "name": "VORINOSTAT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XH",
    "level4_name": "Histone deacetylase (HDAC) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 307009",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 704,
    "name": "VORTIOXETINE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": "28:16.04.24 - Serotonin Modulators - 314019",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1445,
    "name": "VOSORITIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BX",
    "level4_name": "Other drugs affecting bone structure and mineralization",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 952,
    "name": "VOXELOTOR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B06AX",
    "level4_name": "Other hematological agents",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2070,
    "name": "VOXILAPREVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "8:18.40.20 - HCV Protease Inhibitors - 379192",
    "who_mapping_type": "combination_component",
    "who_mapping_notes": "Voxilaprevir is HCV antiviral; WHO lists only as triple combination J05AP56 (sofosbuvir, velpatasvir and voxilaprevir). Corrected 2025-10-16."
  },
  {
    "id": 1559,
    "name": "VUTRISIRAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N07XX",
    "level4_name": "Other nervous system drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2322,
    "name": "Vaccine Adsorbed (DTaP/Tdap)",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "80:08 - Toxoids - 382198",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2135,
    "name": "Vaccinia Immune Globulin IV",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 305009",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2323,
    "name": "Vaccinia Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 379189",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2324,
    "name": "Varicella Virus Vaccine Live",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07XA",
    "level4_name": "Parasitic vaccines",
    "ahfs_category": "80:12 - Vaccines - 397005",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2136,
    "name": "Varicella Zoster Immune Globulin",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J06BD",
    "level4_name": "Antiviral monoclonal antibodies",
    "ahfs_category": "80:04 - Antitoxins and Immune Globulins - 384038",
    "who_mapping_type": "AHFS_CATEGORY_APPROXIMATION",
    "who_mapping_notes": "Approximated based on AHFS_CATEGORY_APPROXIMATION"
  },
  {
    "id": 2231,
    "name": "Vedolizumab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AG",
    "level4_name": "Monoclonal antibodies",
    "ahfs_category": "56:92 - GI Drugs, Miscellaneous - 315017",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2106,
    "name": "Velaglucerase Alfa",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 313012",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2107,
    "name": "Vestronidase Alfa-vjbk",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "A16AB",
    "level4_name": "Enzymes",
    "ahfs_category": "44:00 - Enzymes - 317066",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2122,
    "name": "Von Willebrand Factor (recombinant)",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BD",
    "level4_name": "Blood coagulation factors",
    "ahfs_category": "20:28.16 - Hemostatics - 317006",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2298,
    "name": "Voretigene Neparvovec-rzyl",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "S01XA",
    "level4_name": "Other ophthalmologicals",
    "ahfs_category": "26:12 - Gene Therapy - 379191",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 953,
    "name": "WARFARIN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B01AA",
    "level4_name": "Vitamin K antagonists",
    "ahfs_category": "20:12.04.08 - Coumarin Derivatives - 382277",
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2071,
    "name": "XANOMELINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Too new for WHO ATC database; FDA approved September 2024 (Cobenfy, with trospium) for schizophrenia - first new mechanism in 70 years"
  },
  {
    "id": 2072,
    "name": "XENON XE-127",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09EX",
    "level4_name": "Other respiratory system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2073,
    "name": "XENON XE-129 HYPERPOLARIZED",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09EX",
    "level4_name": "Other respiratory system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2074,
    "name": "XENON XE-133",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V09EX",
    "level4_name": "Other respiratory system diagnostic radiopharmaceuticals",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 2075,
    "name": "XYLOSE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "Diagnostic agent with limited use; D-xylose absorption test for malabsorption; no longer routinely ordered and may not be available everywhere; major gastroenterology organizations do not include in malabsorption evaluation guidelines"
  },
  {
    "id": 2325,
    "name": "Yellow Fever Vaccine",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": "J07BL",
    "level4_name": "Yellow fever vaccines",
    "ahfs_category": "",
    "who_mapping_type": "VACCINE",
    "who_mapping_notes": null
  },
  {
    "id": 2232,
    "name": "Yttrium-90 Ibritumomab tiuxetan",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 1643,
    "name": "ZAFIRLUKAST",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "R03DC",
    "level4_name": "Leukotriene receptor antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1392,
    "name": "ZALCITABINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 593,
    "name": "ZALEPLON",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CF",
    "level4_name": "Benzodiazepine related drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1393,
    "name": "ZANAMIVIR",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AH",
    "level4_name": "Neuraminidase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 553,
    "name": "ZANUBRUTINIB",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01EL",
    "level4_name": "Bruton's tyrosine kinase (BTK) inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1560,
    "name": "ZAVEGEPANT",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CD",
    "level4_name": "Calcitonin gene-related peptide (CGRP) antagonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1561,
    "name": "ZICONOTIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02BG",
    "level4_name": "Other analgesics and antipyretics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1394,
    "name": "ZIDOVUDINE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "J05AF",
    "level4_name": "Nucleoside and nucleotide reverse transcriptase inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2076,
    "name": "ZILEUTON",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": null,
    "who_mapping_type": "not_in_who",
    "who_mapping_notes": "FDA approved 1996 (Zyflo) for asthma - leukotriene synthesis inhibitor; still marketed"
  },
  {
    "id": 554,
    "name": "ZILUCOPLAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AJ",
    "level4_name": "Complement inhibitors",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 626,
    "name": "ZIPRASIDONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05AE",
    "level4_name": "Indole derivatives",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1742,
    "name": "ZIRCONIUM CYCLOSILICATE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AE",
    "level4_name": "Drugs for treatment of hyperkalemia and hyperphosphatemia",
    "ahfs_category": null,
    "who_mapping_type": "name_variant",
    "who_mapping_notes": "Name variant: US/FDA name differs from WHO/INN name or salt/ester form removed"
  },
  {
    "id": 1446,
    "name": "ZOLEDRONIC ACID",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "M05BA",
    "level4_name": "Bisphosphonates",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1562,
    "name": "ZOLMITRIPTAN",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N02CC",
    "level4_name": "Selective serotonin (5HT1) agonists",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 592,
    "name": "ZOLPIDEM",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N05CF",
    "level4_name": "Benzodiazepine related drugs",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 1563,
    "name": "ZONISAMIDE",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "N03AX",
    "level4_name": "Other antiepileptics",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 707,
    "name": "ZURANOLONE",
    "status": "NOT_ALLOWED",
    "topical_only": false,
    "level4_code": "N06AX",
    "level4_name": "Other antidepressants",
    "ahfs_category": null,
    "who_mapping_type": "exact",
    "who_mapping_notes": "Direct match: active moiety name matches WHO substance name"
  },
  {
    "id": 2233,
    "name": "Ziv-aflibercept",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01XX",
    "level4_name": "Other antineoplastic agents",
    "ahfs_category": "",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2326,
    "name": "Zoster Vaccine Live",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2327,
    "name": "Zoster Vaccine Recombinant",
    "status": "ALLOWED",
    "topical_only": false,
    "level4_code": null,
    "level4_name": null,
    "ahfs_category": "",
    "who_mapping_type": null,
    "who_mapping_notes": null
  },
  {
    "id": 2234,
    "name": "idaruCIZUmab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "V03AB",
    "level4_name": "Antidotes",
    "ahfs_category": "20:28.92 - Antihemorrhagic Agents, Miscellaneous -",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2235,
    "name": "inFLIXimab, -abda, -dyyb, -qbtx",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L04AB",
    "level4_name": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
    "ahfs_category": "92:36 - Disease-modifying Antirheumatic Drugs -",
    "who_mapping_type": "PARTIAL_NAME",
    "who_mapping_notes": "Approximated based on PARTIAL_NAME"
  },
  {
    "id": 2236,
    "name": "riTUXimab",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "L01FA",
    "level4_name": "CD20 (Clusters of Differentiation 20) inhibitors",
    "ahfs_category": "10:00 - Antineoplastic Agents - 398003",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  },
  {
    "id": 2299,
    "name": "romiPLOStim",
    "status": "TARGET_FOR_MODERNIZATION",
    "topical_only": false,
    "level4_code": "B02BX",
    "level4_name": "Other systemic hemostatics",
    "ahfs_category": "20:16 - Hematopoietic Agents - 308030",
    "who_mapping_type": "EXACT",
    "who_mapping_notes": null
  }
]